462-06-6 | Fluorobenzene

Packsize	Purity	Availability	Price	Discounted Price
25g	99%	in stock	$18.00	$12.00
100g	99%	in stock	$30.00	$21.00
500g	99%	in stock	$108.00	$75.00

Description

• Catalog Number: AB46161
• Chemical Name: Fluorobenzene
• CAS Number: 462-06-6
• Molecular Formula: C6H5F
• Molecular Weight: 96.1023
• MDL Number: MFCD00000280
• SMILES: Fc1ccccc1
• NSC Number: 68416

Computed Properties

• Complexity: 46.1
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 7
• Hydrogen Bond Acceptor Count: 1
• XLogP3: 2.3

Literature

• Structure-activity relationship study of Aib-containing amphipathic helical peptide-cyclic RGD conjugates as carriers for siRNA delivery.

  Bioorganic & medicinal chemistry letters 20171215

• Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes.

  Toxicology in vitro : an international journal published in association with BIBRA 20140901

• Attenuated effects of Neu2000 on hypoxia-induced synaptic activities in a rat hippocampus.

  Archives of pharmacal research 20140201

• Why receptor reserve matters for neurokinin1 (NK1) receptor antagonists.

  Journal of receptor and signal transduction research 20131201

• Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.

  Sleep 20131201

• 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.

  Synapse (New York, N.Y.) 20121201

• Disposition of atorvastatin, rosuvastatin, and simvastatin in oatp1b2-/- mice and intraindividual variability in human subjects.

  Journal of clinical pharmacology 20121101

• Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia.

  Pharmacogenetics and genomics 20121101

• Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.

  Journal of vascular surgery 20121101

• The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems.

  Drug metabolism and disposition: the biological fate of chemicals 20121101

• Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemia.

  Journal of lipid research 20121101

• Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.

  Upsala journal of medical sciences 20121101

• Isolated cationic crown ether complexes of gallium(I) and indium(I).

  Dalton transactions (Cambridge, England : 2003) 20121021

• Full dimensional quantum-mechanical simulations for the vibronic dynamics of difluorobenzene radical cation isomers using the multilayer multiconfiguration time-dependent Hartree method.

  The Journal of chemical physics 20121007

• Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism.

  Nutrition, metabolism, and cardiovascular diseases : NMCD 20121001

• Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.

  Cardiovascular therapeutics 20121001

• 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.

  The international journal of neuropsychopharmacology 20121001

• Effect of statins on coronary bifurcation atherosclerosis: an intravascular ultrasound virtual histology study.

  The international journal of cardiovascular imaging 20121001

• Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions.

  International journal of clinical pharmacology and therapeutics 20121001

• Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20121001

• Resonance-enhanced two-photon ionization spectroscopy and theoretical calculations of 3,5-difluoroanisole and its Ar-containing complex.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121001

• Effect of rosuvastatin on the echolucency of the common carotid intima-media in low-risk individuals: the METEOR trial.

  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20121001

• Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.

  Atherosclerosis 20121001

• Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.

  Cardiovascular drugs and therapy 20121001

• 5-Ethyl-3-(2-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20121001

• 6-Bromo-4-[2-(4-fluoro-benzyl-idene)hydrazin-1-yl-idene]-1-methyl-3,4-dihydro-1H-2λ(6),1-benzothia-zine-2,2-dione.

  Acta crystallographica. Section E, Structure reports online 20121001

• 2-(4-Fluoro-phen-yl)-1-(4-methyl-phen-yl)-1H-phenanthro[9,10-d]imidazole.

  Acta crystallographica. Section E, Structure reports online 20121001

• 3-(3-Fluoro-phenyl-sulfin-yl)-5-iodo-2,7-dimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20121001

• Ethyl 6-(4-bromo-phen-yl)-4-(4-fluoro-phen-yl)-2-oxocyclo-hex-3-ene-1-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20121001

• 3-Ethyl-sulfinyl-2-(3-fluoro-phen-yl)-5-iodo-7-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20121001

• N-(2,3-Dimethyl-phen-yl)-4-fluoro-N-[(4-fluoro-phen-yl)sulfon-yl]benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20121001

• Propan-2-yl r-4-(4-fluoro-phen-yl)-3-hy-droxy-c-6-methyl-2-phenyl-4,5-dihydro-2H-indazole-t-5-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20121001

• 7-Bromo-1-(3-fluoro-phenyl-sulfon-yl)-2-methyl-naphtho-[2,1-b]furan.

  Acta crystallographica. Section E, Structure reports online 20121001

• Hydrodefluorination and hydrogenation of fluorobenzene under mild aqueous conditions.

  Environmental science & technology 20120918

• Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.

  European journal of pharmacology 20120915

• Effects of rosuvastatin versus pravastatin on low-density lipoprotein diameter in HIV-1-infected patients receiving ritonavir-boosted protease inhibitor.

  AIDS (London, England) 20120910

• The therapeutic effect of rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats.

  Journal of cellular and molecular medicine 20120901

• Degradation of difluorobenzenes by the wild strain Labrys portucalensis.

  Biodegradation 20120901

• Use of uptake intrinsic clearance from attached rat hepatocytes to predict hepatic clearance for poorly permeable compounds.

  Xenobiotica; the fate of foreign compounds in biological systems 20120901

• Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.

  European heart journal 20120901

• Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20120901

• Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER.

  Nutrition, metabolism, and cardiovascular diseases : NMCD 20120901

• Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.

  Oncology reports 20120901

• Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.

  European journal of heart failure 20120901

• Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome.

  International journal of clinical practice 20120901

• 4-(4-Fluoro-phen-yl)-3-(pyridin-4-yl)-1-(2,4,6-trichloro-phen-yl)-1H-pyrazol-5-amine.

  Acta crystallographica. Section E, Structure reports online 20120901

• 1-[4-(4-Fluoro-phen-yl)-6-methyl-2-sulfanyl-idene-1,2,3,4-tetra-hydro-pyrimidin-5-yl]ethanone.

  Acta crystallographica. Section E, Structure reports online 20120901

• 2-(4-Fluoro-phen-yl)-1-phenyl-1H-benzimidazole.

  Acta crystallographica. Section E, Structure reports online 20120901

• 3-(2-Fluoro-phenyl-sulfin-yl)-2,4,5,6-tetra-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120901

• Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: role of signaling pathways and therapeutic impact of rosuvastatin.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120815

• Caveolin-1-eNOS/Hsp70 interactions mediate rosuvastatin antifibrotic effects in neonatal obstructive nephropathy.

  Nitric oxide : biology and chemistry 20120815

• Balancing the cardiometabolic benefits and risks of statins.

  Lancet (London, England) 20120811

• Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.

  Lancet (London, England) 20120811

• Univalent gallium and indium phosphane complexes: from pyramidal M(PPh3)3(+) to carbene-analogous bent M(PtBu3)2(+) (M=Ga, In) complexes.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120806

• Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.

  British journal of clinical pharmacology 20120801

• Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats.

  Xenobiotica; the fate of foreign compounds in biological systems 20120801

• MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.

  Clinical science (London, England : 1979) 20120801

• Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.

  Metabolism: clinical and experimental 20120801

• Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.

  Clinical science (London, England : 1979) 20120801

• Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.

  Journal of cardiovascular pharmacology 20120801

• CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation.

  The American journal of pathology 20120801

• Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II.

  Bioorganic & medicinal chemistry 20120801

• Glutamine suppresses dinitrophenol fluorobenzene-induced allergic contact dermatitis and itching: inhibition of contact dermatitis by glutamine.

  Journal of dermatological science 20120801

• Predictive value of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for the prevention of stroke recurrence in Japanese patients treated with rosuvastatin.

  Clinical drug investigation 20120801

• Effects of statin treatments and polymorphisms in UGT1A1 and SLCO1B1 on serum bilirubin levels in Chinese patients with hypercholesterolaemia.

  Atherosclerosis 20120801

• N-(2-Fluoro-benz-yloxy)-1,3,5-trimethyl-2,6-diphenyl-piperidin-4-imine.

  Acta crystallographica. Section E, Structure reports online 20120801

• (2E)-1-(4,4''-Difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)-3-[4-(methyl-sulfan-yl)phen-yl]prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120801

• (E)-2-[2-(3-Fluoro-phen-yl)ethen-yl]quinolin-8-yl acetate.

  Acta crystallographica. Section E, Structure reports online 20120801

• 5-Fluoro-3-(3-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120801

• 5-Bromo-3-(3-fluoro-phenyl-sulfin-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120801

• Synthesis and structure-activity relationship study of 2-(substituted benzylidene)-7-(4-fluorophenyl)-5-(furan-2-yl)-2H-thiazolo[3,2-a]pyrimidin-3(7H)-one derivatives as anticancer agents.

  Drug discoveries & therapeutics 20120801

• Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.

  International journal of cardiology 20120726

• Rosuvastatin combined with ramipril significantly reduced atheroma volume by anti-inflammatory mechanism: comparative analysis with rosuvastatin alone by intravascular ultrasound.

  International journal of cardiology 20120712

• Formation of highly ordered and orientated gold islands: effect of immersion time on the molecular adlayer structure of pentafluorobenzenethiols (PFBT) SAMs on Au(111).

  Langmuir : the ACS journal of surfaces and colloids 20120710

• Statins: the good, the bad and the ugly.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120710

• Pentafluorophenyl ester-functionalized phosphorylcholine polymers: preparation of linear, two-arm, and grafted polymer-protein conjugates.

  Biomacromolecules 20120709

• Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.

  Synapse (New York, N.Y.) 20120701

• Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats.

  Toxicology mechanisms and methods 20120701

• Rosuvastatin improves pulse wave reflection by restoring endothelial function.

  Microvascular research 20120701

• The farnesoid X receptor -1G>T polymorphism influences the lipid response to rosuvastatin.

  Journal of lipid research 20120701

• Simultaneous and spontaneous bilateral quadriceps tendons rupture.

  American journal of physical medicine & rehabilitation 20120701

• Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.

  Atherosclerosis 20120701

• Non-every day statin administration--a literature review.

  European journal of internal medicine 20120701

• Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.

  Pharmacotherapy 20120701

• GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

  Translational psychiatry 20120701

• (2E)-1-(4,4''-Difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)-3-(2-fluoro-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120701

• 1-(3-Fluoro-phen-yl)-3-(4-nitro-phen-yl)urea.

  Acta crystallographica. Section E, Structure reports online 20120701

• 2-Fluoro-5-(4-fluoro-phen-yl)pyridine.

  Acta crystallographica. Section E, Structure reports online 20120701

• Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.

  Chinese medical journal 20120701

• Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.

  The Journal of heart valve disease 20120701

• Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.

  International journal of cardiology 20120628

• Synthesis and evaluation of novologues as C-terminal Hsp90 inhibitors with cytoprotective activity against sensory neuron glucotoxicity.

  Journal of medicinal chemistry 20120628

• The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).

  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120620

• Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).

  The American journal of cardiology 20120615

• Bis-pentafluorobenzyl derivatives of N-acetyl-L-methionine and N-acetyl-L-selenomethionine for the quantitative determination in human plasma by gas chromatography-negative ion chemical ionisation mass spectrometry.

  Journal of chromatography. A 20120615

• Change in near-infrared spectroscopy of a coronary artery after 1-year treatment with high dose rosuvastatin.

  International journal of cardiology 20120614

• [Effects of domestic rosuvastatin on coronary plaque in patients with mild-to-moderate coronary artery stenosis as evaluated by virtual histology-intravascular ultrasound].

  Zhonghua yi xue za zhi 20120612

• [Effectiveness of generic rosuvastatin in patients with ischaemic cerebrovascular disease].

  Orvosi hetilap 20120603

• Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

  European journal of preventive cardiology 20120601

• Steady-state pharmacokinetic interactions of darunavir/ritonavir with lipid-lowering agent rosuvastatin.

  Journal of clinical pharmacology 20120601

• Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.

  Neuropharmacology 20120601

• Urinary concentrations of organophosphorus insecticide metabolites in Japanese workers.

  Chemosphere 20120601

• Multiple imputation of missing repeated outcome measurements did not add to linear mixed-effects models.

  Journal of clinical epidemiology 20120601

• Biologically implausible carotid intima-media thickness measurement values: effects on rate of change over time.

  Current medical research and opinion 20120601

• N⁴-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: cytotoxicity against human tumor cells, structure-activity relationship studies and investigation on the mechanism of action.

  Bioorganic & medicinal chemistry 20120601

• A review of time courses and predictors of lipid changes with fenofibric acid-statin combination.

  Cardiovascular drugs and therapy 20120601

• Rosuvastatin effect on intima media thickness in adult vs elderly patients.

  Frontiers in bioscience (Elite edition) 20120601

• 2-(3-Fluoro-phen-yl)-5-iodo-7-methyl-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120601

• (E)-1-(2,4-Dinitro-phen-yl)-2-[1-(3-fluoro-phen-yl)ethyl-idene]hydrazine.

  Acta crystallographica. Section E, Structure reports online 20120601

• 1-(4-Fluoro-phen-yl)-2-(phenyl-sulfon-yl)ethanone.

  Acta crystallographica. Section E, Structure reports online 20120601

• 5-[(4-Eth-oxy-anilino)meth-yl]-N-(2-fluoro-phen-yl)-6-methyl-2-phenyl-pyrimidin-4-amine.

  Acta crystallographica. Section E, Structure reports online 20120601

• 3-Amino-N-benzyl-6-(4-fluoro-phen-yl)thieno[2,3-b]pyridine-2-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20120601

• 2,2-Dibromo-N-(4-fluoro-phen-yl)acetamide.

  Acta crystallographica. Section E, Structure reports online 20120601

• (2E)-3-(4-Cyano-phen-yl)-1-(4,4''-difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120601

• 3-(2,4-Dichloro-phen-yl)-5-(4-fluoro-phen-yl)-2-phenyl-7-(trifluoro-meth-yl)pyrazolo-[1,5-a]pyrimidine.

  Acta crystallographica. Section E, Structure reports online 20120601

• 1-[Bis(4-fluoro-phen-yl)meth-yl]-4-[2-(naphthalen-2-yl-oxy)eth-yl]piperazine.

  Acta crystallographica. Section E, Structure reports online 20120601

• (E)-3-(2-Eth-oxy-phen-yl)-1-{4-[(2-fluoro-phen-yl)(4-fluoro-phen-yl)meth-yl]piperazin-1-yl}prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120601

• Severe hypertriglyceridaemia. Treatment with plasmapheresis.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514

• Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.

  Journal of medicinal chemistry 20120510

• Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.

  Immunobiology 20120501

• [Extrapolating the NNT jeopardises biostatistics and leads to immortality].

  Atencion primaria 20120501

• Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study.

  Diabetic medicine : a journal of the British Diabetic Association 20120501

• The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.

  Journal of internal medicine 20120501

• Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach.

  Journal of neurotrauma 20120501

• Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

• Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).

  The American journal of cardiology 20120501

• Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.

  Clinical chemistry 20120501

• Sample size requirements in trials using repeated measurements and the impact of trial design.

  Current medical research and opinion 20120501

• Statins and glycaemic control--a cause for concern?

  Diabetic medicine : a journal of the British Diabetic Association 20120501

• Rosuvastatin might have an effect on C-reactive protein but not on rheumatoid disease activity: Tayside randomized controlled study.

  Scottish medical journal 20120501

• 5-Bromo-2-(3-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120501

• 3-(2,4-Dichloro-phen-yl)-5-(4-fluoro-phen-yl)-2-methyl-7-(trifluoro-meth-yl)pyrazolo-[1,5-a]pyrimidine.

  Acta crystallographica. Section E, Structure reports online 20120501

• 1-(Adamantan-1-yl)-3-(4-fluoro-phen-yl)thio-urea.

  Acta crystallographica. Section E, Structure reports online 20120501

• (E)-3-(2-Chloro-phen-yl)-1-(4,4''-difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120501

• (2E)-1-(4,4''-Difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)-3-(2,6-difluoro-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120501

• Field evaluation of the Off! Clip-on Mosquito Repellent (metofluthrin) against Aedes albopictus and Aedes taeniorhynchus (Diptera: Culicidae) in northeastern Florida.

  Journal of medical entomology 20120501

• On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

  Journal of the American College of Cardiology 20120424

• The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120417

• Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active γ-secretase inhibitor.

  Journal of medicinal chemistry 20120412

• Two-dimensional laser induced fluorescence spectroscopy of van der Waals complexes: fluorobenzene-Ar(n) (n = 1,2).

  The Journal of chemical physics 20120407

• Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared to rosuvastatin 10 mg in high-risk patients with and without type 2 diabetes mellitus inadequately controlled despite prior statin monotherapy.

  Cardiovascular therapeutics 20120401

• Metabolic stress-induced inflammation plays a major role in the development of osteoarthritis in mice.

  Arthritis and rheumatism 20120401

• Understanding the interplay of drug transporters involved in the disposition of rosuvastatin in the isolated perfused rat liver using a physiologically-based pharmacokinetic model.

  Xenobiotica; the fate of foreign compounds in biological systems 20120401

• Effects of rosuvastatin on serum asymmetric dimethylarginine levels and atrial structural remodeling in atrial fibrillation dogs.

  Pacing and clinical electrophysiology : PACE 20120401

• One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20120401

• Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.

  Atherosclerosis 20120401

• Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

  Circulation. Cardiovascular genetics 20120401

• Determination of pharmaceuticals and antiseptics in water by solid-phase extraction and gas chromatography/mass spectrometry: analysis via pentafluorobenzylation and stable isotope dilution.

  Analytical and bioanalytical chemistry 20120401

• Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis.

  Cardiovascular drugs and therapy 20120401

• Efficient formation of heterodimers from peptides and proteins using unsymmetrical polyfluorophenyl esters of dicarboxylic acids.

  Journal of peptide science : an official publication of the European Peptide Society 20120401

• Targeting HDL-cholesterol to reduce residual cardiovascular risk.

  Current opinion in lipidology 20120401

• Reversible dysphasia and statins.

  Journal of Korean medical science 20120401

• Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK.

  Journal of computer-aided molecular design 20120401

• 1-[Bis(4-fluoro-phen-yl)meth-yl]-4-[2-(2-methyl-phen-oxy)eth-yl]piperazine.

  Acta crystallographica. Section E, Structure reports online 20120401

• 7-Benzyl-3-(4-fluoro-phen-yl)-2-propyl-amino-5,6,7,8-tetra-hydro-pyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20120401

• 4-[5-Amino-4-(4-fluoro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzo-nitrile.

  Acta crystallographica. Section E, Structure reports online 20120401

• 5-Cyclo-hexyl-2-(3-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120401

• 4-[Bis(4-fluoro-phen-yl)meth-yl]piperazin-1-ium bis-(trichloro-acetate) 0.4-hydrate.

  Acta crystallographica. Section E, Structure reports online 20120401

• (Z)-1-(2,4-Difluoro-phen-yl)-3-(4-fluoro-phen-yl)-2-(1H-1,2,4-triazol-1-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120401

• 2-(4-Fluoro-phen-yl)-5-iodo-3-phenyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120401

• Rosuvastatin attenuates mucus secretion in a murine model of chronic asthma by inhibiting the gamma-aminobutyric acid type A receptor.

  Chinese medical journal 20120401

• Highly efficient red phosphorescent organic light-emitting devices using iridium(III) complexes based on 2-(biphenyl-3-yl)quinoline derived ligands.

  Journal of nanoscience and nanotechnology 20120401

• Sonic hedgehog expression in corticofugal projection neurons directs cortical microcircuit formation.

  Neuron 20120322

• Formation of cationic [RP5Cl](+)-cages via insertion of [RPCl](+)-cations into a P-P bond of the P4 tetrahedron.

  Inorganic chemistry 20120319

• Metabolism of the insecticide metofluthrin in cabbage (Brassica oleracea).

  Journal of agricultural and food chemistry 20120314

• Wet chemical functionalization of III-V semiconductor surfaces: alkylation of gallium arsenide and gallium nitride by a Grignard reaction sequence.

  Langmuir : the ACS journal of surfaces and colloids 20120313

• Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.

  International journal of cardiology 20120308

• Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations.

  Journal of molecular modeling 20120301

• Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison.

  Journal of internal medicine 20120301

• The effects of rosuvastatin and the CYP51A1 inhibitor LEK-935 on the proteome of primary human hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20120301

• Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.

  Behavioural brain research 20120301

• Rosuvastatin elicits KDR-dependent vasculogenic response of human placental stem cells through PI3K/AKT pathway.

  Pharmacological research 20120301

• Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.

  Current medical research and opinion 20120301

• Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.

  Atherosclerosis 20120301

• Reactions within fluorobenzene-ammonia heterocluster ions: experiment and theory.

  The journal of physical chemistry. A 20120301

• Therapeutic options for statin-intolerant patients.

  Current medical research and opinion 20120301

• The work-up for mixed hyperlipidemia: a case study.

  The Journal of family practice 20120301

• Ethyl 2-amino-4,6-bis-(4-fluoro-phen-yl)cyclo-hexa-1,3-diene-1-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20120301

• 4-(4-Fluoro-phen-yl)-1-phenyl-3-(pyridin-4-yl)-1H-pyrazol-5-amine.

  Acta crystallographica. Section E, Structure reports online 20120301

• 4-(4-Fluoro-phen-yl)-1-(4-nitro-phen-yl)-3-(pyridin-4-yl)-1H-pyrazol-5-amine.

  Acta crystallographica. Section E, Structure reports online 20120301

• (6Z)-3,5-Bis(4-fluoro-phen-yl)-6-(1-hy-droxy-ethyl-idene)cyclo-hex-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120301

• 4-Methyl-2-oxo-2H-chromen-7-yl 4-fluoro-benzene-sulfonate.

  Acta crystallographica. Section E, Structure reports online 20120301

• (Z)-4-(3-Fluoro-phen-yl)-1-(5-nitro-2-oxo-indolin-3-yl-idene)thio-semicarbazide.

  Acta crystallographica. Section E, Structure reports online 20120301

• (2Z)-3-(4-Fluoro-anilino)-1-(5-hy-droxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)but-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20120301

• Effect of rosuvastatin on obesity-induced cardiac oxidative stress in Wistar rats--a preliminary study.

  Indian journal of experimental biology 20120301

• The importance of green chemistry in process research and development.

  Chemical Society reviews 20120221

• Oxidative trifluoromethylation of arylboronates with shelf-stable potassium (trifluoromethyl)trimethoxyborate.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120206

• Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.

  The Journal of pharmacology and experimental therapeutics 20120201

• Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20120201

• Rosuvastatin blocks hERG current and prolongs cardiac repolarization.

  Journal of pharmaceutical sciences 20120201

• Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.

  The American journal of cardiology 20120201

• Effect of pitavastatin vs. rosuvastatin on international normalized ratio in healthy volunteers on steady-state warfarin.

  Current medical research and opinion 20120201

• High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.

  European heart journal 20120201

• The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ('ecstasy'): a concurrent microdialysis and plasma analysis study.

  Hormones and behavior 20120201

• Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.

  Circulation. Cardiovascular genetics 20120201

• [HDL level or HDL function as the primary target in preventive cardiology].

  Herz 20120201

• A second monoclinic polymorph of {2,6-bis[(2,4,5-trifluoro-phen-yl)imino-meth-yl]pyridine-κN,N',N''}dichloridonickel(II).

  Acta crystallographica. Section E, Structure reports online 20120201

• 2-(4-Fluoro-phen-yl)-2H-chromen-4(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20120201

• 2-(4-Fluoro-phen-yl)-5,6-methyl-enedi-oxy-3-phenyl-sulfinyl-1-benzofuran monohydrate.

  Acta crystallographica. Section E, Structure reports online 20120201

• (E)-1-(2,4-Dinitro-phen-yl)-2-[1-(4-fluoro-phen-yl)ethyl-idene]hydrazine.

  Acta crystallographica. Section E, Structure reports online 20120201

• 2,2'-(Disulfanedi-yl)bis-[4,6-(4-fluoro-phen-yl)pyrimidine].

  Acta crystallographica. Section E, Structure reports online 20120201

• My patient has an elevated hs-CRP. What does this mean? What should I do now?

  JPMA. The Journal of the Pakistan Medical Association 20120201

• Synthesis and antidepressant-like activity of selenophenes obtained via iron(III)-PhSeSePh-mediated cyclization of Z-selenoenynes.

  Organic & biomolecular chemistry 20120128

• Impact of 10 mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers.

  Clinica chimica acta; international journal of clinical chemistry 20120118

• An unusual intramolecular transfer of the fluorobenzyl cation between two remote amidic nitrogen atoms induced by collision in the gas phase.

  Rapid communications in mass spectrometry : RCM 20120115

• A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein.

  International journal of cardiology 20120112

• Spectroscopic scanning tunneling microscopy studies of single surface-supported free-base corroles.

  Journal of the American Chemical Society 20120111

• Application of the dissociative electron transfer theory and its extension to the case of in-cage interactions in the electrochemical reduction of arene sulfonyl chlorides.

  Physical chemistry chemical physics : PCCP 20120107

• An electrochemical investigation of intermediates and processes involved in the catalytic reduction of dinitrogen by [HIPTN3N]Mo (HIPTN3N = (3,5-(2,4,6-i-Pr3C6H2)2C6H3NCH2CH2)3N).

  Dalton transactions (Cambridge, England : 2003) 20120107

• 5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study.

  Brain research bulletin 20120104

• Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

  NeuroImage 20120102

• Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.

  ChemMedChem 20120102

• Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats.

  Toxicology mechanisms and methods 20120101

• Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.

  Journal of cardiovascular pharmacology 20120101

• Extensive or restricted ultrasound protocols to measure carotid intima-media thickness: analysis of completeness rates and impact on observed rates of change over time.

  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20120101

• Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.

  American journal of physiology. Heart and circulatory physiology 20120101

• The biological activity of a novel pyrethroid: metofluthrin.

  Topics in current chemistry 20120101

• Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial.

  Journal of medical economics 20120101

• Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial.

  Clinical chemistry 20120101

• Effect of mosquito mats (pyrethroid-based) vapor inhalation on rat brain cytochrome P450s.

  Toxicology mechanisms and methods 20120101

• Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study.

  Circulation journal : official journal of the Japanese Circulation Society 20120101

• Intensive lipid-lowering therapy with statins for primary prevention.

  Circulation journal : official journal of the Japanese Circulation Society 20120101

• A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

  Analytical and bioanalytical chemistry 20120101

• Statins, plasma proprotein convertase subtilisin/kexin type 9 concentrations, and LDL lowering.

  Clinical chemistry 20120101

• Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.

  Psychopharmacology 20120101

• Synthesis and biological evaluation of (4H-1,2,4-triazol-4-yl)isoquinoline derivatives as selective glycine transporter 1 inhibitors.

  Bioorganic & medicinal chemistry 20120101

• Measuring carotid artery intima-media thickness: simplicity versus complexity?

  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20120101

• Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat.

  American journal of nephrology 20120101

• β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats.

  Lipids in health and disease 20120101

• N-[3-(4-Fluoro-benz-yl)-2,4-dioxo-1,3-diaza-spiro-[4.5]dec-8-yl]-2-methyl-benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20120101

• N-{3-[2-(4-Fluoro-phen-oxy)eth-yl]-2,4-dioxo-1,3-diaza-spiro-[4.5]decan-7-yl}-4-meth-oxy-benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20120101

• 3-(4-Fluoro-phenyl-sulfon-yl)-5-iodo-2,7-dimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20120101

• Rhabdomyolysis and acute renal failure following hard physical activity in a patient treated with rosuvastatin.

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120101

• Use of Linear Free Energy Relationships (LFERs) to elucidate the mechanisms of reaction of a γ-methyl-β-alkynyl and an ortho-substituted aryl chloroformate ester.

  International journal of molecular sciences 20120101

• [Almanac 2011: Valvular heart disease. Review of select studies that have driven recent advances in clinical cardiology: in the care of the Editors' Network Task Force of the European Society of Cardiology].

  Giornale italiano di cardiologia (2006) 20120101

• The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs.

  Lipids in health and disease 20120101

• Effects of rosuvastatin and atorvastatin on renal function: meta-analysis.

  Circulation journal : official journal of the Japanese Circulation Society 20120101

• Spatial repellency of transfluthrin-treated hessian strips against laboratory-reared Anopheles arabiensis mosquitoes in a semi-field tunnel cage.

  Parasites & vectors 20120101

• Effects of some anti-diabetic and cardioprotective agents on proliferation and apoptosis of human coronary artery endothelial cells.

  Cardiovascular diabetology 20120101

• Sodium channels as targets for volatile anesthetics.

  Frontiers in pharmacology 20120101

• Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.

  PloS one 20120101

• Synthesis and antibacterial activity against ralstonia solanacearum for novel hydrazone derivatives containing a pyridine moiety.

  Chemistry Central journal 20120101

• The effect of rosuvastatin in a murine model of influenza A infection.

  PloS one 20120101

• The role of natural gas as a primary fuel in the near future, including comparisons of acquisition, transmission and waste handling costs of as with competitive alternatives.

  Chemistry Central journal 20120101

• Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary prevention.

  International journal of occupational and environmental health 20120101

• Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin.

  Annals of clinical microbiology and antimicrobials 20120101

• Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease.

  BMJ case reports 20120101

• Rosuvastatin-induced pemphigoid.

  BMJ case reports 20120101

• Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.

  Internal medicine (Tokyo, Japan) 20120101

• LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibition.

  PloS one 20120101

• Adverse drug reaction: rosuvastatin as a cause for ischaemic colitis in a 64-year-old woman.

  BMJ case reports 20120101

• [The Saturn study].

  Giornale italiano di cardiologia (2006) 20120101

• Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease.

  PloS one 20120101

• The high-dose rosuvastatin once weekly study (the HD-ROWS).

  Journal of clinical lipidology 20120101

• [Atorvastatin or rosuvastatin? Select from the perspective of evidence-based medicine].

  Kardiologiia 20120101

• A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.

  PloS one 20120101

• [Case of purpura nephritis accompanied by idiopathic cholesterol embolism].

  Nihon Jinzo Gakkai shi 20120101

• [How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].

  Kardiologiia 20120101

• Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.

  European journal of pharmacology 20111230

• The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB.

  Psychiatry research 20111230

• Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication.

  Journal of medicinal chemistry 20111222

• Intermolecular vibrations and diffusive orientational dynamics of Cs condensed ring aromatic molecular liquids.

  The journal of physical chemistry. A 20111222

• [Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20111210

• [Symptomatic coronary heart disease. Impressive plaque reduction with high dose statins].

  MMW Fortschritte der Medizin 20111208

• Statins for primary prevention of venous thromboembolism.

  The Cochrane database of systematic reviews 20111207

• The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.

  Expert opinion on pharmacotherapy 20111201

• The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats.

  European journal of drug metabolism and pharmacokinetics 20111201

• Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease.

  Expert opinion on pharmacotherapy 20111201

• Effect of two intensive statin regimens on progression of coronary disease.

  The New England journal of medicine 20111201

• [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].

  Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20111201

• (E)-1-(4,4''-Difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)-3-phenyl-prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• (E)-1-(4,4''-Difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-nitro-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• (E)-1-(4,4''-Difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-methyl-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• [3-({(E)-2-[(4-Fluorophenyl)carbamo-thioyl]hydrazinylidene}methyl)-4-hy-droxy-benzyl]methyl-triphenyl-phos-phonium chloride.

  Acta crystallographica. Section E, Structure reports online 20111201

• (E)-1-{4-[Bis(4-fluoro-phen-yl)meth-yl]piperazin-1-yl}-3-(4-eth-oxy-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• 3-(3-Fluoro-phenyl-sulfon-yl)-2,5,7-trimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20111201

• Methyl 4,4''-difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20111201

• 2-(4-Fluoro-phen-yl)-3-isopropyl-sulfinyl-5,6-methyl-enedi-oxy-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20111201

• (2E)-3-(3-Bromo-4-meth-oxy-phen-yl)-1-(4,4''-difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• [Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].

  Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 20111201

• Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

  JAMA 20111116

• Simultaneous determination of timolol maleate, rosuvastatin calcium and diclofenac sodium in pharmaceuticals and physiological fluids using HPLC-UV.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115

• Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDL.

  British journal of pharmacology 20111101

• [Fibrillary nonamyloid glomerulonephritis: a rare etiology of nephrotic syndrome].

  Nephrologie & therapeutique 20111101

• Differential effect of statins on diabetic nephropathy in db/db mice.

  International journal of molecular medicine 20111101

• FT-IR and FT-Raman, UV spectroscopic investigation of 1-bromo-3-fluorobenzene using DFT (B3LYP, B3PW91 and MPW91PW91) calculations.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111101

• Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

  Biological psychiatry 20111101

• Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.

  Scandinavian journal of rheumatology 20111101

• The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action.

  Pharmacogenetics and genomics 20111101

• Algorithms to measure carotid intima-media thickness in trials: a comparison of reproducibility, rate of progression and treatment effect.

  Journal of hypertension 20111101

• rα Structures of partially oriented pentafluorobenzenes C6F5X (X = H, Cl, I) as determined from 19F NMR spectra with 13C satellites.

  Magnetic resonance in chemistry : MRC 20111101

• Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.

  International journal of clinical practice 20111101

• Drug safety evaluation of rosuvastatin.

  Expert opinion on drug safety 20111101

• Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.

  Annals of clinical biochemistry 20111101

• Clinical experience with rosuvastatin in the management of hyperlipidemia and the reduction of cardiovascular risk.

  Expert review of cardiovascular therapy 20111101

• Pitavastatin: an overview.

  Atherosclerosis. Supplements 20111101

• (2E)-2-(4-Fluoro-benzyl-idene)hydrazinecarboxamide.

  Acta crystallographica. Section E, Structure reports online 20111101

• (2E)-1-(4,4''-Difluoro-5'-meth-oxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-fluoro-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111101

• 2-(3-Fluoro-phen-yl)-3-methyl-sulfanyl-5-phenyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20111101

• 3-(3-Fluoro-phenyl-sulfin-yl)-2,4,6-trimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20111101

• [COSMOS (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects) trial].

  Nihon rinsho. Japanese journal of clinical medicine 20111101

• Syntheses and structural characterizations of anionic borane-capped ammonia borane oligomers: evidence for ammonia borane H2 release via a base-promoted anionic dehydropolymerization mechanism.

  Journal of the American Chemical Society 20111026

• Direct, metal-free amination of heterocyclic amides/ureas with NH-heterocycles and N-substituted anilines in POCl3.

  The Journal of organic chemistry 20111021

• Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.

  Oncogene 20111020

• Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-like photoproduct.

  Chemical research in toxicology 20111017

• p-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission.

  Behavioural brain research 20111010

• Iron(II) template synthesis of benzannulated triphospha- and triarsamacrocycles.

  Dalton transactions (Cambridge, England : 2003) 20111007

• Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488.

  ChemMedChem 20111004

• Synthesis of cis and trans bis-alkynyl complexes of Cr(III) and Rh(III) supported by a tetradentate macrocyclic amine: a spectroscopic investigation of the M(III)-alkynyl interaction.

  Inorganic chemistry 20111003

• Effect of rosuvastatin on hemoglobin levels in patients with anemia and low-grade inflammation: a post hoc analysis of the JUPITER trial.

  Journal of clinical pharmacology 20111001

• Was the low-density lipoprotein cholesterol level really elevated?

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20111001

• The JUPITER trial: myth or reality?

  Current atherosclerosis reports 20111001

• Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome.

  Diabetes & vascular disease research 20111001

• Renal toxicity of lisinopril and rosuvastatin, alone and in combination, in Wistar rats.

  International journal of toxicology 20111001

• Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.

  Journal of hypertension 20111001

• Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.

  Behavioural pharmacology 20111001

• [Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20111001

• N,N,N',N'-Tetra-ethyl-N''-(2-fluoro-benzo-yl)phospho-ric triamide.

  Acta crystallographica. Section E, Structure reports online 20111001

• 4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium picrate.

  Acta crystallographica. Section E, Structure reports online 20111001

• 4-[Bis(4-fluorophenyl)methyl]piperazin-1-ium 2-(2-phenylethyl)benzoate.

  Acta crystallographica. Section E, Structure reports online 20111001

• (E)-2-[1-(4-Fluoro-phen-yl)pent-1-en-3-yl-idene]malononitrile.

  Acta crystallographica. Section E, Structure reports online 20111001

• 5-(4-Fluoro-phen-yl)-3-methyl-sulfanyl-2-phenyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20111001

• (E)-1-(1-Benzyl-5-methyl-1H-1,2,3-triazol-4-yl)-3-(4-fluoro-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111001

• 5-Cyclo-pentyl-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20111001

• I am a 60-year-old woman with CAD. My LDL is 64 and my HDL is 72 on Zocor, but my doctor thinks Crestor may be better for me. He says it is more potent and could reduce my numbers even more. I would have to pay for this drug out-of-pocket. Do you think the additional cost would be worth it?

  Heart advisor 20111001

• Consistent assignment of the vibrations of monosubstituted benzenes.

  The Journal of chemical physics 20110921

• Synthesis and antiproliferative evaluation of 3,5-disubstituted 1,2,4-triazoles containing flurophenyl and trifluoromethanephenyl moieties.

  Bioorganic & medicinal chemistry letters 20110915

• Graphene transistors are insensitive to pH changes in solution.

  Nano letters 20110914

• Synthesis, spectroscopic properties and antipathogenic activity of new thiourea derivatives.

  Molecules (Basel, Switzerland) 20110906

• Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques.

  AIDS research and human retroviruses 20110901

• Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.

  Neuropharmacology 20110901

• Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress.

  British journal of pharmacology 20110901

• Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders.

  Pharmacological research 20110901

• Vibrational spectra, structure, and theoretical calculations of 2-fluoro- and 3-fluoropyridine.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110901

• Rosuvastatin attenuates monocrotaline-induced pulmonary hypertension via regulation of Akt/eNOS signaling and asymmetric dimethylarginine metabolism.

  European journal of pharmacology 20110901

• Structural and spectroscopic characterization of 2,3-difluorobenzoic acid and 2,4-difluorobenzoic acid with experimental techniques and quantum chemical calculations.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110901

• Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20110901

• Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty--a prospective randomized open-label controlled trial.

  Contemporary clinical trials 20110901

• Serotonin 2A receptor antagonists for treatment of schizophrenia.

  Expert opinion on investigational drugs 20110901

• 3-(3-Fluoro-phenyl-sulfin-yl)-2,4,5,6-tetra-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110901

• 2-(4-Fluoro-phen-yl)-1-(phenyl-sulfin-yl)-naphtho-[2,1-b]furan.

  Acta crystallographica. Section E, Structure reports online 20110901

• 5-Bromo-2-(4-fluoro-phen-yl)-3-phenyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110901

• 5-(4-Fluoro-phen-yl)-2-methyl-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110901

• Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.

  Lancet (London, England) 20110820

• Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).

  The American journal of cardiology 20110815

• From attraction to repulsion: anion-π interactions between bromide and fluorinated phenyl groups.

  Chemical communications (Cambridge, England) 20110814

• Rotational spectrum of asymmetric top molecules in combined static and laser fields.

  The Journal of chemical physics 20110814

• Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour.

  The international journal of neuropsychopharmacology 20110801

• Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.

  British journal of clinical pharmacology 20110801

• Statins prevent tissue factor induction by protease-activated receptors 1 and 2 in human umbilical vein endothelial cells in vitro.

  Journal of thrombosis and haemostasis : JTH 20110801

• Dose-dependent effect of rosuvastatin in the regulation of metalloproteinase expression.

  Annals of vascular surgery 20110801

• Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

• Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).

  Journal of molecular histology 20110801

• pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.

  Molecular pharmaceutics 20110801

• Quantification of acetaminophen (paracetamol) in human plasma and urine by stable isotope-dilution GC-MS and GC-MS/MS as pentafluorobenzyl ether derivative.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110801

• Therapy and clinical trials: aggressive statin therapy versus combined and emerging approaches.

  Current opinion in lipidology 20110801

• HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7.

  Atherosclerosis 20110801

• Rosuvastatin blocks advanced glycation end products-elicited reduction of macrophage cholesterol efflux by suppressing NADPH oxidase activity via inhibition of geranylgeranylation of Rac-1.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20110801

• A tale of three labels: translating the JUPITER trial data into regulatory claims.

  Clinical trials (London, England) 20110801

• A tale of five opinions (at least).

  Clinical trials (London, England) 20110801

• Regulatory divergence.

  Clinical trials (London, England) 20110801

• Translating study results to labeling.

  Clinical trials (London, England) 20110801

• Rosuvastatin prevents proteinuria and renal inflammation in nitric oxide-deficient rats.

  Clinics (Sao Paulo, Brazil) 20110801

• Bis{2-[(E)-(4-fluoro-benz-yl)imino-meth-yl]-6-meth-oxy-phenolato-κN,O}nickel(II).

  Acta crystallographica. Section E, Structure reports online 20110801

• Ethyl 1-benzyl-3-(4-bromo-phen-yl)-1H-pyrazole-5-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20110801

• 2-(4-Fluoro-phen-yl)-1-phenyl-1H-imidazo[4,5-f][1,10]phenanthroline monohydrate.

  Acta crystallographica. Section E, Structure reports online 20110801

• [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].

  Zhonghua xin xue guan bing za zhi 20110801

• Synthesis and characterization of fluorophenylpalladium pincer complexes: electronic properties of some pincer ligands evaluated by multinuclear NMR spectroscopy and electrochemical studies.

  Dalton transactions (Cambridge, England : 2003) 20110721

• Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy.

  International journal of cardiology 20110715

• Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.

  The American journal of cardiology 20110715

• Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study.

  Journal of pharmaceutical and biomedical analysis 20110715

• Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial).

  The American journal of cardiology 20110715

• Graft-crosslinked copolymers based on poly(arylene ether ketone)-gc-sulfonated poly(arylene ether sulfone) for PEMFC applications.

  Macromolecular rapid communications 20110715

• Beneficial effects of rosuvastatin on aortic adverse remodeling in nitric oxide-deficient rats.

  Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20110701

• Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease.

  Atherosclerosis 20110701

• The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes.

  Xenobiotica; the fate of foreign compounds in biological systems 20110701

• Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.

  The Journal of endocrinology 20110701

• Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.

  Atherosclerosis 20110701

• Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models.

  Circulation. Cardiovascular imaging 20110701

• Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.

  Hypertension research : official journal of the Japanese Society of Hypertension 20110701

• Rosuvastatin in diabetic hemodialysis patients.

  Journal of the American Society of Nephrology : JASN 20110701

• CRP induces hypertension in animal models: homo sapiens says no.

  Hypertension research : official journal of the Japanese Society of Hypertension 20110701

• Statins, vitamin D, and neuropathic pain.

  Pain 20110701

• A randomized, controlled study comparing the effects of vestipitant or vestipitant and paroxetine combination in subjects with tinnitus.

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20110701

• Sunrise of statins after AURORA and 4D?

  Journal of the American Society of Nephrology : JASN 20110701

• Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats.

  Annals of vascular surgery 20110701

• Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

  American heart journal 20110701

• N-(4-Chloro-butanoyl)-N'-(2-fluoro-phen-yl)thio-urea.

  Acta crystallographica. Section E, Structure reports online 20110701

• [Pharmaco-economic optimization of cholesterol-lowering treatment with statins].

  Medicina clinica 20110625

• Direct palladium-catalyzed intermolecular allylation of highly electron-deficient polyfluoroarenes.

  Angewandte Chemie (International ed. in English) 20110620

• What else does the JUPITER trial add regarding C-reactive protein and cardiovascular disease?

  International journal of cardiology 20110616

• Impact of statins on glucose metabolism--a matter of debate.

  The American journal of cardiology 20110615

• Effects of pravastatin and rosuvastatin on the generation of adiponectin in the visceral adipose tissue in patients with coronary artery disease.

  Fundamental & clinical pharmacology 20110601

• Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats.

  Behavioural brain research 20110601

• Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.

  Arthritis care & research 20110601

• High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia.

  Lipids 20110601

• Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations.

  Xenobiotica; the fate of foreign compounds in biological systems 20110601

• Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease.

  Clinical biochemistry 20110601

• Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.

  Metabolic syndrome and related disorders 20110601

• The effects of oral treatment with transfluthrin on the urothelium of rats and its metabolite, tetrafluorobenzoic acid on urothelial cells in vitro.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20110601

• Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN).

  Current medical research and opinion 20110601

• Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.

  Arteriosclerosis, thrombosis, and vascular biology 20110601

• Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention.

  Circulation. Cardiovascular genetics 20110601

• Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats.

  Behavioural pharmacology 20110601

• Binding modes of diketo-acid inhibitors of HIV-1 integrase: a comparative molecular dynamics simulation study.

  Journal of molecular graphics & modelling 20110601

• Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.

  International journal of clinical practice 20110601

• The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients.

  European journal of internal medicine 20110601

• High-sensitivity C-reactive protein, obesity, and subclinical atherosclerosis: implications of JUPITER from the MESA study.

  Arteriosclerosis, thrombosis, and vascular biology 20110601

• Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis.

  American heart journal 20110601

• Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

  Clinical therapeutics 20110601

• Bis{2-[(E)-(4-fluoro-benz-yl)imino-meth-yl]-6-meth-oxy-phenolato}palladium(II).

  Acta crystallographica. Section E, Structure reports online 20110601

• 3-(3-Fluoro-phenyl-sulfin-yl)-2,4,6,7-tetra-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110601

• 4,6-Bis(4-fluoro-phen-yl)-2-phenyl-1H-indazol-3(2H)-one.

  Acta crystallographica. Section E, Structure reports online 20110601

• Ethyl 1-(4-chloro-benz-yl)-3-(4-fluoro-phen-yl)-1H-pyrazole-5-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20110601

• (2,7-Dimeth-oxy-naphthalen-1-yl)(4-fluoro-phen-yl)methanone.

  Acta crystallographica. Section E, Structure reports online 20110601

• 3-(3-Fluoro-phenyl-sulfin-yl)-2,5,7-trimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110601

• N-(4-Fluoro-benz-yl)-3-nitro-pyridine-2,6-diamine.

  Acta crystallographica. Section E, Structure reports online 20110601

• [Effect of OATP1B1 521T --> C heterogenesis on pharmacokinetic characterstics of rosuvastatin in Chinese volunteers].

  Yao xue xue bao = Acta pharmaceutica Sinica 20110601

• Competition between Birch reduction and fluorine abstraction in reactions of hydrated electrons (H2O)n(-) with the isomers of di- and trifluorobenzene.

  Physical chemistry chemical physics : PCCP 20110521

• Xanthone natural products via N-heterocyclic carbene catalysis: total synthesis of atroviridin.

  The Journal of organic chemistry 20110520

• Fish odour syndrome.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110517

• Stable-isotope dilution GC-MS approach for nitrite quantification in human whole blood, erythrocytes, and plasma using pentafluorobenzyl bromide derivatization: nitrite distribution in human blood.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110515

• Unique pentafluorobenzylation and collision-induced dissociation for specific and accurate GC-MS/MS quantification of the catecholamine metabolite 3,4-dihydroxyphenylglycol (DHPG) in human urine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110515

• In-source formation of N-acetyl-p-benzoquinone imine (NAPQI), the putatively toxic acetaminophen (paracetamol) metabolite, after derivatization with pentafluorobenzyl bromide and GC-ECNICI-MS analysis.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110515

• Enhancement of analysis by analytical derivatization.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110515

• The editor's roundtable: JUPITER follow-up.

  The American journal of cardiology 20110515

• Two dimensional laser induced fluorescence spectroscopy: a powerful technique for elucidating rovibronic structure in electronic transitions of polyatomic molecules.

  The Journal of chemical physics 20110514

• Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C.

  Journal of viral hepatitis 20110501

• No effect of rosuvastatin in the zoledronate-induced acute-phase response.

  Calcified tissue international 20110501

• Statins alleviate experimental nerve injury-induced neuropathic pain.

  Pain 20110501

• Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis.

  Current medical research and opinion 20110501

• Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110501

• The methyl ester of rosuvastatin elicited an endothelium-independent and 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent relaxant effect in rat aorta.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20110501

• 1,1'-Bis(4-fluoro-phen-yl)-3,3'-diisobutyl-4,4'-diphen-oxy-1H,1'H-4,4'-bipyrazole-5,5'(4H,4'H)-dione.

  Acta crystallographica. Section E, Structure reports online 20110501

• 5-Cyclo-hexyl-3-(3-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110501

• 3-(4-Fluoro-phenyl-sulfin-yl)-5-iodo-2,7-dimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110501

• (2E)-3-(3-Bromo-4-meth-oxy-phen-yl)-1-(4-fluoro-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20110501

• 2,4-Bis(4-fluoro-phen-yl)-2,3-dihydro-1H-1,5-benzodiazepine.

  Acta crystallographica. Section E, Structure reports online 20110501

• 5-Ethyl-3-(3-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110501

• Vibrational solvatochromism and electrochromism of infrared probe molecules containing C≡O, C≡N, C=O, or C-F vibrational chromophore.

  The Journal of chemical physics 20110421

• Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

  Journal of the American College of Cardiology 20110419

• Determination of tobramycin in soil by HPLC with ultrasonic-assisted extraction and solid-phase extraction.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110415

• Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure.

  Journal of the American College of Cardiology 20110405

• Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes.

  Inorganic chemistry 20110404

• Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110401

• Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.

  Journal of lipid research 20110401

• The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial.

  Current atherosclerosis reports 20110401

• Different effects of rosuvastatin and simvastatin on myocardial high-energy phosphate metabolism.

  International journal of cardiology 20110401

• Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus.

  European journal of medicinal chemistry 20110401

• Statins should be used with greater caution in patients undergoing thyroid hormone withdrawal for radioactive iodine treatment.

  Thyroid : official journal of the American Thyroid Association 20110401

• High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.

  PLoS neglected tropical diseases 20110401

• Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.

  Prescrire international 20110401

• 5-Cyclo-hexyl-2-(4-fluoro-phen-yl)-3-isopropyl-sulfonyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110401

• 5-Cyclo-hexyl-3-(4-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110401

• 5-Cyclo-hexyl-3-(4-fluoro-phenyl-sulfin-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110401

• 2,5-Bis(4-fluoro-phen-yl)-2-methyl-sulfanyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110401

• Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.

  BMJ (Clinical research ed.) 20110330

• Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: method development, validation and optimization of various experimental parameters.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110315

• GC-MS and HPLC methods for peroxynitrite (ONOO- and O15NOO-) analysis: a study on stability, decomposition to nitrite and nitrate, laboratory synthesis, and formation of peroxynitrite from S-nitrosoglutathione (GSNO) and KO2.

  The Analyst 20110307

• Franck-Condon simulation of the A1B2→X1A1 dispersed fluorescence spectrum of fluorobenzene and its rate of the internal conversion.

  The Journal of chemical physics 20110307

• Ruthenium-catalyzed regioselective [2 + 2 + 2] cyclotrimerization of trifluoromethyl group substituted internal alkynes.

  Organic letters 20110304

• Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia.

  The Journal of pediatrics 20110301

• Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.

  Journal of molecular neuroscience : MN 20110301

• Differential metabolic effects of distinct statins.

  Atherosclerosis 20110301

• Optimal statin type and dosage for vascular patients.

  Journal of vascular surgery 20110301

• Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

  Circulation. Heart failure 20110301

• Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents.

  Chemical biology & drug design 20110301

• Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects.

  The Journal of pediatrics 20110301

• Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity.

  Pharmacogenetics and genomics 20110301

• Evaluation of a metofluthrin fan vaporizer device against phlebotomine sand flies (Diptera: Psychodidae) in a cutaneous leishmaniasis focus in the Judean Desert, Israel.

  Journal of vector ecology : journal of the Society for Vector Ecology 20110301

• Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20110301

• N-[(4-Carbamoylphen-yl)carbamothio-yl]-2,3,4,5-tetra-fluoro-benzamide.

  Acta crystallographica. Section E, Structure reports online 20110301

• 2-Chloro-1-[4-(2-fluoro-benz-yl)piperazin-1-yl]ethanone.

  Acta crystallographica. Section E, Structure reports online 20110301

• [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].

  Zhonghua xin xue guan bing za zhi 20110301

• Low-density lipoprotein cholesterol goal attainment among Malaysian dyslipidemic patients.

  The Southeast Asian journal of tropical medicine and public health 20110301

• Experimental, SOPPA(CCSD), and DFT analysis of substitutent effects on NMR 1JCF coupling constants in fluorobenzene derivatives.

  The journal of physical chemistry. A 20110224

• Electrons, photons, and force: quantitative single-molecule measurements from physics to biology.

  ACS nano 20110222

• The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels.

  Journal of the American College of Cardiology 20110215

• The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).

  Journal of the American College of Cardiology 20110215

• Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.

  International journal of cardiology 20110203

• Insulin resistance due to statin therapy: a potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure?

  International journal of cardiology 20110203

• Outcomes of high dose statin loading therapy.

  International journal of cardiology 20110203

• Small leucine-rich proteoglycans in atherosclerotic lesions: novel targets of chronic statin treatment?

  Journal of cellular and molecular medicine 20110201

• The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B.

  Psychopharmacology 20110201

• Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.

  Psychopharmacology 20110201

• Rosuvastatin induces apoptosis in CD4(+)CD28 (null) T cells in patients with acute coronary syndromes.

  Clinical research in cardiology : official journal of the German Cardiac Society 20110201

• Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats.

  Psychopharmacology 20110201

• Public health impact of statin prescribing strategies based on JUPITER.

  Preventive medicine 20110201

• Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.

  Cardiovascular drugs and therapy 20110201

• Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110201

• A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes.

  Advances in therapy 20110201

• Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation.

  The American journal of cardiology 20110201

• Alternate day rosuvastatin, an underutilized option in statin intolerant hyperlipidemic patients: a case report and literature review.

  Tennessee medicine : journal of the Tennessee Medical Association 20110201

• Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.

  Cardiovascular drugs and therapy 20110201

• {2,6-Bis[(2,6-diphenyl-phosphan-yl)-oxy]-4-fluoro-phenyl-κP,C,P'}(6-methyl-2,2,4-trioxo-3,4-dihydro-1,2,3-oxathia-zin-3-ido-κN)palladium(II).

  Acta crystallographica. Section E, Structure reports online 20110201

• 7-Bromo-1-(4-fluoro-phenyl-sulfon-yl)-2-methyl-naphtho-[2,1-b]furan.

  Acta crystallographica. Section E, Structure reports online 20110201

• rac-4-[4-Cyano-2-(hy-droxy-meth-yl)phen-yl]-4-(4-fluoro-phen-yl)-4-hy-droxy-N,N-dimethyl-butanaminium hemifumarate.

  Acta crystallographica. Section E, Structure reports online 20110201

• (1RS,6SR)-Ethyl 4-(4-chloro-phen-yl)-6-(4-fluoro-phen-yl)-2-oxocyclo-hex-3-ene-1-carboxyl-ate toluene hemisolvate.

  Acta crystallographica. Section E, Structure reports online 20110201

• (1RS,6SR)-Ethyl 4,6-bis-(4-fluoro-phen-yl)-2-oxocyclo-hex-3-ene-1-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20110201

• 5-Bromo-3-(4-fluoro-phenyl-sulfin-yl)-2,7-dimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110201

• (Z)-3-[(2-Fluoro-anilino)carbon-yl]prop-2-enoic acid.

  Acta crystallographica. Section E, Structure reports online 20110201

• (1RS,6SR)-Ethyl 4-(2,4-dichloro-phen-yl)-6-(4-fluoro-phen-yl)-2-oxocyclo-hex-3-ene-1-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20110201

• 5-Cyclo-hexyl-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110201

• 5-Bromo-3-(4-fluoro-phenyl-sulfin-yl)-2,4,6-trimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110201

• 5-Ethyl-2-(4-fluoro-phen-yl)-4-phen-oxy-1H-pyrazol-3(2H)-one.

  Acta crystallographica. Section E, Structure reports online 20110201

• 1-{4-Chloro-2-[2-(2-fluoro-phen-yl)-1,3-dithio-lan-2-yl]phen-yl}-2-methyl-1H-imidazole-5-carbaldehyde.

  Acta crystallographica. Section E, Structure reports online 20110201

• 5-Chloro-2-(4-fluoro-phen-yl)-3-phenyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20110201

• Ethyl 1-benzyl-3-(4-fluoro-phen-yl)-1H-pyrazole-5-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20110201

• Palladium-catalyzed cross-coupling of polyfluoroarenes with simple arenes.

  Organic letters 20110121

• eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.

  European journal of pharmacology 20110115

• High-dose rosuvastatin in chronic heart failure promotes vasculogenesis, corrects endothelial function, and improves cardiac remodeling--results from a randomized, double-blind, and placebo-controlled study.

  International journal of cardiology 20110107

• 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome.

  International journal of cardiology 20110107

• Unending debate: statin dilemma in the management of heart failure.

  International journal of cardiology 20110107

• Pre-procedural use of statins for all patients undergoing percutaneous coronary intervention.

  International journal of cardiology 20110107

• Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats.

  British journal of pharmacology 20110101

• Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.

  Xenobiotica; the fate of foreign compounds in biological systems 20110101

• Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties.

  Naunyn-Schmiedeberg's archives of pharmacology 20110101

• Involvement of the p38 pathway in the differential induction of heme oxygenase-1 by statins in Neuro-2A cells exposed to lipopolysaccharide.

  Drug and chemical toxicology 20110101

• Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥ 5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authorities.

  European heart journal 20110101

• GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.

  Current topics in medicinal chemistry 20110101

• GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.

  Current topics in medicinal chemistry 20110101

• Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

  Atherosclerosis 20110101

• Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression.

  International journal of molecular medicine 20110101

• The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins.

  Expert opinion on drug metabolism & toxicology 20110101

• Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.

  Expert opinion on investigational drugs 20110101

• Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes.

  Annals of clinical biochemistry 20110101

• Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.

  Atherosclerosis 20110101

• The risks of a new hypothesis: why did JUPITER patients have almost twice the predicted event rate of reduction?

  Journal of cardiovascular medicine (Hagerstown, Md.) 20110101

• Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients.

  Acta pharmacologica Sinica 20110101

• Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study).

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.

  Cardiovascular ultrasound 20110101

• P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ.

  Neuropsychobiology 20110101

• Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions.

  PloS one 20110101

• A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.

  Trials 20110101

• Pharmacophore design of p38α MAP kinase inhibitors with either 2,4,5-trisubstituted or 1,2,4,5-tetrasubstituted imidazole scaffold.

  Current medicinal chemistry 20110101

• Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly.

  Clinical interventions in aging 20110101

• Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• 2-Amino-4-(4-fluoro-phen-yl)-6-(naphthalen-1-yl)pyridine-3-carbonitrile.

  Acta crystallographica. Section E, Structure reports online 20110101

• 2-Amino-4-(2-fluoro-phen-yl)-5,6-dihydro-benzo[h]quinoline-3-carbonitrile.

  Acta crystallographica. Section E, Structure reports online 20110101

• [Possible rosuvastatin-induced fatal rhabdomyolysis].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20110101

• Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Inorganic base-catalyzed formation of antivirally active N-substituted benzamides from α-amido sulfones and N-nucleophile.

  Chemistry Central journal 20110101

• Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.

  Antiviral therapy 20110101

• Primary prevention with statins is more cost-effective.

  Cardiovascular journal of Africa 20110101

• Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register.

  PloS one 20110101

• The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.

  Journal of atherosclerosis and thrombosis 20110101

• Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.

  Drug design, development and therapy 20110101

• Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens.

  Journal of signal transduction 20110101

• Design, synthesis, and characterization of a highly effective Hog1 inhibitor: a powerful tool for analyzing MAP kinase signaling in yeast.

  PloS one 20110101

• Efficacy analysis of the lipid-lowering and renoprotective effects of rosuvastatin in patients with chronic kidney disease.

  Endocrine journal 20110101

• A novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse model.

  PloS one 20110101

• Rosuvastatin therapy does not affect serum MMP-13 or TIMP-1 levels in hypercholesterolemic patients.

  Texas Heart Institute journal 20110101

• Content of transfluthrin in indoor air during the use of electro-vaporizers.

  Annals of agricultural and environmental medicine : AAEM 20110101

• Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Effects of triazole derivatives on strigolactone levels and growth retardation in rice.

  PloS one 20110101

• Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones.

  Scientia pharmaceutica 20110101

• Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.

  Journal of clinical lipidology 20110101

• Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study.

  Journal of clinical lipidology 20110101

• Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

  Drug design, development and therapy 20110101

• The role of soluble fiber intake in patients under highly effective lipid-lowering therapy.

  Nutrition journal 20110101

• Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• Synthesis and anticonvulsant evaluation of some novel (thio)semicarbazone derivatives of arylalkylimidazole.

  Arzneimittel-Forschung 20110101

• A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosis.

  BMC systems biology 20110101

• Comparative efficacy of ezetimibe/simvastatin, rosuvastatin, and atorvastatin in uncontrolled hyperlipidemia patients.

  The American journal of managed care 20110101

• Low-dose rosuvastatin improves arterial stiffness in high-risk Japanese patients with dyslipdemia in a primary prevention group.

  Circulation journal : official journal of the Japanese Circulation Society 20110101

• No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.

  Journal of biomedicine & biotechnology 20110101

• Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy.

  Journal of atherosclerosis and thrombosis 20110101

• Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats.

  Lipids in health and disease 20110101

• Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.

  PloS one 20110101

• Estimating treatment effects for individual patients based on the results of randomised clinical trials.

  BMJ (Clinical research ed.) 20110101

• Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥ 2 mg/L). [email protected].

  Journal of clinical lipidology 20110101

• Optimized method for determining free L-cysteine in rat plasma by high-performance liquid chromatography with the 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole conversion reagent.

  Bioscience, biotechnology, and biochemistry 20110101

• Effect of rosuvastatin treatment on cholesterol efflux from human macrophages.

  Neuro endocrinology letters 20110101

• Extreme all-cause mortality in JUPITER requires reexamination of vital records.

  Cardiology 20110101

• Is chronic severe anemia an independent predictor of poor outcomes?

  Cardiology 20110101

• [Statins in primary prophylaxis of cardiovascular diseases].

  Terapevticheskii arkhiv 20110101

• Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.

  The Journal of international medical research 20110101

• In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC).

  BMC bioinformatics 20110101

• Statin resistant dyslipidemia in a patient treated with amiodarone.

  BMJ case reports 20110101

• Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.

  International journal of cancer 20101215

• Trials by independent expert bodies.

  Archives of internal medicine 20101213

• Letter by Wells and Eisenberg regarding article, 'Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials'.

  Circulation 20101207

• Letter by Vos et al regarding article, 'Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials'.

  Circulation 20101207

• Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.

  International journal of cardiology 20101203

• Rosuvastatin and vitamin D: might there be hypovitaminosis D on JUPITER?

  International journal of cardiology 20101203

• Immunomodulatory effects of rosuvastatin on hepatic ischemia/reperfusion induced injury.

  Immunopharmacology and immunotoxicology 20101201

• Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population.

  Metabolism: clinical and experimental 20101201

• Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.

  The Journal of pharmacology and experimental therapeutics 20101201

• Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.

  Pharmacoepidemiology and drug safety 20101201

• Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial.

  European journal of heart failure 20101201

• Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.

  Cardiovascular drugs and therapy 20101201

• Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily).

  The American journal of cardiology 20101201

• Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.

  Minerva cardioangiologica 20101201

• WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction.

  Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al 20101201

• 3-(2-Bromo-eth-oxy)-4-(4-bromo-phen-yl)furan-5(2H)-one.

  Acta crystallographica. Section E, Structure reports online 20101201

• 6-(Adamantan-1-yl)-3-(3-fluoro-phen-yl)-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole.

  Acta crystallographica. Section E, Structure reports online 20101201

• 1-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl]}piperidin-4-one.

  Acta crystallographica. Section E, Structure reports online 20101201

• 2-(4-Fluoro-phen-yl)-5-iodo-3-isopropyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20101201

• 3-(4-Fluoro-phenyl-sulfon-yl)-2-methyl-naphtho-[1,2-b]furan.

  Acta crystallographica. Section E, Structure reports online 20101201

• HDL cholesterol and residual risk of first cardiovascular events.

  Lancet (London, England) 20101120

• Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD.

  Biochemical and biophysical research communications 20101112

• No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.

  International journal of cardiology 20101105

• Application of LC-NMR and HR-NMR to the characterization of biphenyl impurities in the synthetic route development for vestipitant, a novel NK1 antagonist.

  Journal of pharmaceutical and biomedical analysis 20101102

• Synthesis and anti-tubercular and antimicrobial activities of some 2r,4c-diaryl-3-azabicyclo[3.3.1]nonan-9-one N-isonicotinoylhydrazone derivatives.

  European journal of medicinal chemistry 20101101

• Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).

  Thrombosis research 20101101

• [On the current debate on lowering LDL cholesterol with ezetimibe].

  Deutsche medizinische Wochenschrift (1946) 20101101

• Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.

  The American journal of cardiology 20101101

• The JUPITER Trial: responding to the critics.

  The American journal of cardiology 20101101

• Statin therapy in primary prevention: new insights regarding women and the elderly.

  The American journal of cardiology 20101101

• Endothelial progenitor cells in patients with acute cerebrovascular ischemia.

  The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20101101

• Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).

  The Canadian journal of cardiology 20101101

• Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke.

  Drug news & perspectives 20101101

• 3-Ethyl-6-[3-(4-fluoro-phen-yl)-1H-pyrazol-4-yl]-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole.

  Acta crystallographica. Section E, Structure reports online 20101101

• 1-(4-Fluoro-phen-yl)-3-methyl-4-phenyl-sulfanyl-1H-pyrazol-5(4H)-one.

  Acta crystallographica. Section E, Structure reports online 20101101

• Ethyl 2-[5-(4-chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]-4-methyl-thia-zole-5-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20101101

• Serum levels of C-reactive protein in patients with stable coronary artery disease: JUPITER in perspective.

  International journal of cardiology 20101029

• A simple and efficient synthesis of functionalized cyclic carbonate monomers using a versatile pentafluorophenyl ester intermediate.

  Journal of the American Chemical Society 20101027

• High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis.

  Circulation 20101026

• Tunable phosphorescent NIR oxygen indicators based on mixed benzo- and naphthoporphyrin complexes.

  Inorganic chemistry 20101018

• Is diabetes the cost to pay for a greater cardiovascular prevention?

  International journal of cardiology 20101008

• Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).

  Journal of the American College of Cardiology 20101005

• Coenzyme Q10 and statins in heart failure: the dog that didn't bark.

  Journal of the American College of Cardiology 20101005

• C-F activation of fluorobenzene by silylium carboranes: evidence for incipient phenyl cation reactivity.

  Angewandte Chemie (International ed. in English) 20101004

• Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions.

  Journal of clinical pharmacology 20101001

• Quantification of carbonate by gas chromatography-mass spectrometry.

  Analytical chemistry 20101001

• The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101001

• Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode.

  Chemical biology & drug design 20101001

• Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.

  Hypertension (Dallas, Tex. : 1979) 20101001

• Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.

  Pharmacogenetics and genomics 20101001

• Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review.

  Clinical chemistry 20101001

• Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters.

  Current medical research and opinion 20101001

• Lactone pathway to statins utilizing the Wittig reaction. The synthesis of rosuvastatin.

  The Journal of organic chemistry 20101001

• Rhabdomyolysis induced by rosuvastatin and sildenafil.

  Southern medical journal 20101001

• Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER.

  Current medical research and opinion 20101001

• Case report. Hyperlipoproteinaemia(a): which is the optimal therapy? A case report.

  Journal of clinical pharmacy and therapeutics 20101001

• Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction.

  Circulation. Cardiovascular genetics 20101001

• Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.

  Clinical cardiology 20101001

• Heterozygous familial hypercholesterolemia case study.

  Journal of the American Academy of Nurse Practitioners 20101001

• 4-(3-Fluoro-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.

  Acta crystallographica. Section E, Structure reports online 20101001

• 2-(4-Fluoro-phen-yl)-1,4,5-triphenyl-1H-imidazole.

  Acta crystallographica. Section E, Structure reports online 20101001

• N-[(2-Chloro-3-quinol-yl)meth-yl]-4-fluoro-aniline.

  Acta crystallographica. Section E, Structure reports online 20101001

• 5-Ethyl-3-(4-Fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20101001

• Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.

  International journal of cardiology 20100924

• Modification of carbon substrates by aryl and alkynyl iodonium salt reduction.

  Langmuir : the ACS journal of surfaces and colloids 20100921

• An integrated microreactor system for self-optimization of a Heck reaction: from micro- to mesoscale flow systems.

  Angewandte Chemie (International ed. in English) 20100917

• Structure and dynamics of α-aryl amide and ketone enolates: THF, PMDTA, TMTAN, HMPA, and crypt-solvated lithium enolates, and comparison with phosphazenium analogues.

  The Journal of organic chemistry 20100917

• Identifying and quantifying contaminants contributing to endogenous analytes in gas chromatography/mass spectrometry.

  Analytical chemistry 20100915

• Interpreting and evaluating the details of the JUPITER study.

  American family physician 20100915

• Determination of cyanide exposure by gas chromatography-mass spectrometry analysis of cyanide-exposed plasma proteins.

  Analytica chimica acta 20100910

• Effect of a single gemfibrozil dose on the pharmacokinetics of rosuvastatin in bile and plasma in healthy volunteers.

  Journal of clinical pharmacology 20100901

• Rosuvastatin-induced gynaecomastia.

  Clinical endocrinology 20100901

• The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.

  American journal of physiology. Renal physiology 20100901

• Synthesis of some 3-substituted amino-4,5-tetramethylene thieno[2,3-d][ 1,2,3]-triazin-4(3H)-ones as potential antimicrobial agents.

  European journal of medicinal chemistry 20100901

• Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.

  European journal of heart failure 20100901

• Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer.

  European urology 20100901

• Impact of restricted reimbursement on the use of statins in Finland: a register-based study.

  Medical care 20100901

• Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for 'intermediate risk'.

  Circulation. Cardiovascular quality and outcomes 20100901

• Relationship between bicuspid aortic valve morphology and aortic wall degeneration: further evidence is emerging.

  Echocardiography (Mount Kisco, N.Y.) 20100901

• Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.

  Future cardiology 20100901

• [Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].

  Zhonghua xin xue guan bing za zhi 20100901

• N-(4-Chloro-benzo-yl)-N'-(3-fluoro-phen-yl)thio-urea.

  Acta crystallographica. Section E, Structure reports online 20100901

• 4-{2-[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]thia-zol-4-yl}benzonitrile.

  Acta crystallographica. Section E, Structure reports online 20100901

• 5-Chloro-3-(4-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100901

• 3-[(4-Fluoro-phen-yl)sulfon-yl]-5-iodo-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100901

• [Role of rosuvastatin in current lipid-lowering therapy].

  Orvosi hetilap 20100829

• Photophysics of fluorinated benzene. I. Quantum chemistry.

  The Journal of chemical physics 20100828

• Formation and decay of fluorobenzene radical anions affected by their isomeric structures and the number of fluorine atoms.

  The journal of physical chemistry. A 20100812

• Dehydrogenation of saturated CC and BN bonds at cationic N-heterocyclic carbene stabilized M(III) centers (M = Rh, Ir).

  Journal of the American Chemical Society 20100804

• Brønsted analysis of an enzyme-catalyzed pseudo-deglycosylation reaction: mechanism of desialylation in sialidases.

  Biochemistry 20100803

• A new and practical Grignard-coupling-fluorination sequence: synthesis of 2-aryl fluoroarenes.

  Chemistry, an Asian journal 20100802

• C-reactive protein lowering with rosuvastatin in the METEOR study.

  Journal of internal medicine 20100801

• Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models.

  Inflammopharmacology 20100801

• The effect of acute administration of rifampicin and imatinib on the enterohepatic transport of rosuvastatin in vivo.

  Xenobiotica; the fate of foreign compounds in biological systems 20100801

• Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.

  The American journal of the medical sciences 20100801

• Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.

  American heart journal 20100801

• Statin therapy for elevated hsCRP: what are the public health implications?

  The American journal of managed care 20100801

• Statin therapy for elevated hsCRP: more evidence is needed.

  The American journal of managed care 20100801

• Was the FDA misled by JUPITER?

  The Journal of the American Osteopathic Association 20100801

• Cost-effectiveness of rosuvastatin for primary prevention of cardiovascular events according to Framingham Risk Score in patients with elevated C-reactive protein.

  The Journal of the American Osteopathic Association 20100801

• 5-Fluoro-3-(4-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100801

• 3,5-Bis(4-fluoro-phen-yl)-1-phenyl-4,5-dihydro-1H-pyrazole.

  Acta crystallographica. Section E, Structure reports online 20100801

• 5-Bromo-3-(4-fluoro-phenyl-sulfon-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100801

• HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.

  Lancet (London, England) 20100731

• Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.

  Brain research 20100730

• Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.

  The New Zealand medical journal 20100730

• A medicinal chemist's guide to molecular interactions.

  Journal of medicinal chemistry 20100722

• Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

  The American journal of cardiology 20100715

• Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.

  Synapse (New York, N.Y.) 20100701

• Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.

  Cell biology international 20100701

• Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.

  The Journal of pharmacology and experimental therapeutics 20100701

• Synergistic effect of decreased opioid activity and sleep deprivation on head-twitch response in mice.

  Pharmacology, biochemistry, and behavior 20100701

• Expression of the hepatic Niemann-Pick C1 like 1 protein gene is sensitive to rosuvastatin treatment of primary human hepatocytes.

  Pharmacogenetics and genomics 20100701

• Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets.

  International journal of clinical practice 20100701

• Imperfect pharmacovigilance.

  Southern medical journal 20100701

• Rosuvastatin-induced thrombocytopenia.

  Southern medical journal 20100701

• Application of LC-NMR to the identification of bulk drug impurities in NK1 antagonist GW597599 (vestipitant).

  Magnetic resonance in chemistry : MRC 20100701

• Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?

  Pharmacogenomics 20100701

• 5-Fluoro-3-(4-fluoro-phenyl-sulfin-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100701

• 2-(4-Fluoro-phen-yl)-5-iodo-7-methyl-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100701

• 2-(4-Fluoro-phen-yl)-4,5-dimethyl-1-(4-methyl-phen-yl)-1H-imidazole.

  Acta crystallographica. Section E, Structure reports online 20100701

• 2-(4-Fluoro-phen-yl)-3-[5-(4-nitro-phen-yl)-1,3,4-thia-diazol-2-yl]-1,3-thia-zolidin-4-one.

  Acta crystallographica. Section E, Structure reports online 20100701

• 4,5,6,7-Tetra-chloro-2-(4-fluoro-phen-yl)isoindoline-1,3-dione.

  Acta crystallographica. Section E, Structure reports online 20100701

• 2-(4-Fluoro-phen-yl)-1-(4-meth-oxy-phen-yl)-4,5-dimethyl-1H-imidazole.

  Acta crystallographica. Section E, Structure reports online 20100701

• N-[3-Chloro-4-(3-fluoro-benz-yloxy)phen-yl]-6-iodo-quinazolin-4-amine.

  Acta crystallographica. Section E, Structure reports online 20100701

• 3-(4-Fluoro-phenyl-sulfon-yl)-2,5,7-trimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100701

• 2,6-Bis(3-fluoro-phen-yl)-3-isopropyl-piperidin-4-one.

  Acta crystallographica. Section E, Structure reports online 20100701

• 3-(4-Fluoro-phenyl-sulfin-yl)-5-iodo-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100701

• Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal.

  Archives of internal medicine 20100628

• Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.

  International journal of cardiology 20100625

• The palladium-catalyzed trifluoromethylation of aryl chlorides.

  Science (New York, N.Y.) 20100625

• Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.

  Journal of medicinal chemistry 20100624

• Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.

  Biological psychiatry 20100615

• JUPITER, rosuvastatin, and the European Medicines Agency.

  Lancet (London, England) 20100612

• Design, synthesis, and insecticidal activities of phthalamides containing a hydrazone substructure.

  Journal of agricultural and food chemistry 20100609

• Rosuvastatin protects tissue perfusion in the experimental testicular torsion model.

  International urology and nephrology 20100601

• Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.

  Journal of lipid research 20100601

• Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.

  Journal of cardiovascular pharmacology and therapeutics 20100601

• Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study.

  Circulation. Cardiovascular genetics 20100601

• Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin.

  Arteriosclerosis, thrombosis, and vascular biology 20100601

• Acute renal failure with the combined use of rosuvastatin and fenofibrate.

  Renal failure 20100601

• Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.

  Nucleosides, nucleotides & nucleic acids 20100601

• METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.

  The Physician and sportsmedicine 20100601

• [The AURORA study].

  Giornale italiano di cardiologia (2006) 20100601

• 3-Ethyl-sulfinyl-2-(4-fluoro-phen-yl)-5,6-methyl-enedi-oxy-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100601

• 5-Bromo-3-(4-fluoro-phenyl-sulfin-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100601

• Highly stereoselective hydrogenations--as key-steps in the total synthesis of statins.

  Chirality 20100515

• Sensory axon targeting is increased by NGF gene therapy within the lesioned adult femoral nerve.

  Experimental neurology 20100501

• Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study.

  Atherosclerosis 20100501

• Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.

  Atherosclerosis 20100501

• ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin.

  Clinical pharmacology and therapeutics 20100501

• Reversal of age-associated memory impairment by rosuvastatin in rats.

  Experimental gerontology 20100501

• Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico.

  Current medical research and opinion 20100501

• CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling.

  Nature neuroscience 20100501

• Microbial degradation of 17beta -estradiol and 17alpha -ethinylestradiol followed by a validated HPLC-DAD method.

  Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 20100501

• Nanobodies as tools for in vivo imaging of specific immune cell types.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20100501

• 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.

  Nuclear medicine and biology 20100501

• By the way, doctor. I take a fiber supplement, but have heard that I shouldn't be taking it at the same times as medication. How far apart should I take fiber and medicines such as Plavix and Crestor?

  Harvard health letter 20100501

• 7-Bromo-2-(4-fluoro-phen-yl)-1-(methyl-sulfin-yl)naphtho[2,1-b]furan.

  Acta crystallographica. Section E, Structure reports online 20100501

• 4-(2-Fluoro-phen-yl)-1-(2-oxoindolin-3-yl-idene)thio-semicarbazide.

  Acta crystallographica. Section E, Structure reports online 20100501

• 5-Bromo-3-ethyl-sulfinyl-2-(4-fluoro-phen-yl)-7-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100501

• 3-Ethyl-sulfinyl-2-(4-fluoro-phen-yl)-5-iodo-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100501

• 3-(4-Fluoro-phenyl-sulfon-yl)-5-isopropyl-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100501

• 2-(4-Fluoro-phen-yl)-N-{4-[6-(4-fluoro-phen-yl)-2,3-dihydro-imidazo[2,1-b][1,3]thia-zol-5-yl]pyridin-2-yl}acetamide.

  Acta crystallographica. Section E, Structure reports online 20100501

• 2-(4-Fluoro-phen-yl)-3-methyl-sulfinyl-5-phenyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100501

• (E)-4-[(4-Fluoro-benzyl-idene)amino]-3-[1-(4-isobutyl-phen-yl)eth-yl]-1-(morpholino-meth-yl)-1H-1,2,4-triazole-5(4H)-thione methanol hemisolvate.

  Acta crystallographica. Section E, Structure reports online 20100501

• Can intensive lipid-lowering therapy with statins ameliorate atherosclerosis in Japanese patients? Rationale and design of the JART study.

  Journal of atherosclerosis and thrombosis 20100430

• Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.

  Annals of internal medicine 20100420

• Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

  Annals of internal medicine 20100420

• Statins for primary prevention in older adults: who is high risk, who is old, and what denotes primary prevention?

  Annals of internal medicine 20100420

• Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.

  NeuroImage 20100415

• Rosuvastatin and cardiovascular continuum when time is important.

  Journal of the American College of Cardiology 20100413

• Pd(OAc)(2) catalyzed olefination of highly electron-deficient perfluoroarenes.

  Journal of the American Chemical Society 20100407

• FDA approves a statin therapy for some: certain, asymptomatic individuals targeted.

  JAMA 20100407

• Pd-catalyzed decarboxylative arylation of thiazole, benzoxazole, and polyfluorobenzene with substituted benzoic acids.

  Organic letters 20100402

• In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects.

  Acta biomaterialia 20100401

• Does baseline carotid intima-media thickness modify the effect of rosuvastatin when compared with placebo on carotid intima-media thickness progression? The METEOR study.

  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20100401

• Use of a combination of prednisolone and rosuvastatin for treatment of a pyogranuloma in a dog.

  Journal of the American Veterinary Medical Association 20100401

• Should we measure C-reactive protein on earth or just on JUPITER?

  Clinical cardiology 20100401

• Enhanced effect of losartan and rosuvastatin on neointima hyperplasia.

  Archives of pharmacal research 20100401

• Achieving treatment goals in low-risk, asymptomatic patients.

  The Journal of the American Osteopathic Association 20100401

• New analysis supports expanded use of statins in women.

  Harvard women's health watch 20100401

• N-[Bis(4-fluoro-phen-yl)methyl-ene]aniline.

  Acta crystallographica. Section E, Structure reports online 20100401

• 2-(4-Chloro-phen-yl)-3-ethyl-sulfinyl-5-fluoro-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100401

• 2-(4-Chloro-phen-yl)-3-methyl-sulfanyl-5-phenyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100401

• Methyl 4,6-bis-(4-fluoro-phen-yl)-2-oxo-cyclo-hex-3-ene-1-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20100401

• 5-Chloro-3-ethyl-sulfinyl-2-(4-fluoro-phen-yl)-7-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100401

• 5-(4-Fluoro-phen-yl)-4-(4-pyrid-yl)-1,3-oxazol-2-amine.

  Acta crystallographica. Section E, Structure reports online 20100401

• Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.

  Journal of the American College of Cardiology 20100323

• Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia.

  Journal of the American College of Cardiology 20100316

• Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.

  Circulation 20100309

• The numbers are in: statins for the primary prevention of cardiovascular disease in women.

  Circulation 20100309

• Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.

  Journal of the American College of Cardiology 20100309

• Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes.

  Toxicology in vitro : an international journal published in association with BIBRA 20100301

• Comparison of sequential rosuvastatin doses in hypercholesterolaemia: a meta-analysis of randomised controlled trials.

  Current medical research and opinion 20100301

• Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database.

  Pharmacoepidemiology and drug safety 20100301

• Persistent regional diastolic dysfunction after myocardial ischemia and the effect of statin treatment: assessment with two-dimensional radial strain rate.

  Echocardiography (Mount Kisco, N.Y.) 20100301

• Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.

  Psychopharmacology 20100301

• Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.

  The Korean journal of internal medicine 20100301

• Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed.

  Cleveland Clinic journal of medicine 20100301

• The effects of rosuvastatin on the serum cortisol, serum lipid, and serum mevalonic acid levels in the healthy Indian male population.

  AAPS PharmSciTech 20100301

• [Effects of rosuvastatin on left ventricular cardiac function, arteriosclerotic plaque and high sensitive C-reactive protein in hypertensive patients with mild LDL-C elevation].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100301

• Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.

  Clinical therapeutics 20100301

• Pharmacokinetics of rosuvastatin in healthy Chinese volunteers living in China: a randomized, open-label, ascending single- and multiple-dose study.

  Clinical therapeutics 20100301

• Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study.

  Archives of cardiovascular diseases 20100301

• N-(2-Fluoro-phen-yl)cinnamamide.

  Acta crystallographica. Section E, Structure reports online 20100301

• 3-(4-Fluoro-phenyl-sulfin-yl)-2,5-dimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100301

• 3-(4-Fluoro-phenyl-sulfin-yl)-2-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100301

• 1-[3,5-Bis(4-fluoro-phen-yl)-4,5-dihydro-1H-pyrazol-1-yl]ethanone.

  Acta crystallographica. Section E, Structure reports online 20100301

• 3-(4-Fluoro-phenyl-sulfin-yl)-2,4,6-trimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100301

• 2-(4-Fluoro-phen-yl)-5,6-methyl-enedi-oxy-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100301

• 3-Ethyl-sulfinyl-2-(4-fluoro-phen-yl)-5-iodo-7-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100301

• 3-(4-Fluoro-phenyl-sulfin-yl)-2,4,6,7-tetra-methyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100301

• (3,6-Dimeth-oxy-2-naphth-yl)(4-fluoro-benzo-yl)methanone.

  Acta crystallographica. Section E, Structure reports online 20100301

• Determination of separate inhibitor and substrate binding sites in the dehaloperoxidase-hemoglobin from Amphitrite ornata.

  Biochemistry 20100216

• Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).

  The American journal of cardiology 20100215

• Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.

  European journal of pharmacology 20100210

• Development and validation of a RP-HPLC method for the determination of gentamicin sulfate and its related substances in a pharmaceutical cream using a short pentafluorophenyl column and a charged aerosol detector.

  Journal of pharmaceutical and biomedical analysis 20100205

• Human skeletal muscle drug transporters determine local exposure and toxicity of statins.

  Circulation research 20100205

• Association of Bicuspid aortic valve morphology and aortic root dimensions: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study.

  Echocardiography (Mount Kisco, N.Y.) 20100201

• Prescribing statins in aortic stenosis: little to lose, much to gain.

  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20100201

• Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers.

  Colloids and surfaces. B, Biointerfaces 20100201

• Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.

  Neuropharmacology 20100201

• Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.

  The Journal of pharmacology and experimental therapeutics 20100201

• The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.

  The pharmacogenomics journal 20100201

• Rosuvastatin induces delayed preconditioning against L-glutamate excitotoxicity in cultured cortical neurons.

  Neurochemistry international 20100201

• Blockade of serotonin 2A receptors prevents PCP-induced attentional performance deficit and CREB phosphorylation in the dorsal striatum of DBA/2 mice.

  Psychopharmacology 20100201

• Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 2.

  Bioorganic & medicinal chemistry letters 20100201

• Visualization and tissue distribution of alpha1L-adrenoceptor in human prostate by the fluorescently labeled ligand Alexa-488-silodosin.

  The Journal of urology 20100201

• Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted [1,3,5]triazines.

  Bioorganic & medicinal chemistry letters 20100201

• Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?

  PLoS medicine 20100201

• Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin.

  Cardiovascular drugs and therapy 20100201

• 6-Chloro-3-[5-(4-fluoro-phen-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl]-2-methyl-4-phenyl-quinoline.

  Acta crystallographica. Section E, Structure reports online 20100201

• (E)-3-(9-Anthr-yl)-1-(4-fluoro-phen-yl)-2-(4-nitro-1H-imidazol-1-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20100201

• 5-Bromo-3-ethyl-sulfinyl-2-(4-fluoro-phenyl)-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100201

• 3-Ethyl-sulfanyl-2-(4-fluoro-phen-yl)-5-phenyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100201

• 5-Chloro-3-ethyl-sulfinyl-2-(4-fluoro-phen-yl)-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100201

• N,N'-Bis-[(E)-2-fluoro-benzyl-idene]-1-(2-fluoro-phen-yl)methane-diamine.

  Acta crystallographica. Section E, Structure reports online 20100201

• 7-[4-(4-Fluoro-phen-yl)-2-methyl-sulfanyl-1H-imidazol-5-yl]tetra-zolo[1,5-a]pyridine.

  Acta crystallographica. Section E, Structure reports online 20100201

• 3-(4-Fluoro-phenyl-sulfin-yl)-2,5,7-trimethyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100201

• Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20100120

• Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial.

  Circulation 20100119

• Characterization of 1,3-alternate calix[4]arene-silica bonded stationary phases and their comparison to selected commercial columns by using principal component analysis.

  Journal of chromatography. A 20100115

• Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonists.

  Bioorganic & medicinal chemistry letters 20100115

• Catalytic SNAr reaction of non-activated fluoroarenes with amines via Ru eta6-arene complexes.

  Chemical communications (Cambridge, England) 20100114

• Public health. U.S. panel favors wider use of preventive drug treatment.

  Science (New York, N.Y.) 20100108

• Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

  Circulation 20100105

• Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.

  AIDS (London, England) 20100102

• The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury.

  Journal of neurotrauma 20100101

• Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.

  Drug metabolism and disposition: the biological fate of chemicals 20100101

• Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.

  Psychopharmacology 20100101

• Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.

  Diabetes research and clinical practice 20100101

• Difluorobenzenes revisited: an experimental and theoretical study of spin-spin coupling constants for 1,2-, 1,3-, and 1,4-difluorobenzene.

  Magnetic resonance in chemistry : MRC 20100101

• Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study.

  Clinical drug investigation 20100101

• An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.

  European journal of heart failure 20100101

• Earth to JUPITER: how a potent statin may actually be detrimental for lifestyle-associated diseases.

  Angiology 20100101

• HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.

  Journal of Korean medical science 20100101

• Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).

  The American journal of cardiology 20100101

• Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

• One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.

  Pharmacology 20100101

• Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

• Effect of rosuvastatin on cholestasis-induced hepatic injury in rat livers.

  Journal of biochemical and molecular toxicology 20100101

• [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].

  Kardiologiia 20100101

• Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.

  Clinical drug investigation 20100101

• Cardiovascular risk in uremic patients: darkness after AURORA.

  Renal failure 20100101

• Is Jupiter also a god of primary prevention?

  Texas Heart Institute journal 20100101

• 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

  Neuropharmacology 20100101

• The Post-JUPITER trial era and the cost of preventive medicine.

  Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101

• Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.

  Journal of Alzheimer's disease : JAD 20100101

• From CARDS to AURORA: one disease, two responses.

  Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101

• Pharmacokinetic/pharmacodynamic modeling and simulation of rosuvastatin using an extension of the indirect response model by incorporating a circadian rhythm.

  Biological & pharmaceutical bulletin 20100101

• Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

• Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial.

  Journal of medical economics 20100101

• The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.

  Clinical hemorheology and microcirculation 20100101

• Determination of rosuvastatin and ezetimibe in a combined tablet dosage form using high-performance column liquid chromatography and high-performance thin-layer chromatography.

  Journal of AOAC International 20100101

• Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.

  Lipids in health and disease 20100101

• Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101

• Disposition and metabolism of ralfinamide, a novel Na-channel blocker, in healthy male volunteers.

  Pharmacology 20100101

• Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101

• A case report of a diabetic woman with very low HDL cholesterol.

  Journal of clinical lipidology 20100101

• Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature.

  Journal of clinical lipidology 20100101

• Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients.

  Journal of clinical lipidology 20100101

• Bioremediation of fluorophenols by glycosylation with immobilized marine microalga amphidinium crassum.

  Environmental health insights 20100101

• Rosuvastatin reduces neointima formation in a rat model of balloon injury.

  European journal of medical research 20100101

• Design and Synthesis of Some Novel 4-(4-substituted aryl) Semicarbazones as Anticonvulsant Agents.

  Indian journal of pharmaceutical sciences 20100101

• A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190.

  The open medicinal chemistry journal 20100101

• Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective.

  Drug design, development and therapy 20100101

• Pitavastatin: evidence for its place in treatment of hypercholesterolemia.

  Core evidence 20100101

• 5-Bromo-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100101

• N-{4-[4-(4-Fluoro-phen-yl)-1-methyl-2-[(R)-methyl-sulfin-yl]-1H-imidazol-5-yl]-2-pyridyl}acetamide dihydrate.

  Acta crystallographica. Section E, Structure reports online 20100101

• 2,4-Bis(2-fluoro-phen-yl)-1-methyl-3-aza-bicyclo-[3.3.1]nonan-9-one.

  Acta crystallographica. Section E, Structure reports online 20100101

• 5-Bromo-2-(4-fluoro-phen-yl)-7-methyl-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100101

• 2-(4-Fluoro-phen-yl)-5-iodo-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20100101

• (E)-1-[(Diphenyl-amino)meth-yl]-4-(4-fluoro-benzyl-ideneamino)-3-[1-(4-iso-butyl-phen-yl)eth-yl]-1H-1,2,4-triazole-5(4H)-thione.

  Acta crystallographica. Section E, Structure reports online 20100101

• Hepatic lipase deficiency in a Middle-Eastern-Arabic male.

  BMJ case reports 20100101

• Clinical efficacy of rosuvastatin in lipid management in Chinese patients in Hong Kong.

  Chinese medical journal 20091205

• Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.

  Journal of cardiovascular pharmacology and therapeutics 20091201

• A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial.

  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20091201

• Enterohepatic disposition of rosuvastatin in pigs and the impact of concomitant dosing with cyclosporine and gemfibrozil.

  Drug metabolism and disposition: the biological fate of chemicals 20091201

• Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice.

  Pharmacoepidemiology and drug safety 20091201

• Rediscovering bile acid sequestrants.

  Diabetes, obesity & metabolism 20091201

• Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion.

  Pacing and clinical electrophysiology : PACE 20091201

• Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes.

  Endocrine 20091201

• Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.

  European journal of heart failure 20091201

• Effect of targeting mitogen-activated protein kinase on cardiac remodeling in rats.

  Journal of cardiovascular pharmacology and therapeutics 20091201

• Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice.

  Current medical research and opinion 20091201

• Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.

  Circulation 20091201

• Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.

  Metabolic syndrome and related disorders 20091201

• Another look at the results of the JUPITER trial.

  The American journal of cardiology 20091201

• Pharmacokinetics of rosuvastatin in patients with end-stage kidney disease undergoing peritoneal dialysis.

  Clinical nephrology 20091201

• Clinical trial update II: Jupiter trial, rosuvastatin has greater efficacy in elderly populations.

  European heart journal 20091201

• Natural product derivative Bis(4-fluorobenzyl)trisulfide inhibits tumor growth by modification of beta-tubulin at Cys 12 and suppression of microtubule dynamics.

  Molecular cancer therapeutics 20091201

• Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.

  Journal of clinical hypertension (Greenwich, Conn.) 20091201

• [The JUPITER study: background and research hypotheses].

  Giornale italiano di cardiologia (2006) 20091201

• [The JUPITER study: critical review of final results].

  Giornale italiano di cardiologia (2006) 20091201

• [JUPITER, what now?].

  Giornale italiano di cardiologia (2006) 20091201

• N-{4-[4-(4-Fluoro-phen-yl)-1-(2-methoxy-ethyl)-2-methyl-sulfanyl-1H-imidazol-5-yl]-2-pyrid-yl}-2-methyl-3-phenyl-propionamide.

  Acta crystallographica. Section E, Structure reports online 20091201

• (2Z)-2-Fluoro-N-{4-[5-(4-fluoro-phen-yl)-2-methyl-sulfanyl-1H-imidazol-4-yl]-2-pyrid-yl}-3-phenyl-acrylamide.

  Acta crystallographica. Section E, Structure reports online 20091201

• Identifying reactive intermediates in the Ullmann coupling reaction by scanning tunneling microscopy and spectroscopy.

  The journal of physical chemistry. A 20091126

• The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.

  International journal of cardiology 20091112

• High-performance liquid chromatographic method for determination of amino acids by precolumn derivatization with 4-chloro-3,5-dinitrobenzotrifluoride.

  Analytica chimica acta 20091110

• Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

  Journal of the American College of Cardiology 20091110

• Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?

  Journal of the American College of Cardiology 20091110

• Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.

  Journal of internal medicine 20091101

• Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.

  The Journal of pharmacology and experimental therapeutics 20091101

• Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.

  Psychopharmacology 20091101

• Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.

  Current medical research and opinion 20091101

• Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).

  Circulation journal : official journal of the Japanese Circulation Society 20091101

• Cosmic effect of rosuvastatin in COSMOS.

  Circulation journal : official journal of the Japanese Circulation Society 20091101

• Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease.

  The Annals of thoracic surgery 20091101

• [From lipid target values to the JUPITER study. Significance of achieving lipid levels specified by the guidelines and deficiencies in practice].

  Orvosi hetilap 20091101

• Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples.

  Chemosphere 20091101

• Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA.

  Expert review of cardiovascular therapy 20091101

• Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).

  Circulation. Cardiovascular quality and outcomes 20091101

• Implications of dibenzyl trisulphide for disease treatment based on its mode of action.

  The West Indian medical journal 20091101

• (E)-3-(9-Anthr-yl)-1-(4-fluoro-phen-yl)-2-(1H-1,2,4-triazol-1-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20091101

• 5-Fluoro-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20091101

• 3-(4-Fluoro-phen-yl)-2-(2-naphth-yloxy)-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile.

  Acta crystallographica. Section E, Structure reports online 20091101

• 5-Chloro-2-(4-fluoro-phen-yl)-3-methyl-sulfinyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20091101

• 2-(4-Fluoro-phen-yl)-3-methyl-sulfanyl-5-phenyl-1-benzofuran.

  Acta crystallographica. Section E, Structure reports online 20091101

• 4-(4-Fluoro-phen-yl)-1-methoxy-methyl-2-phenyl-1H-imidazole.

  Acta crystallographica. Section E, Structure reports online 20091101

• N'-[(E)-1-(3-Fluoro-phen-yl)ethyl-idene]formohydrazide.

  Acta crystallographica. Section E, Structure reports online 20091101

• 2-(tert-Butoxy-carbonyl-amino)-2-(2-fluoro-phen-yl)acetic acid.

  Acta crystallographica. Section E, Structure reports online 20091101

• Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.

  Basic & clinical pharmacology & toxicology 20091001

• Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.

  Journal of cardiovascular pharmacology 20091001

• Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.

  European heart journal 20091001

• Liquid chromatography-electrospray ionization-mass spectrometric quantitation of juvenile hormone III in whole body extracts of the Formosan subterranean termite.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091001

• Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.

  Annals of the rheumatic diseases 20091001

• Effect of the HMG-CoA reductase inhibitor rosuvastatin on early chronic kidney injury in obese zucker rats fed with an atherogenic diet.

  The American journal of the medical sciences 20091001

• [The role of statins in the treatment of heart failure].

  Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20091001

• [C-reactive protein and coronary heart disease: quo vadis?].

  MMW Fortschritte der Medizin 20091001

• 4-(4-Chloro-phen-yl)-1-[3-(4-fluoro-benzo-yl)prop-yl]-4-hydroxy-piperidin-1-ium 2,4,6-trinitro-phenolate (haloperidol picrate).

  Acta crystallographica. Section E, Structure reports online 20091001

• 2-(4-Fluoro-phen-yl)-3-(4-pyrid-yl)pyrido[2,3-b]pyrazine.

  Acta crystallographica. Section E, Structure reports online 20091001

• 3-(4-Fluoro-phen-yl)-2-(4-pyrid-yl)pyrido[2,3-b]pyrazine.

  Acta crystallographica. Section E, Structure reports online 20091001

• N-{4-[3-(4-Fluoro-phen-yl)pyrido[2,3-b]pyrazin-2-yl]-2-pyrid-yl}isopropyl-amine.

  Acta crystallographica. Section E, Structure reports online 20091001

• Statins and angiogenesis: is it about connections?

  Biochemical and biophysical research communications 20090925

• Dissociation dynamics of C(6)H(6) and C(6)H(5)F molecules following carbon 1s and fluorine 1s photoionization studied by three-dimensional momentum imaging method.

  The Journal of chemical physics 20090921

• [Sympathetic nerve in rat with pressure overload left ventricular hypertrophy].

  Zhonghua yi xue za zhi 20090915

• Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.

  Journal of lipid research 20090901

• Enhanced 5-HT(2A) receptors in brain stem and ALDH activity in brain stem and liver: 5-HT(2A) regulation on ALDH in primary hepatocytes cultures in vitro.

  Neurochemical research 20090901

• A validated HPLC-fluorescence method with a semi-micro column for routine determination of homocysteine, cysteine and cysteamine, and the relation between the thiol derivatives in normal human plasma.

  Biomedical chromatography : BMC 20090901

• Induction of RISK by HMG-CoA reductase inhibition affords cardioprotection after myocardial infarction.

  Atherosclerosis 20090901

• Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.

  Psychopharmacology 20090901

• Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.

  Hypertension (Dallas, Tex. : 1979) 20090901

• Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.

  Schizophrenia research 20090901

• Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.

  American journal of physiology. Heart and circulatory physiology 20090901

• Ion-pairing high-performance liquid chromatography determination of amitrole in apple after solid-phase extraction and precolumn derivatization.

  Analytical and bioanalytical chemistry 20090901

• Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.

  International journal of clinical practice 20090901

• Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.

  Expert review of cardiovascular therapy 20090901

• [To treat or not to treat with statins patients with chronic heart failure?].

  Vnitrni lekarstvi 20090901

• 4-[(4-Fluoro-benzyl-idene)amino]-3-[1-(4-isobutyl-phen-yl)eth-yl]-1H-1,2,4-triazole-5(4H)-thione.

  Acta crystallographica. Section E, Structure reports online 20090901

• Intramolecular charge transfer with 4-fluorofluorazene and the flexible 4-fluoro-N-phenylpyrrole.

  The journal of physical chemistry. A 20090820

• Most would fail to benefit from JUPITER Intervention.

  Journal of the American College of Cardiology 20090818

• Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.

  Journal of medicinal chemistry 20090813

• Synthetically useful Brønsted acid-promoted arylbenzyl ether --> o-benzylphenol rearrangements.

  The Journal of organic chemistry 20090807

• Binding sites, rotational conformers, and electronic states of Sc-C6H5X (X = F, CH3, OH, and CN) probed by pulsed-field-ionization electron spectroscopy.

  The Journal of chemical physics 20090807

• Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients.

  Journal of thrombosis and thrombolysis 20090801

• Insights into atherosclerosis from invasive and non-invasive imaging studies: Should we treat subclinical atherosclerosis?

  Atherosclerosis 20090801

• Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.

  Synapse (New York, N.Y.) 20090801

• Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.

  Psychopharmacology 20090801

• The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.

  Therapeutic advances in cardiovascular disease 20090801

• ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

  Clinical pharmacology and therapeutics 20090801

• Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?

  Cardiovascular drugs and therapy 20090801

• QSAR Studies on antiepileptic and locomotor in vivo activities of 4,5-diphenyl-1H-imidazoles.

  Chemical biology & drug design 20090801

• Severe HIV-associated hypertriglyceridaemia treated with rosuvastatin plus omega-3 fatty acids.

  International journal of STD & AIDS 20090801

• Alternate day dosing of rosuvastatin: potential usefulness in statin-intolerant patients.

  The Canadian journal of cardiology 20090801

• No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

  British journal of clinical pharmacology 20090801

• Effects of rosuvastatin on low-density lipoprotein cholesterol and plasma lipids in Asian patients with hypercholesterolemia.

  Journal of atherosclerosis and thrombosis 20090801

• Rosuvastatin for cardiovascular prevention: too many uncertainties.

  Prescrire international 20090801

• [Significance of determination of lipid-oxidizing catalytic antibodies in patients with ischemic heart diseases].

  Klinicheskaia laboratornaia diagnostika 20090801

• A second polymorph of (2E)-1-(4-fluoro-phen-yl)-3-(3,4,5-trimethoxy-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20090801

• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

  Lancet (London, England) 20090704

• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

  Lancet (London, England) 20090704

• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

  Lancet (London, England) 20090704

• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

  Lancet (London, England) 20090704

• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

  Lancet (London, England) 20090704

• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

  Lancet (London, England) 20090704

• Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.

  Lancet (London, England) 20090704

• Rosuvastatin in patients undergoing hemodialysis.

  The New England journal of medicine 20090702

• Rosuvastatin in patients undergoing hemodialysis.

  The New England journal of medicine 20090702

• Rosuvastatin in patients undergoing hemodialysis.

  The New England journal of medicine 20090702

• Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice.

  Atherosclerosis 20090701

• Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels.

  Atherosclerosis 20090701

• Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.

  Neuropharmacology 20090701

• Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.

  ChemMedChem 20090701

• Activation of glucocorticoid receptors increases 5-HT2A receptor levels.

  Experimental neurology 20090701

• Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage.

  Metabolism: clinical and experimental 20090701

• Moving toward new statin guidelines in a post-JUPITER world: principles to consider.

  Current atherosclerosis reports 20090701

• Statins and venous thromboembolism: a novel effect of statins?

  Current medical research and opinion 20090701

• The Jupiter trial--new territory for statins?

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090701

• Solid-phase extraction and residue determination of glyphosate in apple by ion-pairing reverse-phase liquid chromatography with pre-column derivatization.

  Journal of separation science 20090701

• The effects of sustained release metofluthrin on the biting, movement, and mortality of Aedes aegypti in a domestic setting.

  The American journal of tropical medicine and hygiene 20090701

• Statin therapy in patients with heart failure and preserved left ventricular function.

  Circulation journal : official journal of the Japanese Circulation Society 20090701

• Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study).

  The American journal of cardiology 20090701

• Enhanced cholinergic response in pancreata of nonhuman primates with impaired glucose tolerance shown on [18F]fluorobenzyltrozamicol positron emission tomography.

  Diabetes technology & therapeutics 20090701

• Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.

  Expert review of cardiovascular therapy 20090701

• Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.

  Current vascular pharmacology 20090701

• Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.

  JACC. Cardiovascular interventions 20090701

• Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.

  JACC. Cardiovascular interventions 20090701

• Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?

  JACC. Cardiovascular interventions 20090701

• Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.

  Archives of medical research 20090701

• 4,8,9,10-Tetra-kis(4-fluoro-phen-yl)-1,3-diaza-tricyclo-[3.3.1.1]decan-6-one.

  Acta crystallographica. Section E, Structure reports online 20090701

• 2,4-Bis(2-fluoro-phen-yl)-3-aza-bicyclo-[3.3.1]nonan-9-one.

  Acta crystallographica. Section E, Structure reports online 20090701

• 3-(4-Fluoro-phen-yl)-6-meth-oxy-2-(4-pyrid-yl)quinoxaline.

  Acta crystallographica. Section E, Structure reports online 20090701

• 4-Fluoro-N-[3-(2-fluoro-phen-yl)-4-methyl-2,3-dihydro-2-thienyl-idene]benzamide.

  Acta crystallographica. Section E, Structure reports online 20090701

• Determination of amitrole in environmental water samples with precolumn derivatization by high-performance liquid chromatography.

  Journal of agricultural and food chemistry 20090610

• Versatile Pd(OTf)2 x 2 H2O-catalyzed ortho-fluorination using NMP as a promoter.

  Journal of the American Chemical Society 20090610

• Exceptional sensitivity of metal-aryl bond energies to ortho-fluorine substituents: influence of the metal, the coordination sphere, and the spectator ligands on M-C/H-C bond energy correlations.

  Journal of the American Chemical Society 20090610

• Peptide surface modification of P(HEMA-co-MMA)-b-PIB-b-P(HEMA-co-MMA) block copolymers.

  Langmuir : the ACS journal of surfaces and colloids 20090602

• Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907.

  The international journal of neuropsychopharmacology 20090601

• Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

  Journal of lipid research 20090601

• Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study.

  Diabetes care 20090601

• Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.

  Journal of internal medicine 20090601

• The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons.

  Journal of neurochemistry 20090601

• Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.

  Arteriosclerosis, thrombosis, and vascular biology 20090601

• The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients.

  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20090601

• The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.

  Journal of neurochemistry 20090601

• Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia.

  Appetite 20090601

• [The JUPITER study emphasizes primary prevention].

  Lakartidningen 20090601

• The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.

  Acta cardiologica 20090601

• [The JUPITER study poses more questions than answers].

  Lakartidningen 20090601

• [JUPITER--think first, act subsequently!].

  Lakartidningen 20090601

• [Treat the primary cause of inflammation in overweight individuals without symptoms of coronary disease].

  Lakartidningen 20090601

• Automated liquid-liquid extraction method for high-throughput analysis of rosuvastatin in human EDTA K2 plasma by LC-MS/MS.

  Bioanalysis 20090601

• Dimethyl [(4-fluoro-phen-yl)(6-methoxy-benzothia-zol-2-ylamino)meth-yl]phospho-nate.

  Acta crystallographica. Section E, Structure reports online 20090601

• 4-[3-(4-Fluoro-phen-yl)quinoxalin-2-yl]-N-isopropyl-pyridin-2-amine.

  Acta crystallographica. Section E, Structure reports online 20090601

• 4-(4-Fluoro-phen-yl)-2-oxo-1,2,5,6-tetra-hydro-benzo[h]quinoline-3-carbonitrile.

  Acta crystallographica. Section E, Structure reports online 20090601

• 6-(1-Adamant-yl)-3-(2-fluoro-phen-yl)-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole.

  Acta crystallographica. Section E, Structure reports online 20090601

• 1-[2-(Benzyl-amino)-4-pyrid-yl]-2-(4-fluoro-phen-yl)ethane-1,2-dione.

  Acta crystallographica. Section E, Structure reports online 20090601

• Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.

  Journal of medicinal chemistry 20090528

• Identification and simultaneous determination of p-FHA and p-FBA, two metabolites of anti-tumor agent--Fluorapacin in rat urine.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090515

• The editor's roundtable: the JUPITER trial--initial results and clinical implications.

  The American journal of cardiology 20090515

• Improved pharmacokinetic and bioavailability support of drug discovery using serial blood sampling in mice.

  Journal of pharmaceutical sciences 20090501

• LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia.

  Atherosclerosis 20090501

• Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.

  Atherosclerosis 20090501

• Utility of MetaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-acetamide.

  Drug metabolism and disposition: the biological fate of chemicals 20090501

• Exaggerated benefits of rosuvastatin compared with other statins.

  Pharmacoepidemiology and drug safety 20090501

• Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.

  Haematologica 20090501

• Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

  Advances in therapy 20090501

• The gravity of JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin).

  Postgraduate medicine 20090501

• [The JUPITER study].

  Giornale italiano di cardiologia (2006) 20090501

• Glycosylation of fluorophenols by plant cell cultures.

  International journal of molecular sciences 20090501

• [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].

  Lakartidningen 20090501

• [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].

  Lakartidningen 20090501

• Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.

  Future cardiology 20090501

• The JUPITER trial: results, controversies, and implications for prevention.

  Circulation. Cardiovascular quality and outcomes 20090501

• JUPITER: a few words of caution.

  Circulation. Cardiovascular quality and outcomes 20090501

• A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

  The New England journal of medicine 20090430

• Simultaneous telemetric monitoring of tail-skin and core body temperature in a rat model of thermoregulatory dysfunction.

  Journal of neuroscience methods 20090415

• Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety.

  Bioorganic & medicinal chemistry letters 20090415

• Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.

  Bioorganic & medicinal chemistry 20090415

• Experimental and theoretical study of the Br...N halogen bond in complexes of 1,4-dibromotetrafluorobenzene with dipyridyl derivatives.

  The journal of physical chemistry. A 20090409

• Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes.

  Toxicology 20090405

• Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

  Lancet (London, England) 20090404

• Bringing JUPITER down to earth.

  Lancet (London, England) 20090404

• Lipid lowering for primary prevention.

  Lancet (London, England) 20090404

• Sunset for statins after AURORA?

  The New England journal of medicine 20090402

• Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

  The New England journal of medicine 20090402

• Study of the voltammetric behaviour of the ethalfluralin and methalpropalin and its determination in environmental matrices at hanging mercury drop electrode.

  Environmental monitoring and assessment 20090401

• Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.

  Journal of lipid research 20090401

• Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.

  Pharmaceutical research 20090401

• Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.

  Journal of molecular and cellular cardiology 20090401

• Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin.

  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20090401

• Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.

  International journal of clinical practice 20090401

• Study stirs debate about statin use in those without high cholesterol.

  Mayo Clinic women's healthsource 20090401

• Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.

  Southern medical journal 20090401

• Significant progress in predicting the crystal structures of small organic molecules--a report on the fourth blind test.

  Acta crystallographica. Section B, Structural science 20090401

• [Rosuvastatin in patients with chronic heart failure].

  Der Internist 20090401

• Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model.

  Behavioral neuroscience 20090401

• Using statins to treat 'healthy' patients: are we there yet?

  Expert review of pharmacoeconomics & outcomes research 20090401

• [The JUPITER trial: a new approach in primary prevention].

  Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20090401

• cis-Bis[2-(1,3-benzothia-zol-2-yl)-1-(4-fluoro-phen-yl)ethen-yl](pentane-2,4-dionato-κO,O')iridium(III).

  Acta crystallographica. Section E, Structure reports online 20090401

• 4-Fluoro-N-methyl-N-(1,2,3,4-tetra-hydro-carbazol-3-yl)benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20090401

• 2-Fluoro-N-(4-methoxy-phen-yl)benzamide.

  Acta crystallographica. Section E, Structure reports online 20090401

• 1-(4-Chloro-phenyl-sulfon-yl)-5-(4-fluoro-phen-yl)-5-methyl-imidazolidine-2,4-dione.

  Acta crystallographica. Section E, Structure reports online 20090401

• 1-(2-Fluoro-phen-yl)-6,7-dimethoxy-isochroman.

  Acta crystallographica. Section E, Structure reports online 20090401

• Blockade of 5-HT2A receptors suppresses hyperthermic but not cardiovascular responses to psychosocial stress in rats.

  Neuroscience 20090331

• Shape-persistent macrocycles comprising perfluorinated benzene subunits: synthesis, aggregation behaviour and unexpected mu-rod formation.

  Organic & biomolecular chemistry 20090321

• Reactions within p-difluorobenzene/methanol heterocluster ions: a detailed experimental and theoretical investigation.

  The journal of physical chemistry. A 20090319

• Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.

  Journal of the American College of Cardiology 20090317

• Oligomerization of styrenes mediated by cationic allyl nickel complexes containing triphenylstibine or triphenylarsine.

  Dalton transactions (Cambridge, England : 2003) 20090314

• Residue determination of glyphosate in environmental water samples with high-performance liquid chromatography and UV detection after derivatization with 4-chloro-3,5-dinitrobenzotrifluoride.

  Analytica chimica acta 20090309

• Hydrogen bonding to multifunctional molecules: spectroscopic and ab initio investigation of water complexes of fluorophenylacetylenes.

  The journal of physical chemistry. A 20090305

• JUPITER clinical directions--polling results.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Rosuvastatin in patients with elevated C-reactive protein.

  The New England journal of medicine 20090305

• Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice?

  Clinical immunology (Orlando, Fla.) 20090301

• Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.

  The Journal of pharmacology and experimental therapeutics 20090301

• Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.

  Journal of cardiovascular pharmacology and therapeutics 20090301

• Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.

  European journal of heart failure 20090301

• Rosuvastatin positively changes nerve electrophysiology in diabetic rats.

  Diabetes/metabolism research and reviews 20090301

• Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation.

  Toxicological sciences : an official journal of the Society of Toxicology 20090301

• Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action.

  Toxicological sciences : an official journal of the Society of Toxicology 20090301

• JUPITER: wake up and smell the coffee--the absolute and relative merits of statin use.

  International journal of clinical practice 20090301

• Quantitative and qualitative effects of rosuvastatin on LDL-cholesterol: what is the clinical significance?

  International journal of clinical practice 20090301

• JUPITER strikes earth.

  Nature clinical practice. Cardiovascular medicine 20090301

• The Jupiter trial: key findings, controversies, and implications.

  Current cardiology reports 20090301

• Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.

  Journal of cardiovascular pharmacology and therapeutics 20090301

• Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.

  Journal of hypertension 20090301

• Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

  The journal of sexual medicine 20090301

• [The GISSI-HF trial].

  Giornale italiano di cardiologia (2006) 20090301

• The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.

  South Dakota medicine : the journal of the South Dakota State Medical Association 20090301

• 4-[2-(4-Fluoro-phen-yl)-1H-pyrrol-3-yl]pyridine.

  Acta crystallographica. Section E, Structure reports online 20090301

• 4-[2-(4-Fluoro-phen-yl)furan-3-yl]pyridine.

  Acta crystallographica. Section E, Structure reports online 20090301

• 2-Fluoro-N-(2-fluoro-benzo-yl)-N-(2-pyrid-yl)benzamide.

  Acta crystallographica. Section E, Structure reports online 20090301

• 4-[5-(4-Fluoro-phen-yl)-1H-imidazol-4-yl]pyridine.

  Acta crystallographica. Section E, Structure reports online 20090301

• Determination of biogenic amines in beer with pre-column derivatization by high performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090215

• Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.

  The American journal of cardiology 20090215

• [Statin therapy and muscle disorders].

  Orvosi hetilap 20090208

• Lariat ethers with fluoroaryl side-arms: a study of CFmetal cation interaction in the complexes of N-(o-fluoroaryl)azacrown ethers.

  Dalton transactions (Cambridge, England : 2003) 20090207

• [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].

  Nederlands tijdschrift voor geneeskunde 20090207

• [JUPITER study (2). For now no reason to give statins to more people].

  Nederlands tijdschrift voor geneeskunde 20090207

• [Less vascular risk with rosuvastatin in elevated CRP].

  Nederlands tijdschrift voor geneeskunde 20090207

• Analytic calculations of nonlinear mixed electric and magnetic frequency-dependent molecular properties using London atomic orbitals: Buckingham birefringence.

  Physical chemistry chemical physics : PCCP 20090207

• Comparison of electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization for determining estrogenic chemicals in water by liquid chromatography tandem mass spectrometry with chemical derivatizations.

  Journal of chromatography. A 20090206

• Efficient method for the synthesis of 2,3-unsubstituted nitro containing indoles from o-fluoronitrobenzenes.

  Organic letters 20090205

• [Comment from the lipidologic viewpoint].

  Praxis 20090204

• [Comment from the cardiologic viewpoint].

  Praxis 20090204

• [Comment from the family practice viewpoint].

  Praxis 20090204

• Rosuvastatin protects against podocyte apoptosis in vitro.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090201

• Therapeutic traditions, patient socioeconomic characteristics and physicians' early new drug prescribing--a multilevel analysis of rosuvastatin prescription in south Sweden.

  European journal of clinical pharmacology 20090201

• Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent.

  Drug metabolism and disposition: the biological fate of chemicals 20090201

• Is hsCRP Back on Board? Implications from the JUPITER Trial.

  Clinical chemistry 20090201

• Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study.

  Clinical chemistry 20090201

• Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.

  Archiv der Pharmazie 20090201

• Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?

  Metabolism: clinical and experimental 20090201

• Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance.

  The American journal of cardiology 20090201

• [Pharmacogenomics: inter-ethnic and intra-ethnic differences in pharmacokinetic and pharmacodynamic profiles of clinically relevant drugs].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20090201

• Reduced efficacy of rosuvastatin by St. John's Wort.

  The American journal of medicine 20090201

• Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.

  Journal of cardiovascular pharmacology 20090201

• Use of statins for the treatment of spontaneous intracerebral hemorrhage: results of a pilot study.

  Central European neurosurgery 20090201

• Efficacy of alternate day versus daily dosing of rosuvastatin.

  The Canadian journal of cardiology 20090201

• Dual radiotracer analysis of cholinergic neuronal changes in prediabetic mouse pancreas.

  Diabetes technology & therapeutics 20090201

• N-(3-Bromo-1,4-dioxo-1,4-dihydro-2-naphth-yl)-4-fluoro-N-(4-fluoro-benzo-yl)benzamide.

  Acta crystallographica. Section E, Structure reports online 20090201

• N-3 polyunsaturated fatty acids and statins in heart failure.

  Lancet (London, England) 20090131

• Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20090128

• Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists.

  Bioorganic & medicinal chemistry 20090115

• Studies examine inflammatory biomarker in prevention and prediction of heart disease.

  JAMA 20090107

• Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090101

• Skin blood flowmotion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases.

  Physiological research 20090101

• Models for the analysis of C-reactive protein in statin trials.

  Pharmaceutical statistics 20090101

• Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia.

  Journal of lipid research 20090101

• Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine].

  Pharmacology, biochemistry, and behavior 20090101

• ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.

  Journal of clinical pharmacology 20090101

• Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons.

  American journal of physiology. Cell physiology 20090101

• Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.

  Journal of neurochemistry 20090101

• Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging.

  Circulation journal : official journal of the Japanese Circulation Society 20090101

• A case of asymptomatic cytoplasmic body myopathy revealed by sinvastatin.

  Neuromuscular disorders : NMD 20090101

• Surprises and reaffirmations in 2008 clinical trials.

  Cleveland Clinic journal of medicine 20090101

• Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?

  Cleveland Clinic journal of medicine 20090101

• Concern still warranted: medication burden and persistence with lipid-lowering drugs.

  The American journal of managed care 20090101

• Beneficial effect of rosuvastatin on cardiac dysfunction is associated with alterations in calcium-regulatory proteins.

  European journal of heart failure 20090101

• Rosuvastatin induced rhabdomyolysis in a low risk patient: a case report and review of the literature.

  Current clinical pharmacology 20090101

• In vivo saturation binding of GABA-A receptor ligands to estimate receptor occupancy using liquid chromatography/tandem mass spectrometry.

  Biopharmaceutics & drug disposition 20090101

• Comparison of different methods to investigate postprandial lipaemia.

  The Netherlands journal of medicine 20090101

• Jupiter to Earth: CRP promotes atherothrombosis.

  Metabolic syndrome and related disorders 20090101

• Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy.

  Xenobiotica; the fate of foreign compounds in biological systems 20090101

• Rosuvastatin in hemodialysis: short-term effects on lipids and C-reactive protein.

  Journal of nephrology 20090101

• [Rosuvastatin and fenofibrate in patients with diabetes and low high density lipoprotein cholesterol: comparison of changes of lipid levels and some markers of inflammation].

  Kardiologiia 20090101

• Rosuvastatin-induced rhabdomyolysis probably via CYP2C9 saturation.

  Drug metabolism and drug interactions 20090101

• Efficacy and safety of rosuvastatin in the management of dyslipidemia.

  Vascular health and risk management 20090101

• Prevention of atherosclerosis in patients living with HIV.

  Vascular health and risk management 20090101

• [Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial].

  Kardiologiia 20090101

• [Effect of therapy with rosuvastatin on circulating endothelial progenitor cells in patients with chronic heart failure].

  Kardiologiia 20090101

• JUPITER study highlights value of anti-inflammatory action of rosuvastatin.

  Cardiovascular journal of Africa 20090101

• The JUPITER trial: How will it change clinical practice?

  Reviews in cardiovascular medicine 20090101

• [Rosuvastatin attenuates vascular endothelial adhesiveness in apolipoprotein E-deficient mice].

  Zhonghua xin xue guan bing za zhi 20090101

• Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?

  World review of nutrition and dietetics 20090101

• Cytotoxicity of 1-aryl-3-buthylamino-1-propanone hydrochlorides against Jurkat and L6 cells.

  Arzneimittel-Forschung 20090101

• Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia.

  Journal of nephrology 20090101

• Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemia.

  Internal medicine (Tokyo, Japan) 20090101

• Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals.

  Vascular health and risk management 20090101

• Antimicrobial action of atorvastatin and rosuvastatin.

  Pathology 20090101

• The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences.

  Vascular health and risk management 20090101

• [Rosuvastatin in prevention of cardiac complications following surgical treatment of patients with vascular pathology].

  Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery 20090101

• Comparative single- and multiple-dose pharmacokinetics of rosuvastatin following oral administration in Chinese volunteers.

  European journal of drug metabolism and pharmacokinetics 20090101

• 3-Fluoro-N-(3-fluoro-benzo-yl)-N-(2-pyrid-yl)benzamide.

  Acta crystallographica. Section E, Structure reports online 20090101

• 3-[3-(3-Fluoro-phen-yl)-1,2,4-oxadiazol-5-yl]propionic acid.

  Acta crystallographica. Section E, Structure reports online 20090101

• 2-Fluoro-N-o-tolyl-benzamide.

  Acta crystallographica. Section E, Structure reports online 20090101

• 2,2'-Bis(4-fluoro-anilino)-3,3'-(3,6-dioxa-octane-1,8-di-yl)diquinazolin-4(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20090101

• (Z)-Ethyl 3-(4-chloro-benzamido)-2-cyano-3-(4-fluoro-phen-yl)acrylate.

  Acta crystallographica. Section E, Structure reports online 20090101

• [By JUPITER! Disease mongering!].

  Lakartidningen 20081217

• Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.

  The American journal of cardiology 20081215

• [Sequelae of the JUPITER study. What is changing in primary prevention? (interview by Dr. med. Dirk Einecke)].

  MMW Fortschritte der Medizin 20081204

• [Statin cuts cardiovascular risk in half].

  MMW Fortschritte der Medizin 20081204

• Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20081201

• Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20081201

• Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation.

  Psychopharmacology 20081201

• The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.

  The Journal of pharmacology and experimental therapeutics 20081201

• Poly(ethylene glycol)-based stable isotope labeling reagents for the quantitative analysis of low molecular weight metabolites by LC-MS.

  Analytical chemistry 20081201

• Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults.

  Expert opinion on pharmacotherapy 20081201

• Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.

  European journal of heart failure 20081201

• Intensive lipid-lowering therapy for patients with aortic stenosis.

  The American journal of cardiology 20081201

• Four 2-amino-6-aryl-4-methoxy-11H-pyrimido[4,5-b][1,4]benzodiazepines: similar molecular structures but different crystal structures.

  Acta crystallographica. Section C, Crystal structure communications 20081201

• Superior benefit of aggressive lipid-lowering therapy for high- risk patients using statins: the SUBARU study--more hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin therapy.

  Journal of atherosclerosis and thrombosis 20081201

• A high-throughput functional assay for characterization of gamma-aminobutyric acid(A) channel modulators using cryopreserved transiently transfected cells.

  Assay and drug development technologies 20081201

• Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.

  The Journal of thoracic and cardiovascular surgery 20081201

• GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes.

  Annals of the New York Academy of Sciences 20081201

• Enantioseparation of chiral sulfoxides using teicoplanine chiral stationary phases and kinetic study of decomposition in human plasma.

  Die Pharmazie 20081201

• [JUPITER: reduction by rosuvastatin of cardiovascular events and mortality in healthy subjects without hyperlipidaemia but with elevated C-reactive protein].

  Revue medicale de Liege 20081201

• Lack of insecticidal effect of mosquito coils containing either metofluthrin or esbiothrin on Anopheles gambiae sensu lato mosquitoes.

  Tropical biomedicine 20081201

• Achieving lipid goals with rosuvastatin compared with simvastatin in high risk patients in real clinical practice: a randomized, open-label, parallel-group, multi-center study: the DISCOVERY-Beta study.

  Vascular health and risk management 20081201

• Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia.

  Vascular health and risk management 20081201

• (Z)-Ethyl 3-(4-chloro-phen-yl)-2-cyano-3-(2,6-difluoro-benzamido)acrylate.

  Acta crystallographica. Section E, Structure reports online 20081201

• 3-(3-Fluoro-benz-yl)-1H-isochromen-1-one.

  Acta crystallographica. Section E, Structure reports online 20081201

• 2-(2-Fluoro-benzoyl-meth-yl)benzoic acid.

  Acta crystallographica. Section E, Structure reports online 20081201

• (E)-Ethyl 3-(4-fluoro-anilino)-2-(4-methoxy-phen-yl)acrylate.

  Acta crystallographica. Section E, Structure reports online 20081201

• Cationic terminal gallylene complexes by halide abstraction: coordination chemistry of a valence isoelectronic analogue of CO and N2.

  Journal of the American Chemical Society 20081126

• Letter by Kaneda regarding article, 'Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden'.

  Circulation 20081125

• Letter by Sutton et al regarding article, 'Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden'.

  Circulation 20081125

• Expanding the orbit of primary prevention--moving beyond JUPITER.

  The New England journal of medicine 20081120

• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  The New England journal of medicine 20081120

• Adsorption of well-defined fluorine-containing polymers onto poly(tetrafluoroethylene).

  Langmuir : the ACS journal of surfaces and colloids 20081118

• Cardiovascular health. Statin therapy reduces disease in healthy volunteers--but how, exactly?

  Science (New York, N.Y.) 20081114

• Trial stopped early after rosuvastatin found to cut the risk of heart attack and stroke by 44% in healthy people.

  BMJ (Clinical research ed.) 20081112

• Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.

  Journal of pharmaceutical and biomedical analysis 20081104

• Determinants of the unexpected stability of RNA fluorobenzene self pairs.

  Chembiochem : a European journal of chemical biology 20081103

• Impact of adherence to statins on chronic heart failure in primary prevention.

  British journal of clinical pharmacology 20081101

• Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis.

  American journal of physiology. Heart and circulatory physiology 20081101

• The effects of volatile aromatic anesthetics on voltage-gated Na+ channels expressed in Xenopus oocytes.

  Anesthesia and analgesia 20081101

• Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors.

  Current HIV research 20081101

• 6-(2-Fluoro-phen-yl)-5,6-dihydro-benzimidazolo[1,2-c]quinazoline.

  Acta crystallographica. Section E, Structure reports online 20081101

• 3-Fluoro-N-(p-tol-yl)benzamide.

  Acta crystallographica. Section E, Structure reports online 20081101

• N-Cyclo-hexyl-2-fluoro-benzamide.

  Acta crystallographica. Section E, Structure reports online 20081101

• (Z)-3-(4-Fluoro-phen-yl)-1-[4-(methyl-sulfon-yl)phen-yl]-2-tosyl-prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20081101

• N-Cyclo-hexyl-3-fluoro-benzamide.

  Acta crystallographica. Section E, Structure reports online 20081101

• tert-Butyl N-benzyl-N-[4-(4-fluoro-benzoyl-meth-yl)-2-pyrid-yl]carbamate.

  Acta crystallographica. Section E, Structure reports online 20081101

• 1,1-Bis(4-fluoro-phen-yl)-3,4-dihydro-1H-1,3-oxazino[3,4-a]indole.

  Acta crystallographica. Section E, Structure reports online 20081101

• 3-(2-Amino-ethyl)-2-(4-fluoroanilino)-quinazolin-4(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20081101

• A new Met inhibitory-scaffold identified by a focused forward chemical biological screen.

  Biochemical and biophysical research communications 20081017

• Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat.

  Pain 20081015

• Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

  Lancet (London, England) 20081004

• The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.

  Pharmacoepidemiology and drug safety 20081001

• The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.

  Pharmacoepidemiology and drug safety 20081001

• Human proximal tubular epithelium actively secretes but does not retain rosuvastatin.

  Molecular pharmacology 20081001

• Determination of serum methylmalonic acid by alkylative extraction and liquid chromatography coupled to tandem mass spectrometry.

  Analytical biochemistry 20081001

• Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin.

  Drug metabolism and disposition: the biological fate of chemicals 20081001

• Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20081001

• Rosuvastatin reduces intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease: the Asymptomatic Carotid Atherosclerotic Disease in Manfredonia (ACADIM) Study.

  Expert opinion on pharmacotherapy 20081001

• Treatment of hyperlipidaemia with fenofibrate and related fibrates.

  Expert opinion on investigational drugs 20081001

• 5-(3-Fluoro-phen-yl)-1-phenyl-pyrazolidin-3-one.

  Acta crystallographica. Section E, Structure reports online 20081001

• Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.

  Journal of medicinal chemistry 20080925

• Rhodium-catalyzed substitution reaction of aryl fluorides with disulfides: p-orientation in the polyarylthiolation of polyfluorobenzenes.

  Journal of the American Chemical Society 20080917

• An excited state ab initio and multidimensional Franck-Condon analysis of the A (1)B2 <-- X (1)A1 band system of fluorobenzene.

  The Journal of chemical physics 20080914

• Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.

  European journal of pharmacology 20080904

• Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080901

• Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study.

  Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 20080901

• The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.

  Biological psychiatry 20080901

• An overview of the extra-lipid effects of rosuvastatin.

  Journal of cardiovascular pharmacology and therapeutics 20080901

• The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation.

  Diabetologia 20080901

• Participation of K+ channels in the endothelium-dependent and endothelium-independent components of the relaxant effect of rosuvastatin in rat aortic rings.

  Journal of cardiovascular pharmacology and therapeutics 20080901

• Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins.

  Current medical research and opinion 20080901

• Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia.

  Current medical research and opinion 20080901

• Effect of rosuvastatin on methionine-induced hyperhomocysteinaemia and haematological changes in rats.

  Basic & clinical pharmacology & toxicology 20080901

• Field evaluation of spatial repellency of metofluthrin-impregnated plastic strips against Anopheles gambiae complex in Bagamoyo, coastal Tanzania.

  Journal of the American Mosquito Control Association 20080901

• 3-(4-Fluoro-phen-yl)-2-(4-methoxy-phen-oxy)-4-oxo-5-phenyl-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile.

  Acta crystallographica. Section E, Structure reports online 20080901

• 2,4-Bis(3-fluoro-phen-yl)-3-aza-bicyclo-[3.3.1]nonan-9-one.

  Acta crystallographica. Section E, Structure reports online 20080901

• 2,4-Bis(4-fluoro-phen-yl)-3-aza-bicyclo-[3.3.1]nonan-9-one.

  Acta crystallographica. Section E, Structure reports online 20080901

• 10-(4-Chloro-phen-yl)-9-(4-fluoro-phen-yl)-3,3,6,6-tetra-methyl-3,4,6,7,9,10-hexa-hydro-acridine-1,8(2H,5H)-dione.

  Acta crystallographica. Section E, Structure reports online 20080901

• Multistate vibronic interactions in difluorobenzene radical cations. I. Electronic structure calculations.

  The Journal of chemical physics 20080821

• Multistate vibronic interactions in difluorobenzene radical cations. II. Quantum dynamical simulations.

  The Journal of chemical physics 20080821

• Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.

  European journal of pharmacology 20080820

• Substituent effects in the benzene dimer are due to direct interactions of the substituents with the unsubstituted benzene.

  Journal of the American Chemical Society 20080820

• Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.

  Journal of the American College of Cardiology 20080819

• Re-evaluating therapeutic target goals for statin-treated patients: time for revolutionary changes?

  Journal of the American College of Cardiology 20080819

• Silanol-based pincer Pt(II) complexes: synthesis, structure, and unusual reactivity.

  Inorganic chemistry 20080818

• Concurrent anion...pi interactions between a perchlorate ion and two pi-acidic aromatic rings, namely pentafluorophenol and 1,3,5-triazine.

  Chemical communications (Cambridge, England) 20080807

• Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080801

• Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis.

  Atherosclerosis 20080801

• Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy.

  Atherosclerosis 20080801

• Effect of silymarin supplement on the pharmacokinetics of rosuvastatin.

  Pharmaceutical research 20080801

• Hepatic nuclear factor 1alpha inhibitor ursodeoxycholic acid influences pharmacokinetics of the organic anion transporting polypeptide 1B1 substrate rosuvastatin and bilirubin.

  Drug metabolism and disposition: the biological fate of chemicals 20080801

• Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.

  Diabetes care 20080801

• Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan.

  Journal of clinical pharmacology 20080801

• Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.

  Diabetologia 20080801

• Potential role of statins in the treatment of heart failure.

  Current atherosclerosis reports 20080801

• Lipophilicity and cardiovascular outcome in patients with CHF.

  American heart journal 20080801

• Rosuvastatin and progression of atherosclerosis.

  Expert review of cardiovascular therapy 20080801

• Rosuvastatin: efficacy, safety and clinical effectiveness.

  Expert opinion on pharmacotherapy 20080801

• Intensive lipid intervention in the post-ENHANCE era.

  Mayo Clinic proceedings 20080801

• Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758).

  Journal of neurotrauma 20080801

• Discovery Belux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia.

  Acta cardiologica 20080801

• Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20080801

• Chlorido[6-phenyl-4-(p-tol-yl)-2,2'-bipyridyl-κN,N']platinum(II).

  Acta crystallographica. Section E, Structure reports online 20080801

• 1-Acetyl-3-(4-chloro-phen-yl)-5-(4-fluoro-phen-yl)-2-pyrazoline.

  Acta crystallographica. Section E, Structure reports online 20080801

• 1-[2-(4-Fluoro-benz-yloxy)-2-phenyl-ethyl]-1H-benzimidazole.

  Acta crystallographica. Section E, Structure reports online 20080801

• 1-[2-(3,4-Dichloro-benz-yloxy)-2-phenyl-ethyl]-1H-benzimidazole.

  Acta crystallographica. Section E, Structure reports online 20080801

• Adsorption of benzene, fluorobenzene and meta-di-fluorobenzene on Cu(110): a computational study.

  Journal of computational chemistry 20080730

• Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia.

  Swiss medical weekly 20080726

• Synthesis and biological evaluation of trisubstituted imidazole derivatives as inhibitors of p38alpha mitogen-activated protein kinase.

  Bioorganic & medicinal chemistry letters 20080715

• Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

  Journal of medicinal chemistry 20080710

• Rapid response to lipids profile and leukocyte gene expression after rosuvastatin administration in Chinese healthy volunteers.

  Chinese medical journal 20080705

• Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080701

• Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.

  Pharmacology, biochemistry, and behavior 20080701

• Method for tracking nanogel particles in vivo and in vitro.

  Biotechnology journal 20080701

• [Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)].

  Der Internist 20080701

• Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.

  Metabolism: clinical and experimental 20080701

• A multimodal, evidence-based approach to achieve lipid targets in the treatment of antiretroviral-associated dyslipidemia: case report and review of the literature.

  Pharmacotherapy 20080701

• Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study.

  Clinical therapeutics 20080701

• Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective.

  Clinical therapeutics 20080701

• Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.

  Journal of the American Geriatrics Society 20080701

• Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.

  Journal of endocrinological investigation 20080701

• Reversible acute hepatitis induced by rosuvastatin.

  Southern medical journal 20080701

• Methyl 4-[5-(4-fluoro-phen-yl)-4-(pyridin-4-yl)-1H-imidazol-2-ylsulfan-yl]butanoate.

  Acta crystallographica. Section E, Structure reports online 20080701

• 3-[5-(4-Fluoro-phen-yl)-1,3,4-thia-diazol-2-yl]-2-(4-methoxy-phen-yl)-1,3-thia-zolidin-4-one.

  Acta crystallographica. Section E, Structure reports online 20080701

• The mechanism of 1,4 alkyl group migration in hypervalent halonium ylides: the stereochemical course.

  Journal of the American Chemical Society 20080618

• Myxochelin biosynthesis: direct evidence for two- and four-electron reduction of a carrier protein-bound thioester.

  Journal of the American Chemical Society 20080618

• Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins.

  The American journal of cardiology 20080615

• Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).

  The American journal of cardiology 20080615

• Analysis of carbonyl compounds via headspace solid-phase microextraction with on-fiber derivatization and gas chromatographic-ion trap tandem mass spectrometric determination of their O-(2,3,4,5,6-pentafluorobenzyl)oxime derivatives.

  Analytica chimica acta 20080609

• Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes.

  Diabetes research and clinical practice 20080601

• Crystal structure determination of new antimitotic agent bis(p-fluorobenzyl)trisulfide.

  AAPS PharmSciTech 20080601

• The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal.

  International journal of clinical practice 20080601

• Determination of anti-tumor agent bis(p-fluorobenzyl)trisulfide and its degraded compound in rat blood using reversed phase high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080601

• Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.

  Current medical research and opinion 20080601

• The effects of aromatic anesthetics on dorsal horn neuronal responses to noxious stimulation.

  Anesthesia and analgesia 20080601

• Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin.

  Journal of cardiovascular pharmacology 20080601

• The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression.

  The Journal of invasive cardiology 20080601

• Gametogenesis in malaria parasites is mediated by the cGMP-dependent protein kinase.

  PLoS biology 20080601

• [Cardiology 2008].

  Deutsche medizinische Wochenschrift (1946) 20080601

• [Pleiotropic effects of statins].

  Revista medica de Chile 20080601

• Statin, the black box.

  Archives of cardiovascular diseases 20080601

• Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.

  Archives of cardiovascular diseases 20080601

• Prodrugs of fluoro-substituted benzoates of EGC as tumor cellular proteasome inhibitors and apoptosis inducers.

  International journal of molecular sciences 20080601

• Influence of solvent on carbene intersystem crossing rates.

  Journal of the American Chemical Society 20080521

• Scope and limitations of the SCS-MP2 method for stacking and hydrogen bonding interactions.

  Physical chemistry chemical physics : PCCP 20080521

• A versatile method for grafting polymers on nanoparticles.

  Langmuir : the ACS journal of surfaces and colloids 20080520

• Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.

  Circulation 20080513

• Van der waals and polar intermolecular contact distances: quantifying supramolecular synthons.

  Chemistry, an Asian journal 20080505

• Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization.

  Atherosclerosis 20080501

• In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin.

  Clinical and experimental pharmacology & physiology 20080501

• Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.

  The Journal of pharmacology and experimental therapeutics 20080501

• Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.

  Pharmacotherapy 20080501

• Method for stabilizing non carrier added 2-[(18)F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation.

  Nuclear medicine and biology 20080501

• I am 72, had a heart attack 16 years ago, and had angioplasty at Cleveland Clinic. My LDL was over 100 and HDL was in the low 30s. I take rosuvastatin and now my LDL is below 70, but my HDL has been driven down also, to 22. I am unable to raise HDL independent of LDL. Is it more important to control LDL below 70 and let HDL find its own level?

  Heart advisor 20080501

• Bis{4-[(Z)-(4-fluoro-benzyl-amino)(phenyl)-methyl-ene]-3-methyl-1-phenyl-1H-pyrazol-5(4H)-onato-κN,O}nickel(II).

  Acta crystallographica. Section E, Structure reports online 20080501

• (3S,4R)-4-(4-Fluoro-phen-yl)-3-(hydroxy-meth-yl)piperidinium chloride.

  Acta crystallographica. Section E, Structure reports online 20080501

• 5-Butyl-amino-6-(4-fluoro-phen-yl)-7-oxo-1-p-tolyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidine-3-carbonitrile.

  Acta crystallographica. Section E, Structure reports online 20080501

• 5,6-Dichloro-2-(2-fluoro-phen-yl)iso-indoline-1,3-dione.

  Acta crystallographica. Section E, Structure reports online 20080501

• Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers.

  Journal of acquired immune deficiency syndromes (1999) 20080415

• Lipid levels after acute coronary syndromes.

  Journal of the American College of Cardiology 20080415

• Lipid levels in the post-acute coronary syndrome setting: destabilizing another myth?

  Journal of the American College of Cardiology 20080415

• First CoMFA characterization of vesamicol analogs as ligands for the vesicular acetylcholine transporter.

  Journal of medicinal chemistry 20080410

• Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.

  Life sciences 20080409

• Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin.

  Atherosclerosis 20080401

• Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis.

  American journal of physiology. Renal physiology 20080401

• Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.

  Neuropharmacology 20080401

• Determinants of CRP level in statin-treated patients.

  Current medical research and opinion 20080401

• Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.

  Expert opinion on pharmacotherapy 20080401

• The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics.

  Current medical research and opinion 20080401

• Gynecomastia possibly induced by rosuvastatin.

  Pharmacotherapy 20080401

• Effects of rosuvastatin and pitavastatin on ischemia-induced myocardial stunning in dogs.

  Journal of pharmacological sciences 20080401

• [The CORONA study].

  Giornale italiano di cardiologia (2006) 20080401

• Clinical efficacy and safety of statins in managing cardiovascular risk.

  Vascular health and risk management 20080401

• 3-(2-Fluoro-phen-yl)-6-(phenoxy-meth-yl)-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole.

  Acta crystallographica. Section E, Structure reports online 20080401

• Improved solid-phase extraction procedure for the isolation and in-sorbent pentafluorobenzyl alkylation of polyfunctional mercaptans. Optimized procedure and analytical applications.

  Journal of chromatography. A 20080321

• N-heterocyclic carbene-catalyzed nucleophilic aroylation of fluorobenzenes.

  The Journal of organic chemistry 20080321

• Rosuvastatin in older patients with systolic heart failure.

  The New England journal of medicine 20080320

• 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.

  Bioorganic & medicinal chemistry letters 20080315

• Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.

  Atherosclerosis 20080301

• Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.

  Atherosclerosis 20080301

• A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia.

  Atherosclerosis 20080301

• The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1.

  Clinical pharmacology and therapeutics 20080301

• The effect of rosuvastatin treatment on the mean platelet volume in patients with uncontrolled primary dyslipidemia with hypolipidemic diet treatment.

  Platelets 20080301

• Quantification of pentafluorobenzyl oxime derivatives of long chain aldehydes by GC-MS analysis.

  Lipids 20080301

• Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.

  The Annals of pharmacotherapy 20080301

• Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.

  American heart journal 20080301

• Selective blockade of 5-HT2A receptors attenuates the increased temperature response in brown adipose tissue to restraint stress in rats.

  Stress (Amsterdam, Netherlands) 20080301

• Labrys portucalensis sp. nov., a fluorobenzene-degrading bacterium isolated from an industrially contaminated sediment in northern Portugal.

  International journal of systematic and evolutionary microbiology 20080301

• Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats.

  Free radical research 20080301

• An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability.

  Expert opinion on drug metabolism & toxicology 20080301

• Efficacy and safety of rosuvastatin in Taiwanese patients.

  Journal of the Chinese Medical Association : JCMA 20080301

• Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?

  Lupus 20080301

• [No reason to start treatment with statins in patients with moderate to severe heart failure].

  Nederlands tijdschrift voor geneeskunde 20080301

• [Determination of bis (p-fluorobenzyl) trisulfide and bis (p-fluoro-benzyl) disulfide in lungs of rat by HPLC].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20080301

• The year in valvular heart disease.

  Journal of the American College of Cardiology 20080219

• Total synthesis and evaluation of [18F]MHMZ.

  Bioorganic & medicinal chemistry letters 20080215

• Rosuvastatin improves basal nitric oxide activity of the renal vasculature in patients with hypercholesterolemia.

  Atherosclerosis 20080201

• Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

  Clinical pharmacology and therapeutics 20080201

• The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes.

  Atherosclerosis 20080201

• Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.

  Psychopharmacology 20080201

• Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.

  The Journal of clinical endocrinology and metabolism 20080201

• Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats.

  American journal of physiology. Heart and circulatory physiology 20080201

• Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors.

  Bioorganic & medicinal chemistry letters 20080201

• Intravenous rosuvastatin for acute stroke treatment: an animal study.

  Stroke 20080201

• Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.

  Hypertension (Dallas, Tex. : 1979) 20080201

• In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model.

  Pharmacogenetics and genomics 20080201

• Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

  The American journal of cardiology 20080201

• Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.

  The American journal of cardiology 20080201

• In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.

  Experimental and clinical psychopharmacology 20080201

• Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.

  Coronary artery disease 20080201

• Rosuvastatin: characterization of induced myopathy in the rat.

  Toxicologic pathology 20080201

• Statins in the spectrum of neurologic disease.

  Current atherosclerosis reports 20080201

• 5-(4-Fluoro-phen-yl)-2-furylmethyl N-(2,6-difluoro-benzo-yl)carbamate.

  Acta crystallographica. Section E, Structure reports online 20080201

• (E)-Ethyl 3-(2-fluoro-anilino)-2-(4-methoxy-phen-yl)acrylate.

  Acta crystallographica. Section E, Structure reports online 20080201

• 4-(4-Fluoro-phen-yl)-2-methyl-3-(1-oxy-4-pyridyl)isoxazol-5(2H)-one.

  Acta crystallographica. Section E, Structure reports online 20080201

• 2-(Dibutyl-amino)-3-(4-fluoro-phen-yl)-5,6,7,8-tetra-hydro-7-methyl-6,8-di-phenyl-pyridine-[3',4':2,3]thieno[5,4-d]pyrimidin-4(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20080201

• Reversal of pathological pain through specific spinal GABAA receptor subtypes.

  Nature 20080117

• Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia.

  European journal of pharmacology 20080114

• Quantitative determination of anti-tumor agent bis(4-fluorobenzyl)trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography.

  Journal of pharmaceutical and biomedical analysis 20080107

• Does hypercholesterolemia impair left ventricular function?

  Atherosclerosis 20080101

• Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.

  Pharmacology, biochemistry, and behavior 20080101

• Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.

  American journal of nephrology 20080101

• The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.

  Pharmacology, biochemistry, and behavior 20080101

• Isostructural materials achieved by using structurally equivalent donors and acceptors in halogen-bonded cocrystals.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20080101

• Intramolecular alkyl phosphine dehydrogenation in cationic rhodium complexes of tris(cyclopentylphosphine).

  Chemistry (Weinheim an der Bergstrasse, Germany) 20080101

• Rosuvastatin increases vascular endothelial PPARgamma expression and corrects blood pressure variability in obese dyslipidaemic mice.

  European heart journal 20080101

• Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.

  Vascular pharmacology 20080101

• CORONA--rosuvastatin in older patients with systolic heart failure.

  International journal of clinical practice 20080101

• Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy.

  European journal of heart failure 20080101

• The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.

  Journal of diabetes and its complications 20080101

• Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats.

  Sleep 20080101

• Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.

  Obesity (Silver Spring, Md.) 20080101

• Is the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) the answer to the cholesterol paradox in heart failure?

  Congestive heart failure (Greenwich, Conn.) 20080101

• [Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)].

  Kardiologiia 20080101

• Structure-activity relationship study and NMR analysis of fluorobenzoyl pentapeptide GPR54 agonists.

  Biopolymers 20080101

• CORONA, statins, and heart failure: who lost the crown?

  Angiology 20080101

• First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.

  Cardiovascular journal of Africa 20080101

• Cost-effectiveness of rosuvastatin in the prevention of ischemic heart disease in Portugal.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101

• Rosuvastatin: a review of its effect on atherosclerosis.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101

• Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation.

  Thrombosis research 20080101

• Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.

  Cardiology 20080101

• Rosuvastatin outcomes study JUPITER closes early due to evidence of benefit.

  Cardiovascular journal of Africa 20080101

• [Rosuvastatin for the treatment of dyslipidemia in HIV-infected patients receiving highly active antiretroviral therapy. Preliminary experience].

  Enfermedades infecciosas y microbiologia clinica 20080101

• Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises?

  Angiology 20080101

• Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101

• Effects of lipid-lowering therapy with rosuvastatin on atherosclerotic burden in patients with chronic kidney disease.

  Internal medicine (Tokyo, Japan) 20080101

• Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.

  Clinical drug investigation 20080101

• [Molecular mechanisms of effects of rosuvastatin on systemic oxidative stress and endogenous inflammation in patients with atherosclerosis].

  Kardiologiia 20080101

• Statin contraindicated in heart failure.

  Angiology 20080101

• Prediction of specificity-determining residues for small-molecule kinase inhibitors.

  BMC bioinformatics 20080101

• Going for gold, from Beijing to Munich, highlights from the ESC 2008 Congress: BEAUTIFUL, GISSI-HF, and potential new therapies for acute decompensated heart failure.

  Cardiovascular therapeutics 20080101

• Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.

  Cardiovascular journal of Africa 20080101

• [Influence of rosuvastatin in endothelial function and oxidative stress, in patients with acute coronary syndrome].

  Archivos de cardiologia de Mexico 20080101

• Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing.

  Perspectives in medicinal chemistry 20080101

• 3-(3-Chloro-4-methyl-phen-yl)-2-(4-fluoro-phen-yl)thia-zolidin-4-one.

  Acta crystallographica. Section E, Structure reports online 20080101

• 4-[4-(4-Fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-3-yl]-1-methyl-pyridinium iodide-4-[3-(4-fluoro-phen-yl)-2-methyl-5-oxo-2,5-dihydro-isoxazol-4-yl]-1-methyl-pyridinium iodide (0.6/0.4).

  Acta crystallographica. Section E, Structure reports online 20080101

• Fluorinated diphenylpolyenes: crystal structures and emission properties.

  The journal of physical chemistry. A 20071227

• Ionic liquids as designer solvents for nucleophilic aromatic substitutions.

  Organic letters 20071206

• Adsorption of fluorobenzene onto granular activated carbon: isotherm and bioavailability studies.

  Bioresource technology 20071201

• Rosuvastatin regulates vascular smooth muscle cell phenotypic modulation in vascular remodeling: role for the urokinase receptor.

  Atherosclerosis 20071201

• Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin.

  Clinical pharmacology and therapeutics 20071201

• Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary findings.

  Clinical science (London, England : 1979) 20071201

• Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.

  Psychopharmacology 20071201

• Pi-pi stacking tackled with density functional theory.

  Journal of molecular modeling 20071201

• Statin treatment and 3' polyadenylation of eNOS mRNA.

  Arteriosclerosis, thrombosis, and vascular biology 20071201

• The new acyl-CoA cholesterol acyltransferase inhibitor SMP-797 does not interact with statins via OATP1B1 in human cryopreserved hepatocytes and oocytes expressing systems.

  Biopharmaceutics & drug disposition 20071201

• Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.

  The American journal of cardiology 20071201

• Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.

  Journal of interventional cardiology 20071201

• Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg.

  Journal of interventional cardiology 20071201

• [Inflammation, atherosclerosis, classic cardiovascular risk factors, biostatistics, clinical significance. Where are we?].

  Revista espanola de cardiologia 20071201

• [Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia].

  Revista espanola de cardiologia 20071201

• Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.

  The American journal of managed care 20071201

• Dose-dependent effect of rosuvastatin treatment on urinary protein excretion.

  Journal of cardiovascular pharmacology and therapeutics 20071201

• A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study).

  Current medical research and opinion 20071201

• Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity.

  Vascular health and risk management 20071201

• Rosuvastatin in older patients with systolic heart failure.

  The New England journal of medicine 20071129

• Statins for ischemic systolic heart failure.

  The New England journal of medicine 20071129

• Influence of the d orbital occupation on the nature and strength of copper cation-pi interactions: threshold collision-induced dissociation and theoretical studies.

  Physical chemistry chemical physics : PCCP 20071128

• Effects of ralfinamide, a Na+ channel blocker, on firing properties of nociceptive dorsal root ganglion neurons of adult rats.

  Experimental neurology 20071101

• Behavioral response to emotional stress in rabbits: role of serotonin and serotonin2A receptors.

  Behavioural pharmacology 20071101

• Long-term efficacy and safety of rosuvastatin 40 mg in patients with severe hypercholesterolemia.

  The American journal of cardiology 20071101

• Volatile aromatic anesthetics variably impact human gamma-aminobutyric acid type A receptor function.

  Anesthesia and analgesia 20071101

• Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.

  Clinical therapeutics 20071101

• Synthesis and structure of new compounds with Zn-Ga bonds: insertion of the gallium(I) bisimidinate Ga(DDP) into Zn-X (X = CH3, Cl) and the homoleptic complex cation [Zn(GaCp*)4]2+.

  Inorganic chemistry 20071029

• Correlation of metal spin-state in alpha-diimine iron catalysts with polymerization mechanism.

  Inorganic chemistry 20071015

• Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study).

  The American journal of cardiology 20071015

• Polyfluorinated bis-styrylbenzene beta-amyloid plaque binding ligands.

  Journal of medicinal chemistry 20071004

• Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.

  Atherosclerosis 20071001

• Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study.

  Atherosclerosis 20071001

• Validation of critical points in the electron density as descriptors by building quantitative structure-property relationships for the atomic polar tensor.

  Journal of computational chemistry 20071001

• Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.

  European journal of pharmacology 20071001

• Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.

  Arteriosclerosis, thrombosis, and vascular biology 20071001

• The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates.

  ChemMedChem 20071001

• Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data.

  International journal of clinical practice 20071001

• Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study.

  Clinical therapeutics 20071001

• Infrared spectroscopy of anionic hydrated fluorobenzenes.

  The Journal of chemical physics 20070921

• Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors.

  Psychopharmacology 20070901

• Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: application to a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901

• The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin.

  The Journal of pharmacology and experimental therapeutics 20070901

• Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.

  Current medical research and opinion 20070901

• Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study.

  Kidney & blood pressure research 20070901

• Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.

  Current medical research and opinion 20070901

• Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070901

• The safety of rosuvastatin: effects on renal and hepatic function.

  Expert opinion on drug safety 20070901

• Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.

  Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20070901

• McArdle disease with rhabdomyolysis induced by rosuvastatin: case report.

  Arquivos de neuro-psiquiatria 20070901

• Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

  The American journal of geriatric pharmacotherapy 20070901

• Efforts toward expansion of the genetic alphabet: structure and replication of unnatural base pairs.

  Journal of the American Chemical Society 20070829

• Assessment of time-dependent density functional schemes for computing the oscillator strengths of benzene, phenol, aniline, and fluorobenzene.

  The Journal of chemical physics 20070828

• Coordinatively unsaturated semisandwich complexes of ruthenium with phosphinoamine ligands and related species: a complex containing (R,R)-1,2-bis((diisopropylphosphino)amino)cyclohexane in a new coordination form kappa(3)P,P',N-eta(2)-P,N.

  Inorganic chemistry 20070820

• Preventive effects of bicarbonate on cerivastatin-induced apoptosis.

  International journal of pharmaceutics 20070816

• The fluorobenzene-argon S(1) excited-state intermolecular potential energy surface.

  The journal of physical chemistry. A 20070816

• Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors.

  Bioorganic & medicinal chemistry letters 20070815

• Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.

  European journal of pharmacology 20070813

• Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.

  Journal of the American College of Cardiology 20070807

• Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice.

  Pain 20070801

• Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats.

  British journal of pharmacology 20070801

• METEOR: aiming at the stars for asymptomatic carotid artery atherosclerosis?

  International journal of clinical practice 20070801

• Effects of once weekly rosuvastatin among patients with a prior statin intolerance.

  The American journal of cardiology 20070801

• Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.

  Nuclear medicine and biology 20070801

• Ask the doctor. Are Lipitor and Crestor equally good for me?

  Harvard heart letter : from Harvard Medical School 20070801

• Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection.

  Canadian journal of physiology and pharmacology 20070801

• Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study.

  Vascular health and risk management 20070801

• Role of Rac1 GTPase activation in atrial fibrillation.

  Journal of the American College of Cardiology 20070724

• Pentafluorophenyl copper: aggregation and complexation phenomena, photoluminescence properties, and applications as reagent in organometallic synthesis.

  Dalton transactions (Cambridge, England : 2003) 20070721

• Chemical and biological effects of substitution of the 2-position of ring-expanded ('fat') nucleosides containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system: the role of electronic and steric factors on glycosidic bond stability and anti-HCV activity.

  Bioorganic & medicinal chemistry 20070715

• Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia.

  Nutrition, metabolism, and cardiovascular diseases : NMCD 20070701

• Use of Pseudomonas mendocina, or recombinant Escherichia coli cells expressing toluene-4-monooxygenase, and a cell-free tyrosinase for the synthesis of 4-fluorocatechol from fluorobenzene.

  Biotechnology letters 20070701

• Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity.

  Behavioural pharmacology 20070701

• A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.

  Clinical therapeutics 20070701

• Quantitative determination of rosuvastatin in human plasma by ion pair liquid-liquid extraction using liquid chromatography with electrospray ionization tandem mass spectrometry.

  Journal of pharmaceutical and biomedical analysis 20070628

• Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070601

• Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study).

  Atherosclerosis 20070601

• Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.

  American journal of physiology. Heart and circulatory physiology 20070601

• Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.

  British journal of pharmacology 20070601

• Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).

  The American journal of cardiology 20070601

• Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial.

  American heart journal 20070601

• Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.

  Journal of cardiovascular pharmacology 20070601

• Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion.

  International journal of clinical pharmacology and therapeutics 20070601

• Spectrophotometric determination of rosuvastatin calcium in tablets.

  Die Pharmazie 20070601

• Personalised medicine: who is an Asian?

  Lancet (London, England) 20070526

• Rosuvastatin reduces gliosis and the accelerated weight gain observed in WT and ApoE-/- mice exposed to a high cholesterol diet.

  Neuroscience letters 20070523

• Oxidative dehalogenation of perhalogenated benzenes by cytochrome P450 compound I.

  Biochemistry 20070522

• 9- and 10-Nitro-oleic acid do not interfere with the GC-MS quantitative determination of nitrite and nitrate in biological fluids when measured as their pentafluorobenzyl derivatives.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070515

• Template controlled synthesis of a coordinated [11]ane-P2C NHC macrocycle.

  Chemical communications (Cambridge, England) 20070514

• NMR and IR study of fluorobenzene and hexafluorobenzene adsorbed on alumina.

  Langmuir : the ACS journal of surfaces and colloids 20070508

• Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus.

  Biochemical pharmacology 20070501

• Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive Zygomycetes.

  FEMS microbiology letters 20070501

• Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.

  Endocrinology 20070501

• Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.

  Pharmacological research 20070501

• Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes.

  Diabetic medicine : a journal of the British Diabetic Association 20070501

• Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test.

  Behavioural pharmacology 20070501

• Statin wars: emphasis on potency vs event reduction and safety?

  Mayo Clinic proceedings 20070501

• Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.

  Mayo Clinic proceedings 20070501

• Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals.

  Current medical research and opinion 20070501

• Will drugs someday reverse CAD? Three recent advances bring the possibility closer to reality.

  Heart advisor 20070501

• Systematic studies of early actinide complexes: thorium(IV) fluoroketimides.

  Journal of the American Chemical Society 20070425

• The weak hydrogen bond in the fluorobenzene-ammonia van der Waals complex: Insights into the effects of electron withdrawing substituents on pi versus in-plane bonding.

  The Journal of chemical physics 20070421

• Use of high-sensitivity CRP to predict first cardiovascular events.

  Lancet (London, England) 20070414

• Theoretical investigation of in-plane hydrogen-bonded complexes of ammonia with partially substituted fluorobenzenes.

  The journal of physical chemistry. A 20070412

• Quantitative determination of wine polyfunctional mercaptans at nanogram per liter level by gas chromatography-negative ion mass spectrometric analysis of their pentafluorobenzyl derivatives.

  Journal of chromatography. A 20070406

• Free and bound intracellular calmodulin measurements in cardiac myocytes.

  Cell calcium 20070401

• Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis.

  Molecular pharmacology 20070401

• Quantitative analysis of thiols in consumer products on a microfluidic CE chip with fluorescence detection.

  Electrophoresis 20070401

• Hexafluorobenzene acts in the spinal cord, whereas o-difluorobenzene acts in both brain and spinal cord, to produce immobility.

  Anesthesia and analgesia 20070401

• Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats.

  The American journal of pathology 20070401

• Statins for aortic valve narrowing?

  Harvard heart letter : from Harvard Medical School 20070401

• Rosuvastatin: renal disorders and rhabdomyolysis.

  Prescrire international 20070401

• [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)].

  Annales de cardiologie et d'angeiologie 20070401

• Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.

  JAMA 20070328

• Van der Waals complexes of small molecules with benzenoid rings: influence of multipole moments on their mutual orientation.

  The journal of physical chemistry. A 20070322

• Trichlorophenol (TCP) sulfonate esters: a selective alternative to pentafluorophenol (PFP) esters and sulfonyl chlorides for the preparation of sulfonamides.

  Chemical communications (Cambridge, England) 20070314

• Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070301

• Pharmacological and computational analysis of alpha-subunit preferential GABA(A) positive allosteric modulators on the rat septo-hippocampal activity.

  Neuropharmacology 20070301

• Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).

  The American journal of cardiology 20070301

• Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.

  The American journal of cardiology 20070301

• Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.

  Expert review of cardiovascular therapy 20070301

• The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk.

  Expert review of cardiovascular therapy 20070301

• 6-(4-Fluorophenyl)-8-phenyl-2,3-dihydro-4H-imidazo[5,1-b][1,3]thiazin-4-one: an unusual [6-5] fused-ring system.

  Acta crystallographica. Section C, Crystal structure communications 20070301

• Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: baseline data from the METEOR study.

  Current medical research and opinion 20070301

• By the way, doctor. I am 80 and am taking a 40-milligram Crestor pill every day. Recently I saw a Crestor ad that said blood tests should be done to monitor for possible side effects of liver or muscle injury. Can you tell me something about those tests?

  Harvard health letter 20070301

• U.S. laboratory and field trials of metofluthrin (SumiOne) emanators for reducing mosquito biting outdoors.

  Journal of the American Mosquito Control Association 20070301

• [The efficacy and safety of rosuvastatin on treating patients with hypercholesterolemia in Chinese: a randomized, double-blind, multi-center clinical trial].

  Zhonghua xin xue guan bing za zhi 20070301

• Asymptomatic hypothyroidism and statin-induced myopathy.

  Canadian family physician Medecin de famille canadien 20070301

• Liver toxicity of rosuvastatin therapy.

  World journal of gastroenterology 20070227

• Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

  Journal of the American College of Cardiology 20070206

• Degradation of mono-fluorophenols by an acclimated activated sludge.

  Biodegradation 20070201

• 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.

  The Journal of pharmacology and experimental therapeutics 20070201

• Measuring and modelling experimental densities and ultrasonic velocities of aromatic and halogenated environmental pollutants.

  Chemosphere 20070201

• Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070201

• Rationale and design for a study using intravascular ultrasound to evaluate effects of rosuvastatin on coronary artery atheroma in Japanese subjects: COSMOS study (Coronary Atherosclerosis Study Measuring Effects of Rosuvastatin Using Intravascular Ultrasound in Japanese Subjects).

  Circulation journal : official journal of the Japanese Circulation Society 20070201

• Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.

  Journal of cardiac failure 20070201

• Myopathy caused by a combination rosuvastatin and fenofibrate.

  The Journal of the Association of Physicians of India 20070201

• Antioxidant and antiplatelet effects of rosuvastatin in a hamster model of prediabetes.

  Free radical biology & medicine 20070115

• Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry.

  Analytical chemistry 20070115

• Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.

  The American journal of cardiology 20070115

• Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070101

• Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine.

  Journal of pharmacological and toxicological methods 20070101

• Analysis of trace levels of pesticides in rainwater by SPME and GC-tandem mass spectrometry after derivatisation with PFBBr.

  Analytical and bioanalytical chemistry 20070101

• Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.

  American journal of nephrology 20070101

• [Recent and potential drugs for treatment of insomnia].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070101

• Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patients.

  Drug safety 20070101

• Statins ameliorate glomerular permeability changes in streptozotocin-induced diabetic rats.

  American journal of therapeutics 20070101

• Diabetes and metabolic syndrome (MS).

  Archives of gerontology and geriatrics 20070101

• Safety of rosuvastatin: update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program.

  Cardiology 20070101

• Evaluation of a novel tablet splitter.

  Journal of the American Pharmacists Association : JAPhA 20070101

• Analysis of steroid estrogens in water using liquid chromatography/tandem mass spectrometry with chemical derivatizations.

  Rapid communications in mass spectrometry : RCM 20070101

• A convenient catalyst system for microwave accelerated cross-coupling of a range of aryl boronic acids with aryl chlorides.

  Beilstein journal of organic chemistry 20070101

• Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.

  The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20070101

• [Treatment for dyslipidemias in patients with arterial hypertension].

  Terapevticheskii arkhiv 20070101

• Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV.

  Lipids in health and disease 20070101

• Methylene transfer from SnMe groups mediated by a rhodium(I) pincer complex: Sn-C, C-C, and C-H bond activation.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20070101

• Direct ester condensation catalyzed by bulky diarylammonium pentafluorobenzenesulfonates.

  Nature protocols 20070101

• Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients.

  Advances in therapy 20070101

• 3-Amino-4-(2-((4-[18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies.

  Bioconjugate chemistry 20070101

• Effect of medium pH on the cytotoxicity of hydrophilic statins.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20070101

• Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation.

  American journal of nephrology 20070101

• Synthesis of novel trifluoromethyl-bearing bifunctional acyl-acceptant arenes: 2,2'-bis(trifluoromethylated aryloxy)biphenyls.

  Journal of oleo science 20070101

• Rosuvastatin in elderly patients.

  Drugs & aging 20070101

• Are HIV positive patients resistant to statin therapy?

  Lipids in health and disease 20070101

• Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.

  Antiviral therapy 20070101

• [Massive lower gastrointestinal bleeding due to diverticular disease during antiplatelet therapy. Case report].

  Il Giornale di chirurgia 20070101

• Reduction of intima-media thickness in subjects with asymptomatic carotid disease: two cases from the Asymptomatic Carotid Atherosclerosis DIsease Manfredonia Study (ACADIM Study).

  La Clinica terapeutica 20070101

• Florobenzene as artificial nucleobases-base pairing and stacking interactions.

  Nucleosides, nucleotides & nucleic acids 20070101

• CORONA study highlights challenges of treating older patients with systolic heart failure.

  Cardiovascular journal of Africa 20070101

• Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for quantification of rosuvastatin in small volume human plasma samples and its application to a clinical study.

  Arzneimittel-Forschung 20070101

• [Effect of statin therapy on dynamics of vascular endothelial growth factor and fibroblast growth factor in patients with ischemic heart disease].

  Kardiologiia 20070101

• [Effect of rosuvastatin therapy and myocardial revascularization on angiogenesis in coronary artery disease patients].

  Kardiologiia 20070101

• [Influence of perindopril, rosuvastatin, or omega-3 polyunsaturated fatty acids on efficacy of antirecurrence therapy with sotalol in patients with persistent atrial fibrillation].

  Kardiologiia 20070101

• [Coronary perfusion, necrosis area, pumping function of the myocardium, and cardiac electrical stability following revascularisation of infarction-affected myocardium].

  Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery 20070101

• Ultrafast spectroscopic study of the photochemistry and photophysics of arylhalodiazirines: direct observation of carbene and zwitterion formation.

  Journal of the American Chemical Society 20061227

• Dioxygenase-catalysed dihydroxylation of arene cis-dihydrodiols and acetonide derivatives: a new approach to the synthesis of enantiopure tetraoxygenated bioproducts from arenes.

  Chemical communications (Cambridge, England) 20061221

• Effects of fluoroquinolones on HERG channels and on pancreatic beta-cell ATP-sensitive K+ channels.

  Toxicology 20061207

• Highly active antiretroviral therapy attenuates re-endothelialization and alters neointima formation in the rat carotid artery after balloon injury.

  Journal of acquired immune deficiency syndromes (1999) 20061201

• Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome.

  European heart journal 20061201

• Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.

  Psychopharmacology 20061201

• Field evaluation of spatial repellency of metofluthrin-impregnated latticework plastic strips against Aedes aegypti (L.) and analysis of environmental factors affecting its efficacy in My Tho City, Tien Giang, Vietnam.

  The American journal of tropical medicine and hygiene 20061201

• Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.

  The Journal of clinical psychiatry 20061201

• Dispersion and repulsion contributions to the solvation free energy: comparison of quantum mechanical and classical approaches in the polarizable continuum model.

  Journal of computational chemistry 20061130

• Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs.

  European journal of pharmacology 20061121

• 4-(4'-Methyltetrafluorophenyl)-2,3,5,6-tetrafluorobenzyl bromide: a new electrophoric derivatizing reagent.

  Journal of chromatography. A 20061117

• Enhancement of MALDI-MS spectra of C-terminal peptides by the modification of proteins via an active ester generated in situ from an oxazolone.

  Analytical chemistry 20061115

• Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.

  Clinica chimica acta; international journal of clinical chemistry 20061101

• Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20061101

• Simultaneous quantitation of rosuvastatin and gemfibrozil in human plasma by high-performance liquid chromatography and its application to a pharmacokinetic study.

  Biomedical chromatography : BMC 20061101

• Efficacy and safety of rosuvastatin every other day compared with once daily in patients with hypercholesterolemia.

  The Annals of pharmacotherapy 20061101

• Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia.

  Journal of clinical pharmacology 20061101

• Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.

  The American journal of managed care 20061101

• Expanding options with a wider range of rosuvastatin doses.

  Clinical therapeutics 20061101

• High-dose statins and atherosclerosis regression.

  JAMA 20061018

• High-dose statins and atherosclerosis regression.

  JAMA 20061018

• High-dose statins and atherosclerosis regression.

  JAMA 20061018

• Photodissociation dynamics of fluorobenzene (C6H5F) at 157 and 193 nm: Branching ratios and distributions of kinetic energy.

  The Journal of chemical physics 20061014

• Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats.

  Neuroscience letters 20061002

• Cardiac baroreflex facilitation evoked by hypothalamus and prefrontal cortex stimulation: role of the nucleus tractus solitarius 5-HT2A receptors.

  American journal of physiology. Regulatory, integrative and comparative physiology 20061001

• Validation of the LC-MS/MS method for the quantification of mevalonic acid in human plasma and determination of the matrix effect.

  Journal of lipid research 20061001

• Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia.

  Current medical research and opinion 20061001

• Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.

  Current medical research and opinion 20061001

• A projection of the impact of lipid-lowering therapy on high-risk employee disability and medical costs.

  Journal of occupational and environmental medicine 20061001

• Coronary atherosclerosis can regress with very intensive statin therapy.

  Cleveland Clinic journal of medicine 20061001

• Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial).

  The American journal of cardiology 20060915

• Atorvastatin for stroke prevention.

  The Medical letter on drugs and therapeutics 20060911

• Molecular pair analysis: C-H...F interactions in the crystal structure of fluorobenzene? And related matters.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20060906

• Determination of rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies.

  Biomedical chromatography : BMC 20060901

• Biodegradation of benzene and its derivatives by a psychrotolerant and moderately haloalkaliphilic Planococcus sp. strain ZD22.

  Research in microbiology 20060901

• Rhabdomyolysis associated with pomegranate juice consumption.

  The American journal of cardiology 20060901

• Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

  The American journal of psychiatry 20060901

• 4-(4-fluoro-3-phenoxyphenyl)-6-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile and the 6-(4-methylphenyl)- analogue.

  Acta crystallographica. Section C, Crystal structure communications 20060901

• Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.

  Clinical therapeutics 20060901

• I've just been diagnosed with atherosclerosis. Is there anything I can do to unclog my arteries?

  The Johns Hopkins medical letter health after 50 20060901

• Synthesis of 7-chloro-5-trifluoromethyl/7-fluoro/7-trifluoromethyl-4H-1,4-benzothiazines as antimicrobial agents.

  Bioorganic & medicinal chemistry 20060815

• Neuronal organization of the rat inferior colliculus participating in four major auditory pathways.

  Hearing research 20060801

• Short-term memory loss associated with rosuvastatin.

  Pharmacotherapy 20060801

• Critical aspects of the determination of pentafluorobenzyl derivatives of aldehydes by gas chromatography with electron-capture or mass spectrometric detection: Validation of an optimized strategy for the determination of oxygen-related odor-active aldehydes in wine.

  Journal of chromatography. A 20060728

• Asymmetric reduction of 3-aryl-3-keto esters using Rhizopus species.

  Bioorganic & medicinal chemistry 20060715

• Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.

  Cardiovascular research 20060715

• Long-term performance and microbial dynamics of an up-flow fixed bed reactor established for the biodegradation of fluorobenzene.

  Applied microbiology and biotechnology 20060701

• Micellar electrokinetic chromatography of fluorescently labeled proteins on poly(dimethylsiloxane)-based microchips.

  Electrophoresis 20060701

• Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme.

  Pharmacoepidemiology and drug safety 20060701

• Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study.

  Pharmacoepidemiology and drug safety 20060701

• The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy.

  Pharmacoepidemiology and drug safety 20060701

• Med could reverse arterial blockages.

  Health news (Waltham, Mass.) 20060701

• [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].

  MMW Fortschritte der Medizin 20060615

• Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway.

  British journal of pharmacology 20060601

• Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.

  International journal of molecular medicine 20060601

• Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.

  The American journal of cardiology 20060601

• The clinical relevance of low-density-lipoproteins size modulation by statins.

  Cardiovascular drugs and therapy 20060601

• Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study).

  Current medical research and opinion 20060601

• Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis.

  Current medical research and opinion 20060601

• Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.

  Clinical therapeutics 20060601

• Spinning stars: ASTEROID's impact on atherosclerosis.

  Lancet (London, England) 20060520

• Force field calculations for 2-amino-5-chloro- and 2-amino-5-bromo-benzotrifluorides.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20060515

• Statin therapy might be beneficial for patients with ankylosing spondylitis.

  Annals of the rheumatic diseases 20060501

• ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein.

  Drug metabolism and disposition: the biological fate of chemicals 20060501

• Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.

  Neuropharmacology 20060501

• Contrasting roles of the N-methyl-D-aspartate receptor in the production of immobilization by conventional and aromatic anesthetics.

  Anesthesia and analgesia 20060501

• An overview of statin-associated proteinuria.

  Drug discovery today 20060501

• Rosuvastatin: a safe and effective treatment for dyslipidaemia associated with non-alcoholic steatohepatitis (NASH).

  Scandinavian journal of gastroenterology 20060501

• Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II.

  American heart journal 20060501

• Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

  Gastroenterology 20060501

• Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND.

  European journal of heart failure 20060501

• ASTEROID--when spinning a star leads to a collision with reality.

  International journal of clinical practice 20060501

• Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints.

  Reviews on recent clinical trials 20060501

• Lithographic techniques and surface chemistries for the fabrication of PEG-passivated protein microarrays.

  Biosensors & bioelectronics 20060415

• Total synthesis and confirmation of the revised structures of azaspiracid-2 and azaspiracid-3.

  Angewandte Chemie (International ed. in English) 20060410

• Rosuvastatin reduces rat intestinal ischemia-reperfusion injury associated with the preservation of endothelial nitric oxide synthase protein.

  World journal of gastroenterology 20060407

• Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

  JAMA 20060405

• Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis.

  Atherosclerosis 20060401

• Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060401

• Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients.

  Diabetes research and clinical practice 20060401

• Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.

  Pharmacotherapy 20060401

• 3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart.

  Journal of cardiovascular pharmacology 20060401

• [Clinical study of the month: ASTEROID: regression of coronary atherosclerosis with rosuvastatin at a maximal daily dose of 40 mg].

  Revue medicale de Liege 20060401

• Gas chromatographic determination of amino acids via one-step phase-transfer catalytic pentafluorobenzylation-preconcentration.

  Journal of chromatography. A 20060331

• Fluorobenzene-nucleobase interactions: hydrogen bonding or pi-stacking?

  The journal of physical chemistry. A 20060330

• Hydrogen bonding of the nucleobase mimic 2-pyridone to fluorobenzenes: an ab initio investigation.

  The journal of physical chemistry. A 20060330

• Synthesis and characterization of novel lacZ gene reporter molecules: detection of beta-galactosidase activity by 19F nuclear magnetic resonance of polyglycosylated fluorinated vitamin B6.

  Journal of medicinal chemistry 20060323

• Application of microbore HPLC in combination with tandem MS for the quantification of rosuvastatin in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060307

• Novel synthesis of desymmetrized resorcinol derivatives: aryl fluoride displacement on deactivated substrates.

  The Journal of organic chemistry 20060303

• Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.

  Atherosclerosis 20060301

• Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.

  Biomedical chromatography : BMC 20060301

• Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production.

  American journal of physiology. Heart and circulatory physiology 20060301

• Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.

  The Journal of pharmacology and experimental therapeutics 20060301

• Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.

  Pharmaceutical research 20060301

• Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy.

  British journal of clinical pharmacology 20060301

• Statin-associated myasthenia gravis: report of 4 cases and review of the literature.

  Medicine 20060301

• Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.

  Journal of cardiovascular pharmacology 20060301

• Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?

  Nature clinical practice. Endocrinology & metabolism 20060301

• Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.

  Journal of medicinal chemistry 20060209

• Dissociative ion-pair formation in collisions of fast potassium atoms with benzene and fluorobenzene.

  The Journal of chemical physics 20060207

• Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.

  Atherosclerosis 20060201

• Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys.

  British journal of pharmacology 20060201

• Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.

  Behavioural pharmacology 20060201

• Statins prevent dextrose-induced endothelial barrier dysfunction, possibly through inhibition of superoxide formation.

  Diabetes 20060201

• [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].

  Presse medicale (Paris, France : 1983) 20060201

• Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

  The American journal of cardiology 20060116

• Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial.

  The American journal of cardiology 20060115

• Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients.

  Atherosclerosis 20060101

• Rosuvastatin as treatment for non alcoholic steatohepatitis (NASH) and highly active antiretroviral therapy (HAART)-dyslipidaemia: new treatment for global dangers.

  Medical hypotheses 20060101

• Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats.

  Psychopharmacology 20060101

• Statins and osteoporosis: new role for old drugs.

  The Journal of pharmacy and pharmacology 20060101

• Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.

  Pharmacology, biochemistry, and behavior 20060101

• Liquid chromatography/negative ion electrospray tandem mass spectrometry method for the quantification of fluvastatin in human plasma: validation and its application to pharmacokinetic studies.

  Rapid communications in mass spectrometry : RCM 20060101

• Suppression of thiol exchange reaction in the determination of reduced-form thiols by high-performance liquid chromatography with fluorescence detection after derivatization with fluorogenic benzofurazan reagent, 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate and 4-aminosulfonyl-7-fluoro-2,1,3-benzoxadiazole.

  Biomedical chromatography : BMC 20060101

• Synthesis and structure-activity relationship on anticonvulsant aryl semicarbazones.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20060101

• Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20060101

• [Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease].

  Kardiologiia 20060101

• [Pronounced lowering of low density cholesterol combined with elevation of high density cholesterol was associated with reduction of coronary atheroma. Results of ASTEROID trial].

  Kardiologiia 20060101

• Is rosuvastatin really a more efficient therapeutic option than atorvastatin?

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20060101

• Rosuvastatin: an independent analysis of risks and benefits.

  MedGenMed : Medscape general medicine 20060101

• How safe is aggressive statin therapy?

  Progress in cardiovascular nursing 20060101

• Analysis of rosuvatatin by imaging mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20060101

• A new approach to determine method detection limits for compound-specific isotope analysis of volatile organic compounds.

  Rapid communications in mass spectrometry : RCM 20060101

• The protective effect of rosuvastatin on ischemic brain injury and its mechanism.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101

• A fluorobenzene adduct of Ti(IV), and catalytic carboamination to prepare alpha,beta-unsaturated imines and triaryl-substituted quinolines.

  Journal of the American Chemical Society 20051228

• Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

  Synapse (New York, N.Y.) 20051215

• Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.

  Life sciences 20051212

• Molecular elimination in photolysis of o- and p-fluorotoluene at 193 nm: Internal energy of HF determined with time-resolved Fourier transform spectroscopy.

  The Journal of chemical physics 20051208

• Ab initio study of temporary anions of benzene and fluorobenzenes using the multipartitioning many-body perturbation theory.

  Physical chemistry chemical physics : PCCP 20051207

• The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051201

• A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study.

  European heart journal 20051201

• Achieving lipid goals in real life: the Dutch DISCOVERY study.

  International journal of clinical practice 20051201

• Field trial on the spatial repellency of metofluthrin-impregnated plastic strips for mosquitoes in shelters without walls (beruga) in Lombok, Indonesia.

  Journal of vector ecology : journal of the Society for Vector Ecology 20051201

• A novel approach in analyzing aromaticity by homo- and isostructural reactions: an ab initio study of fluorobenzenes.

  The journal of physical chemistry. A 20051124

• Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.

  Biochemical and biophysical research communications 20051104

• A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.

  Psychopharmacology 20051101

• Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease.

  The American journal of cardiology 20051101

• LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.

  Current medical research and opinion 20051101

• Naked (C5Me5)2M cations (M = Sc, Ti, and V) and their fluoroarene complexes.

  Journal of the American Chemical Society 20051019

• Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals.

  International journal of cardiology 20051010

• Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.

  Psychopharmacology 20051001

• Pharmacodynamic evaluation of warfarin and rosuvastatin co-administration in healthy subjects.

  European journal of clinical pharmacology 20051001

• Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats.

  Diabetes 20051001

• Ethnic differences in statin disposition.

  Clinical pharmacology and therapeutics 20051001

• Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

  Clinical pharmacology and therapeutics 20051001

• A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.

  European journal of heart failure 20051001

• Relationship of cocaine-induced c-Fos expression to behaviors and the role of serotonin 5-HT2A receptors in cocaine-induced c-Fos expression.

  Behavioral neuroscience 20051001

• [Hypolipidemic treatment under special conditions: posttransplant and/or immunosuppressive therapy].

  Arquivos brasileiros de cardiologia 20051001

• The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.

  European journal of pharmacology 20050927

• Quantitative analysis of valienamine in the microbial degradation of validamycin A after derivatization with p-nitrofluorobenzene by reversed-phase high-performance liquid chromatography.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050925

• Effects of benzodiazepines receptor agonists on the hypothalamic-pituitary-adrenocortical axis.

  European journal of pharmacology 20050920

• Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study.

  Journal of pharmaceutical and biomedical analysis 20050915

• A spectrophotometric method for the quantification of an enzyme activity producing 4-substituted phenols: determination of toluene-4-monooxygenase activity.

  Analytical biochemistry 20050915

• Protonation sites of isolated fluorobenzene revealed by IR spectroscopy in the fingerprint range.

  The journal of physical chemistry. A 20050908

• Binding thermodynamics of statins to HMG-CoA reductase.

  Biochemistry 20050906

• Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901

• Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.

  Neuropharmacology 20050901

• Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia.

  European journal of clinical investigation 20050901

• Two N-substituted 3,5-diphenyl-2-pyrazoline-1-thiocarboxamides.

  Acta crystallographica. Section C, Crystal structure communications 20050901

• Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.

  Expert opinion on pharmacotherapy 20050901

• Serotonergic regulation of calcium-activated potassium currents in rodent prefrontal cortex.

  The European journal of neuroscience 20050901

• Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).

  Current medical research and opinion 20050901

• Using Crestor--and all statins--safely. Some simple steps can help minimize or avoid muscle problems from these cholesterol-lowering drugs.

  Harvard heart letter : from Harvard Medical School 20050901

• [Pharmacological and clinical profile of rosuvastatin calcium (Crestor)].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20050901

• Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.

  The American journal of cardiology 20050822

• 5alpha-Reductase activity in Lycopersicon esculentum: cloning and functional characterization of LeDET2 and evidence of the presence of two isoenzymes.

  The Journal of steroid biochemistry and molecular biology 20050801

• The stimulus properties of LSD in C57BL/6 mice.

  Pharmacology, biochemistry, and behavior 20050801

• Effect of rosuvastatin on warfarin pharmacodynamics and pharmacokinetics.

  Journal of clinical pharmacology 20050801

• Rosuvastatin treatment protects against nitrate-induced oxidative stress.

  Journal of cardiovascular pharmacology 20050801

• Myalgia, hyper-CK-aemia, and hypocoagulability in a patient under rosuvastatin and warfarin.

  European journal of neurology 20050801

• The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.

  Current medical research and opinion 20050801

• Not all statins interfere with clopidogrel during antiplatelet therapy.

  European journal of clinical investigation 20050801

• Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients.

  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20050801

• Field evaluation of spatial repellency of metofluthrin impregnated plastic strips against mosquitoes in Hai Phong City, Vietnam.

  The American journal of tropical medicine and hygiene 20050801

• New light on statin side effects. What recent research on the cholesterol drugs means to you.

  Heart advisor 20050801

• Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.

  Brain research 20050712

• Drug induced pancreatitis might be a class effect of statin drugs.

  JOP : Journal of the pancreas 20050708

• Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.

  Circulation 20050705

• Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

  Psychopharmacology 20050701

• Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents.

  Bioorganic & medicinal chemistry letters 20050701

• Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.

  Diabetes, obesity & metabolism 20050701

• Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study.

  AIDS (London, England) 20050701

• Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.

  Pharmacology, biochemistry, and behavior 20050701

• Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.

  Current medical research and opinion 20050701

• Rosuvastatin for the treatment of hypercholesterolemia.

  Pharmacotherapy 20050701

• A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control.

  Neuroreport 20050621

• The issue of statin safety: where do we stand?

  Circulation 20050614

• The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis.

  Circulation 20050614

• Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.

  Annals of internal medicine 20050607

• Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.

  Psychopharmacology 20050601

• Abstracts of the XV International Symposium on Drugs Affecting Lipid Metabolism, 24-27 October, 2004, Venice, Italy.

  International journal of clinical practice. Supplement 20050601

• Cost effectiveness of rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US Analysis of the STELLAR Trial).

  The American journal of cardiology 20050601

• Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.

  Journal of internal medicine 20050601

• Accelerated arene ligand exchange in the (Arene)Cr(CO)2L series.

  Journal of the American Chemical Society 20050601

• Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.

  Cardiovascular research 20050601

• Rosuvastatin-acenocoumarol interaction.

  Clinical therapeutics 20050601

• Structure and binding energy of anion-pi and cation-pi complexes: a comparison of MP2, RI-MP2, DFT, and DF-DFT methods.

  The journal of physical chemistry. A 20050526

• The kinetic acidity of oligofluorobenzenes correlated with their gas phase deprotonation energies.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20050520

• Efficacy and safety of rosuvastatin in treatment of dyslipidemia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050515

• Interaction of tetraphenyl-porphyrin derivatives with DPPC-liposomes: an EPR study.

  Journal of photochemistry and photobiology. B, Biology 20050513

• Simultaneous determination of thyreostatic residues in animal tissues by matrix solid-phase dispersion and gas chromatography-mass spectrometry.

  Journal of chromatography. A 20050513

• Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).

  Journal of medicinal chemistry 20050505

• Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice.

  The Journal of pharmacology and experimental therapeutics 20050501

• Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.

  Arteriosclerosis, thrombosis, and vascular biology 20050501

• Side-chain-anchored N(alpha)-Fmoc-Tyr-OPfp for bidirectional solid-phase synthesis.

  Organic letters 20050428

• Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study.

  International journal of cardiology 20050420

• Activation of slowly conducting medullary raphe-spinal neurons, including serotonergic neurons, increases cutaneous sympathetic vasomotor discharge in rabbit.

  American journal of physiology. Regulatory, integrative and comparative physiology 20050401

• Rosuvastatin reduces experimental left ventricular infarct size after ischemia-reperfusion injury but not total coronary occlusion.

  American journal of physiology. Heart and circulatory physiology 20050401

• Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.

  American journal of physiology. Endocrinology and metabolism 20050401

• Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.

  Psychopharmacology 20050401

• Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.

  Bioorganic & medicinal chemistry letters 20050401

• Separation of single-walled carbon nanotubes on silica gel. Materials morphology and Raman excitation wavelength affect data interpretation.

  Journal of the American Chemical Society 20050330

• Measurement of urinary excretion of 5-hydroxymethyluracil in human by GC/NICI/MS: correlation with cigarette smoking, urinary TBARS and etheno DNA adduct.

  Toxicology letters 20050315

• The anti-nociceptive agent ralfinamide inhibits tetrodotoxin-resistant and tetrodotoxin-sensitive Na+ currents in dorsal root ganglion neurons.

  European journal of pharmacology 20050314

• Unusual collision-induced dissociation of fluorated and non-fluorated alpha-nitrotoluene analogs in a gas chromatograph triple-stage quadrupole mass spectrometer under electron-capturing negative-ion chemical ionization conditions.

  Journal of chromatography. A 20050304

• Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.

  Arteriosclerosis, thrombosis, and vascular biology 20050301

• Effects of a novel glutamate transporter blocker, (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA), on activities of hippocampal neurons.

  Neuropharmacology 20050301

• A multiresidue method using ion-trap gas chromatography-tandem mass spectrometry with or without derivatisation with pentafluorobenzylbromide for the analysis of pesticides in the atmosphere.

  Analytical and bioanalytical chemistry 20050301

• Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridin-(5H)ones.

  Bioorganic & medicinal chemistry 20050215

• Ultrafast dynamics in the dispersed phase of oil-in-water microemulsions: monosubstituted benzenes incorporated into dodecyltrimethylammonium bromide (DTAB) aqueous micelles.

  Langmuir : the ACS journal of surfaces and colloids 20050215

• Infrared and ab initio studies on 1,2,4,5-tetrafluorobenzene clusters with methanol and 2,2,2-trifluoroethanol: presence and absence of an aromatic C-H...O hydrogen bond.

  The journal of physical chemistry. A 20050210

• The gas phase acidity of oligofluorobenzenes and oligochlorobenzenes: about the additivity or non-additivity of substituent effects.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20050204

• Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.

  Stroke 20050201

• Isolation and properties of a pure bacterial strain capable of fluorobenzene degradation as sole carbon and energy source.

  Environmental microbiology 20050201

• Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome.

  The American journal of cardiology 20050201

• Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.

  Acta physiologica Scandinavica 20050201

• Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial.

  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20050201

• Dihydrogen complexes of electrophilic metal centers: observation of Cr(CO)5(H2), W(CO)5(H2) and [Re(CO)5(H2)]+.

  Journal of the American Chemical Society 20050126

• Synthesis of alpha-fluoro- and alpha,alpha-difluoro-benzenemethanesulfonamides: new inhibitors of carbonic anhydrase.

  Organic & biomolecular chemistry 20050121

• Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.

  The American journal of cardiology 20050115

• Rodent pharmacokinetics and receptor occupancy of the GABAA receptor subtype selective benzodiazepine site ligand L-838417.

  Biopharmaceutics & drug disposition 20050101

• Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice.

  Journal of cardiovascular pharmacology 20050101

• Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury.

  Thrombosis and haemostasis 20050101

• Review of efficacy of rosuvastatin 5 mg.

  International journal of clinical practice 20050101

• Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats.

  Pharmacological reports : PR 20050101

• Statins and the response to myocardial injury.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101

• Polymeric grafting of acrylic acid onto poly(3-hydroxybutyrate-co-3-hydroxyvalerate): surface functionalization for tissue engineering applications.

  Biomacromolecules 20050101

• [Efficacy of lipid correcting therapy with the use of rosuvastatin].

  Kardiologiia 20050101

• Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.

  Neuroscience 20050101

• Plaque composition changes on rosuvastatin treatment.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20050101

• New warning for statin drug.

  FDA consumer 20050101

• Rosuvastatin: a high-potency HMG-CoA reductase inhibitor.

  Journal of the American Pharmacists Association : JAPhA 20050101

• Determination of rosuvastatin in the presence of its degradation products by a stability-indicating LC method.

  Journal of AOAC International 20050101

• Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?

  Angiology 20050101

• [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].

  Archives des maladies du coeur et des vaisseaux 20050101

• Decreasing LDL cholesterol and medication cost with every-other-day statin therapy.

  Preventive cardiology 20050101

• Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.

  Preventive cardiology 20050101

• Synthesis and purification of fluorinated benzimidazole and benzene nucleoside-5'-triphosphates.

  Nucleosides, nucleotides & nucleic acids 20050101

• Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective.

  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20050101

• [Treatment of chronic heart failure. The time of statins?].

  Kardiologiia 20050101

• Complications and side effects. Crestor tested in PHAs.

  TreatmentUpdate 20050101

• Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1.

  Biochemical and biophysical research communications 20041217

• Development of fluorinated low temperature glassy carbon films for solid-phase microextraction.

  Journal of chromatography. A 20041210

• Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction.

  Brain research 20041203

• Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20041201

• 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants.

  The European journal of neuroscience 20041201

• Rosuvastatin and the statin wars--the way to peace.

  Lancet (London, England) 20041201

• Assessment of the efficacy of different statins in murine collagen-induced arthritis.

  Arthritis and rheumatism 20041201

• Economic evaluation of a compliance-enhancing intervention in patients with hypercholesterolemia: design and baseline results of the Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives To Achievements of LDL Goals (ORBITAL) study.

  American heart journal 20041201

• Trial of spatial repellency of metofluthrin-impregnated paper strip against Anopheles and Culex in shelters without walls in Lombok, Indonesia.

  Journal of the American Mosquito Control Association 20041201

• Rosuvastatin reduces caspase-3 activity and up-regulates alpha-secretase in human neuroblastoma SH-SY5Y cells exposed to A beta.

  Neuroscience letters 20041123

• Marked effect of aromatic solvent on unfolding rate of helical ethynylhelicene oligomer.

  Journal of the American Chemical Society 20041117

• Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect?

  JOP : Journal of the pancreas 20041110

• Molecular elimination in photolysis of fluorobenzene at 193 nm: internal energy of HF determined with time-resolved Fourier-transform spectroscopy.

  The Journal of chemical physics 20041108

• 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion.

  Psychopharmacology 20041101

• Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment.

  Journal of internal medicine 20041101

• Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.

  Expert opinion on drug safety 20041101

• Statins: can the new generation make an impression?

  Expert opinion on emerging drugs 20041101

• Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.

  Clinical therapeutics 20041101

• Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial.

  Clinical therapeutics 20041101

• ZP8, a neuronal zinc sensor with improved dynamic range; imaging zinc in hippocampal slices with two-photon microscopy.

  Inorganic chemistry 20041018

• The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.

  Journal of neurochemistry 20041001

• Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.

  Journal of neurochemistry 20041001

• Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis.

  Journal of cardiovascular pharmacology 20041001

• Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy.

  Current medical research and opinion 20041001

• Anxioselective anxiolytics: can less be more?

  European journal of pharmacology 20041001

• Safety of rosuvastatin.

  The American journal of cardiology 20041001

• Ralfinamide. Newron Pharmaceuticals.

  IDrugs : the investigational drugs journal 20041001

• Should rosuvastatin be withdrawn from the market?

  Lancet (London, England) 20041001

• Should rosuvastatin be withdrawn from the market?

  Lancet (London, England) 20041001

• Should rosuvastatin be withdrawn from the market?

  Lancet (London, England) 20041001

• Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.

  Atherosclerosis. Supplements 20041001

• A review of the efficacy of rosuvastatin in patients with type 2 diabetes.

  International journal of clinical practice. Supplement 20041001

• [Hypercholesterolemia, practical guidelines].

  Presse medicale (Paris, France : 1983) 20040925

• Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin.

  Journal of immunology (Baltimore, Md. : 1950) 20040915

• Liquid-phase microextraction of tributyltin and triphenyltin coupled with gas chromatography-tandem mass spectrometry. Comparison between 4-fluorophenyl and ethyl derivatizations.

  Journal of chromatography. A 20040903

• The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040901

• Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses.

  The Journal of pharmacology and experimental therapeutics 20040901

• Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.

  Journal of the American Society of Nephrology : JASN 20040901

• New drugs 04. Part III.

  Nursing 20040901

• The level playing field.

  Alternative medicine review : a journal of clinical therapeutic 20040901

• Rosuvastatin in the management of hyperlipidemia.

  Clinical therapeutics 20040901

• Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

  Clinical therapeutics 20040901

• Laboratory and field evaluation of spatial repellency with metofluthrin-impregnated paper strip against mosquitoes in Lombok Island, Indonesia.

  Journal of the American Mosquito Control Association 20040901

• Turbulence effects on volatilization rates of liquids and solutes.

  Environmental science & technology 20040815

• The essential role of H-F substitution in the electron-phonon interactions and electron transfer in the negatively charged acenes.

  The Journal of chemical physics 20040801

• NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20040801

• The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48.

  Acta crystallographica. Section D, Biological crystallography 20040801

• Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.

  Clinical pharmacology and therapeutics 20040801

• Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.

  European journal of heart failure 20040801

• Pharmacodynamic interaction between ezetimibe and rosuvastatin.

  Current medical research and opinion 20040801

• Rosuvastatin: new preparation. Opt for statins with evidence of efficacy on clinical outcome.

  Prescrire international 20040801

• Rosuvastatin (Crestor) and rhabdomyolysis.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20040720

• Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, 'Ecstasy') and its reversal by clozapine.

  Brain research 20040716

• Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.

  The American journal of cardiology 20040715

• Reactions of halobenzenes with methanol on the microporous solid acids hbeta, HZSM-5, and HSAPO-5: halogenation does not improve the hydrocarbon pool.

  Langmuir : the ACS journal of surfaces and colloids 20040706

• Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats.

  American journal of physiology. Regulatory, integrative and comparative physiology 20040701

• Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.

  The Journal of pharmacology and experimental therapeutics 20040701

• Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.

  American heart journal 20040701

• (R)-4-(4-fluorophenyl)-1-[2-hydroxy-2-(3-methyl-1-benzofuran-2-yl)ethyl]piperazinium chloride propan-1-ol solvate.

  Acta crystallographica. Section C, Crystal structure communications 20040701

• Safety and efficacy of rosuvastatin.

  Lancet (London, England) 20040701

• Dangers of rosuvastatin identified before and after FDA approval.

  Lancet (London, England) 20040626

• Diagnosing familial combined hyperlipidemia.

  Circulation 20040622

• Update on statins.

  Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 20040601

• Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection.

  Journal of pharmaceutical and biomedical analysis 20040528

• Fluorobenzene-argon ground-state intermolecular potential energy surface.

  The Journal of chemical physics 20040508

• Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.

  Psychopharmacology 20040501

• Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex.

  The Journal of physiology 20040501

• Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.

  Diabetes research and clinical practice 20040501

• The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.

  Clinical pharmacology and therapeutics 20040501

• Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability.

  Atherosclerosis 20040501

• Investigating cardiovascular risk reduction--the Rosuvastatin GALAXY Programme.

  Expert opinion on pharmacotherapy 20040501

• Treatment and prevention of dyslipidemia with rosuvastatin (Crestor).

  The Nurse practitioner 20040501

• Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study.

  Cardiovascular drugs and therapy 20040501

• Design of a functional protein for molecular recognition: specificity of ligand binding in a metal-assembled protein cavity probed by 19f NMR.

  Journal of the American Chemical Society 20040407

• Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.

  American heart journal 20040401

• Acute poisoning with phosphamidon: determination of dimethyl phosphate (DMP) as a stable metabolite in a case of organophosphate insecticide intoxication.

  Journal of analytical toxicology 20040401

• Two more drugs for dyslipidemia.

  The American journal of cardiology 20040315

• Rosuvastatin-warfarin drug interaction.

  Lancet (London, England) 20040313

• Pressure group urges rosuvastatin recall.

  Lancet (London, England) 20040313

• Determination of important odor-active aldehydes of wine through gas chromatography-mass spectrometry of their O-(2,3,4,5,6-pentafluorobenzyl)oximes formed directly in the solid phase extraction cartridge used for selective isolation.

  Journal of chromatography. A 20040305

• The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptive.

  British journal of clinical pharmacology 20040301

• cis-Bis[1,3-bis(2-fluorophenyl)triazenido-kappa2N1,N3]bis(pyridine-kappaN)cadmium(II).

  Acta crystallographica. Section C, Crystal structure communications 20040301

• Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia.

  Coronary artery disease 20040301

• H-Bonded complexes of adenine with Rebek imide receptors are stabilised by cation-pi interactions and destabilised by stacking with perfluoroaromatics.

  Chemical communications (Cambridge, England) 20040221

• Synthesis of cavity extended cyclotriveratrylenes.

  The Journal of organic chemistry 20040220

• The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040201

• An ab initio study of di- and trifluorobenzene-benzene complexes as relevant to carbonic anhydrase II-drug interactions.

  Journal of molecular modeling 20040201

• Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour.

  Neuropharmacology 20040201

• More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.

  Circulation journal : official journal of the Japanese Circulation Society 20040201

• Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.

  Pharmacology, biochemistry, and behavior 20040201

• An aza-steroidal [17,16-c]pyrazole derivative: 2'-(p-fluorophenyl)-17a-aza-2'H-pyrazolo[4',3':16,17]-D-homoandrost-4-en-3-one.

  Acta crystallographica. Section C, Crystal structure communications 20040201

• Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol.

  European journal of nuclear medicine and molecular imaging 20040201

• Rosuvastatin-warfarin drug interaction.

  Lancet (London, England) 20040124

• Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase.

  FEBS letters 20040102

• Metofluthrin: a potent new synthetic pyrethroid with high vapor activity against mosquitoes.

  Bioscience, biotechnology, and biochemistry 20040101

• Derivatization of tributyltin with sodium tetrakis(4-fluorophenyl)-borate for sensitivity improvement of tandem mass spectrometry.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20040101

• Is there a 'best' statin drug?

  The Johns Hopkins medical letter health after 50 20040101

• [Drug of the month. Rosuvastatin (Crestor)].

  Revue medicale de Liege 20040101

• Rosuvastatin: a review of its use in the management of dyslipidemia.

  American journal of cardiovascular drugs : drugs, devices, and other interventions 20040101

• Rosuvastatin-induced arrest in progression of renal disease.

  Cardiology 20040101

• New developments in pharmacotherapy.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101

• Approximate equivalent rosuvastatin doses for temporary statin interchange programs.

  The Annals of pharmacotherapy 20040101

• Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: the first Indian study.

  Journal of the Indian Medical Association 20040101

• Measurement of nitric oxide synthase activity in vivo and in vitro by gas chromatography-mass spectrometry.

  Methods in molecular biology (Clifton, N.J.) 20040101

• Clinical efficacy and safety of rosuvastatin in Japanese patients with heterozygous familial hypercholesterolemia.

  Journal of atherosclerosis and thrombosis 20040101

• Rosuvastatin alone or with extended-release niacin: a new therapeutic option for patients with combined hyperlipidemia.

  Preventive cardiology 20040101

• Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.

  American journal of nephrology 20040101

• Tetrafluorobenzyne thermochemistry: experiment and theory.

  European journal of mass spectrometry (Chichester, England) 20040101

• 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20031203

• Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies.

  Synapse (New York, N.Y.) 20031201

• Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia.

  The American journal of cardiology 20031201

• Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.

  Atherosclerosis 20031201

• [Diabetes and multimetabolic syndrome].

  Italian heart journal : official journal of the Italian Federation of Cardiology 20031201

• [Rosuvastatin: pharmacologic features].

  Italian heart journal : official journal of the Italian Federation of Cardiology 20031201

• [Clinical trials with rosuvastatin: efficacy and safety of its use].

  Italian heart journal : official journal of the Italian Federation of Cardiology 20031201

• [Ongoing trials and future prospects].

  Italian heart journal : official journal of the Italian Federation of Cardiology 20031201

• The statin wars.

  Lancet (London, England) 20031129

• The stain wars.

  Lancet (London, England) 20031129

• The stain wars.

  Lancet (London, England) 20031129

• The stain wars.

  Lancet (London, England) 20031129

• The stain wars.

  Lancet (London, England) 20031129

• Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product.

  Journal of medicinal chemistry 20031120

• Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.

  Circulation 20031111

• Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex.

  Bioorganic & medicinal chemistry letters 20031103

• The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism.

  Psychopharmacology 20031101

• Newer pharmaceutical agents to treat lipid disorders.

  Current cardiology reports 20031101

• Aggregation feature of fluorine-substituted benzene rings and intermolecular C-H.F interaction: crystal structure analyses of mono- and trifluoro-L-phenylalanines.

  Chemical & pharmaceutical bulletin 20031101

• Synthesis and brain regional distribution of [11C]NPS 1506 in mice and rat: an N-methyl-D-aspartate (NMDA) receptor antagonist.

  Biological & pharmaceutical bulletin 20031101

• The statin wars.

  Lancet (London, England) 20031101

• The cost-effectiveness of a new statin (rosuvastatin) in the UK NHS.

  International journal of clinical practice 20031101

• Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.

  Clinical therapeutics 20031101

• [Solid phase microextraction and derivatization of sulfide in blood with pentafluorobenzylbromide].

  Wei sheng yan jiu = Journal of hygiene research 20031101

• Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia.

  Expert review of cardiovascular therapy 20031101

• Avoid the risks of mixed medications. How to minimize dangerous interactions with cardiovascular drugs.

  Heart advisor 20031101

• The statin wars: why AstraZeneca must retreat.

  Lancet (London, England) 20031025

• Organolathanide-catalyzed regioselective intermolecular hydroamination of alkenes, alkynes, vinylarenes, di- and trivinylarenes, and methylenecyclopropanes. Scope and mechanistic comparison to intramolecular cyclohydroaminations.

  Journal of the American Chemical Society 20031015

• Rosuvastatin--a new lipid-lowering drug.

  The Medical letter on drugs and therapeutics 20031013

• Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.

  Neuropharmacology 20031001

• New drugs and dosage forms.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031001

• Rosuvastatin calcium.

  Nature reviews. Drug discovery 20031001

• Statins: how far have we come? A review of rosuvastatin.

  International journal of clinical practice. Supplement 20031001

• Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.

  Clinical therapeutics 20031001

• Cholesterol medication makes a debut in the U.S.

  Heart advisor 20031001

• Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.

  Journal of medicinal chemistry 20030925

• Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models.

  Journal of the American College of Cardiology 20030917

• Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin.

  Circulation 20030916

• Latent inhibition in 35-day-old rats is not an 'adult' latent inhibition: implications for neurodevelopmental models of schizophrenia.

  Psychopharmacology 20030901

• Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering.

  Diabetes 20030901

• In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.

  The European journal of neuroscience 20030901

• Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.

  Psychopharmacology 20030901

• High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention.

  The American journal of cardiology 20030821

• Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams.

  The American journal of cardiology 20030821

• Simultaneous determination of trace levels of nine haloacetic acids in biological samples as their pentafluorobenzyl derivatives by gas chromatography/tandem mass spectrometry in electron capture negative ion chemical ionization mode.

  Analytical chemistry 20030815

• Photodissociation dynamics of fluorobenzene.

  Journal of the American Chemical Society 20030813

• The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.

  Neuroscience letters 20030807

• A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers.

  Clinical therapeutics 20030801

• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

  The American journal of cardiology 20030715

• Reducing coronary heart disease associated with type 2 diabetes: lifestyle intervention and treatment of dyslipidaemia.

  Diabetes research and clinical practice 20030701

• Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models.

  Diabetes research and clinical practice 20030701

• Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.

  Archiv der Pharmazie 20030701

• Iminophosphorane mediated imine metathesis.

  Inorganic chemistry 20030602

• Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels.

  The American journal of cardiology 20030601

• Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin.

  Biochemical Society transactions 20030601

• Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysis.

  American heart journal 20030601

• Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo.

  Circulation 20030520

• 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

  Brain research 20030516

• Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

  Psychopharmacology 20030501

• The effect of erythromycin on the pharmacokinetics of rosuvastatin.

  European journal of clinical pharmacology 20030501

• Why do we need a statin trial in hemodialysis patients?

  Kidney international. Supplement 20030501

• 52nd Annual Scientific Session of the American College of Cardiology, Chicago, March 30-April 2, 2003.

  International journal of clinical practice 20030501

• Halophenyl furanopyrimidines as potent and selective anti-VZV agents.

  Antiviral chemistry & chemotherapy 20030501

• Separate spectroscopic detection of carbenium and fluoronium isomers of protonated fluorobenzene.

  Angewandte Chemie (International ed. in English) 20030404

• Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats.

  Journal of cardiovascular pharmacology 20030401

• Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907.

  Neuropharmacology 20030401

• Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.

  Behavioral neuroscience 20030401

• The power of statins: aggressive lipid lowering.

  Clinical cardiology 20030401

• Pharmacologic characteristics of statins.

  Clinical cardiology 20030401

• Effect of itraconazole on the pharmacokinetics of rosuvastatin.

  Clinical pharmacology and therapeutics 20030401

• Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin.

  Xenobiotica; the fate of foreign compounds in biological systems 20030401

• Eosinophil peroxidase-derived reactive brominating species target the vinyl ether bond of plasmalogens generating a novel chemoattractant, alpha-bromo fatty aldehyde.

  The Journal of biological chemistry 20030314

• Introduction: rosuvastatin--an efficacy assessment based on pooled trial data.

  The American journal of cardiology 20030306

• Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.

  The American journal of cardiology 20030306

• Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

  The American journal of cardiology 20030306

• Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.

  The American journal of cardiology 20030306

• Efficacy of rosuvastatin 10 mg in patients with the metabolic syndrome.

  The American journal of cardiology 20030306

• Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ('ecstasy') and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.

  Psychopharmacology 20030301

• Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.

  The Journal of pharmacology and experimental therapeutics 20030301

• Identification of MEK1 as a novel target for the treatment of neuropathic pain.

  British journal of pharmacology 20030301

• Statin inhibition of HMG-CoA reductase: a 3-dimensional view.

  Atherosclerosis. Supplements 20030301

• Comparative pharmacology of rosuvastatin.

  Atherosclerosis. Supplements 20030301

• Preparation of 8-Amido-2-dimethylamino-1,2,3,4-tetrahydro-2-dibenzofurans and several fluorinated derivatives via [3,3]-sigmatropic rearrangement of O-aryloximes.

  The Journal of organic chemistry 20030207

• Protonation of gas-phase aromatic molecules: IR spectrum of the fluoronium isomer of protonated fluorobenzene.

  Journal of the American Chemical Society 20030205

• Utilizing capillary gas chromatography mass spectrometry to determine 4-benzotrifluoride t-butyl ether as a reaction by-product in fluoxetine synthesized using potassium t-butoxide as base.

  Journal of pharmaceutical and biomedical analysis 20030205

• Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.

  Psychopharmacology 20030201

• Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment.

  European journal of clinical pharmacology 20030201

• An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers.

  Clinical therapeutics 20030201

• Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease.

  The American journal of cardiology 20030101

• Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects.

  British journal of clinical pharmacology 20030101

• New dimension of statin action on ApoB atherogenicity.

  Clinical cardiology 20030101

• Molecular-level investigation of monoaromatic compound sorption to suspended soil particles by deuterium nuclear magnetic resonance.

  Journal of environmental quality 20030101

• Rosuvastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia.

  Heart disease (Hagerstown, Md.) 20030101

• Determination of trace amounts of bisphenol A in urine by negative-ion chemical-ionization-gas chromatography/mass spectrometry.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20030101

• Protein kinase C is involved in clozapine's facilitation of N-methyl-D-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex.

  Neuroscience 20030101

• Measurement of 8-epi-PGF2alpha as a marker of lipid peroxidation in vivo by immunoaffinity extraction and gas chromatography-mass spectrometry.

  Methods in molecular biology (Clifton, N.J.) 20030101

• Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients.

  Cardiology 20030101

• Rosuvastatin achieves new standards in lipid management.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20030101

• [Pharmacologic characteristics of rosuvastatin, a new HMG-CoA reductase inhibitor].

  Therapie 20030101

• The effect of universal fluorinated nucleobases on the catalytic activity of ribozymes.

  Nucleosides, nucleotides & nucleic acids 20030101

• A galaxy of acronyms and GALAXY as an acronym.

  Cardiology 20030101

• Rosuvastatin receives FDA approval.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20030101

• Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.

  Current medical research and opinion 20030101

• Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials.

  BMC family practice 20030101

• New drug to lower cholesterol.

  FDA consumer 20030101

• Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia.

  Journal of atherosclerosis and thrombosis 20030101

• [New statin introduction. With more power against hypercholesterolemia].

  MMW Fortschritte der Medizin 20021212

• Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity.

  Bioorganic & medicinal chemistry 20021201

• The future direction of cholesterol-lowering therapy.

  Current opinion in lipidology 20021201

• No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteers.

  Journal of clinical pharmacology 20021201

• Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

  The American journal of pathology 20021201

• Latent inhibition is attenuated by noise and partially restored by a 5-HT2A receptor antagonist.

  Behavioural pharmacology 20021201

• Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.

  American heart journal 20021201

• Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia.

  American heart journal 20021201

• Structure of the decamethyl titanocene cation, a metallocene with two agostic C-h bonds, and its interaction with fluorocarbons.

  Journal of the American Chemical Society 20021106

• Liver-specific distribution of rosuvastatin in rats: comparison with pravastatin and simvastatin.

  Drug metabolism and disposition: the biological fate of chemicals 20021101

• Effects of fibrates on metabolism of statins in human hepatocytes.

  Drug metabolism and disposition: the biological fate of chemicals 20021101

• Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20021101

• Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers.

  British journal of clinical pharmacology 20021101

• The effect of fluconazole on the pharmacokinetics of rosuvastatin.

  European journal of clinical pharmacology 20021101

• Design, synthesis and bioactivities of novel diarylthiophenes: inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.

  Bioorganic & medicinal chemistry 20021001

• No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor.

  Journal of clinical pharmacology 20021001

• Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021001

• Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition.

  Arteriosclerosis, thrombosis, and vascular biology 20021001

• A comparison of the Low Mode and Monte Carlo conformational search methods.

  Journal of molecular graphics & modelling 20021001

• An efficient and large-scale enantioselective synthesis of PNP405: a purine nucleoside phosphorylase inhibitor.

  The Journal of organic chemistry 20020920

• Direct vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.

  Journal of the American College of Cardiology 20020918

• A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin.

  Journal of clinical pharmacology 20020901

• SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020901

• 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.

  Brain research 20020830

• High-performance liquid chromatographic method to quantify total cysteine excretion in urine.

  Analytical biochemistry 20020801

• Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity.

  Journal of neurochemistry 20020801

• Pharmacology of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins), including rosuvastatin and pitavastatin.

  Journal of clinical pharmacology 20020801

• Structure-activity relationships of 6-nitroquinazolines: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.

  Chemical & pharmaceutical bulletin 20020801

• Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat.

  Xenobiotica; the fate of foreign compounds in biological systems 20020801

• Are some statins more equal than others.

  Diabetes, obesity & metabolism 20020701

• Primary prevention: a simple, effective means of risk reduction.

  International journal of clinical practice. Supplement 20020701

• Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.

  Brain research 20020628

• 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.

  Brain research 20020607

• Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020605

• Application of a pentafluorobenzyl bromide derivatization method in gas chromatography/mass spectrometry of trace levels of halogenated phenols in air, water and sediment samples.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20020601

• 5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis.

  Cephalalgia : an international journal of headache 20020601

• Statin therapy: rationale for a new agent, rosuvastatin.

  International journal of clinical practice 20020601

• trans-Bis[3-(2-fluorophenyl)-1-(4-nitrophenyl)triazenido-kappaN3]bis(pyridine-kappaN)palladium(II).

  Acta crystallographica. Section C, Crystal structure communications 20020501

• Novel statins: pharmacological and clinical results.

  Cardiovascular drugs and therapy 20020501

• Living polymerization of ethylene catalyzed by titanium complexes having fluorine-containing phenoxy-imine chelate ligands.

  Journal of the American Chemical Society 20020403

• A substrate-unspecified glycosylation reaction promoted by copper(II) trifluoromethanesulfonate in benzotrifluoride.

  Carbohydrate research 20020402

• The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in rats.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020401

• Optimizing the pharmacology of statins: characteristics of rosuvastatin.

  Atherosclerosis. Supplements 20020401

• Polyfluoroether derivatives via nucleophilic fluorination of glyoxal hydrates with deoxofluor.

  The Journal of organic chemistry 20020322

• Coordination and oxidative addition at a low-coordinate rhodium(I) beta-diiminate centre.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20020315

• Managing dyslipidemia in the high-risk patient.

  The American journal of cardiology 20020307

• Unexpected substituent effects in offset pi-pi stacked interactions in water.

  Journal of the American Chemical Society 20020306

• Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin.

  Neurochemistry international 20020301

• Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.

  Hypertension (Dallas, Tex. : 1979) 20020301

• Synthesis and antimicrobial activity of some novel 2-(p-substituted-phenyl)-5-substituted-carbonylaminobenzoxazoles.

  Farmaco (Societa chimica italiana : 1989) 20020301

• Preparation and antibacterial activity of 3-methyl-1-p-substituted phenylpyrazole-5-thiol.

  Archiv der Pharmazie 20020301

• Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia.

  Expert opinion on investigational drugs 20020301

• Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.

  Neuropharmacology 20020201

• Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.

  The American journal of cardiology 20020201

• Abstracts from the XIV International Symposium on Drugs Affecting Lipid Metabolism. September 9-12, 2001, New York, USA.

  International journal of clinical practice. Supplement 20020201

• (3R,4S)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine: conformation and structure monitoring by vibrational circular dichroism.

  The Journal of organic chemistry 20020111

• Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020101

• Regulation of striatal neuropeptide mRNAs: effects of the 5-HT(2) antagonist SR46349B in adult rats with a neonatal 6-hydroxydopamine lesion.

  Journal of neuroscience research 20020101

• Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia.

  Expert opinion on investigational drugs 20020101

• Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

  British journal of pharmacology 20020101

• Rosuvastatin for the treatment of patients with hypercholesterolemia.

  The Annals of pharmacotherapy 20020101

• N-O glucuronidation: a major human metabolic pathway in the elimination of two novel anti-convulsant drug candidates.

  Xenobiotica; the fate of foreign compounds in biological systems 20020101

• [Kinetics and mechanism of peptide synthesis in solution].

  Bioorganicheskaia khimiia 20020101

• Gas chromatography/negative-ion chemical ionisation mass spectrometry for the quantitative analysis of morphine in human plasma using pentafluorobenzyl carbonate derivatives.

  Rapid communications in mass spectrometry : RCM 20020101

• New advances in lipid-modifying therapies for reducing cardiovascular risk.

  Cardiology 20020101

• Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study.

  Journal of atherosclerosis and thrombosis 20020101

• Rosuvastatin.

  Drugs 20020101

• Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.

  Cardiovascular drug reviews 20020101

• Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20011215

• Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.

  Brain research 20011213

• Diethyl 1-(p-fluorophenyl)-5-oxo-3-(2-thienyl)pyrrolidine-2,2-dicarboxylate.

  Acta crystallographica. Section C, Crystal structure communications 20011201

• [Lipid-lowering drugs].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20011201

• m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.

  Behavioural pharmacology 20011201

• Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study.

  Journal of cardiovascular risk 20011201

• Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex.

  Biological psychiatry 20011115

• Aliphatic and aromatic carbon-fluorine bond activation with Cp*(2)ZrH(2): mechanisms of hydrodefluorination.

  Journal of the American Chemical Society 20011107

• [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high].

  MMW Fortschritte der Medizin 20011101

• Evaluation of 7-hydroxy-flavones as inhibitors of oestrone and oestradiol biosynthesis.

  Journal of enzyme inhibition 20011101

• Rhodium-catalyzed asymmetric 1,4-addition of organoboron reagents to 5,6-dihydro-2(1H)-pyridinones. Asymmetric synthesis of 4-aryl-2-piperidinones.

  The Journal of organic chemistry 20011019

• Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20011015

• Synthesis and biological evaluations of quinoline-based HMG-CoA reductase inhibitors.

  Bioorganic & medicinal chemistry 20011001

• Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.

  Molecular pharmacology 20011001

• Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20011001

• A study of C-F...M(+) interaction: metal complexes of fluorine-containing cage compounds.

  Journal of the American Chemical Society 20010926

• Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia.

  The American journal of cardiology 20010901

• Enzymatically enantioselective hydrolysis of prochiral 1,3-diacyloxyglycerol derivatives.

  Bioscience, biotechnology, and biochemistry 20010901

• A new statin: a new standard.

  Clinical cardiology 20010801

• Therapies on the horizon for cholesterol reduction.

  Clinical cardiology 20010801

• Anxiolytic-like action of diazepam: which GABA(A) receptor subtype is involved?

  Trends in pharmacological sciences 20010801

• The discovery of linezolid, the first oxazolidinone antibacterial agent.

  Current drug targets. Infectious disorders 20010801

• DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.

  Brain research 20010713

• Rosuvastatin: do we need another statin?

  Issues in emerging health technologies 20010701

• A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid.

  British journal of pharmacology 20010601

• Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tether.

  Journal of medicinal chemistry 20010524

• Discrimination in resolving systems. VI. Comparison of the diastereomers of deoxyephedrinium and ephedrinium 4'-fluoromandelates.

  Chirality 20010515

• 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20010515

• Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.

  Synapse (New York, N.Y.) 20010501

• New therapies on the horizon.

  The American journal of managed care 20010501

• A new statin: a new standard.

  The American journal of managed care 20010501

• A study of C-F.M+ interaction: alkali metal complexes of the fluorine-containing cage compound.

  The Journal of organic chemistry 20010420

• Inhibition of the expression of inducible nitric oxide synthase and cyclooxygenase-2 in macrophages by 7HQ derivatives: involvement of IkappaB-alpha stabilization.

  European journal of pharmacology 20010420

• A novel type of nucleophilic substitution reactions on nonactivated aromatic compounds and benzene itself with trimethylsiliconide anions.

  Organic letters 20010419

• M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain.

  European journal of pharmacology 20010413

• Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.

  The Journal of pharmacology and experimental therapeutics 20010401

• [Synthesis and biological activities of new 5-HT2A selective ligands--N-substituted-piperidinyl-4-phenylthioether and sulfone derivatives].

  Yao xue xue bao = Acta pharmaceutica Sinica 20010401

• Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

  The American journal of cardiology 20010308

• Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin.

  The American journal of cardiology 20010308

• Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010301

• Morphine-induced spinal cholinergic activation: in vivo imaging with positron emission tomography.

  Pain 20010301

• Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.

  Pharmacology, biochemistry, and behavior 20010301

• [New statins under clinical development: nisvastatin and rosuvastatin].

  Nihon rinsho. Japanese journal of clinical medicine 20010301

• Monitoring of allethrin, deltamethrin, esbiothrin, prallethrin and transfluthrin in air during the use of household mosquito repellents.

  Journal of environmental monitoring : JEM 20010201

• Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.

  The Journal of comparative neurology 20010122

• 2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.

  Journal of medicinal chemistry 20010118

• M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.

  Brain research 20010105

• Cholinergic activity of aged rhesus monkeys revealed by positron emission tomography.

  Synapse (New York, N.Y.) 20010101

• New statins and new doses of older statins.

  Current atherosclerosis reports 20010101

• Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles.

  British journal of pharmacology 20010101

• Clinical rationale for rosuvastatin, a potent new HMG-CoA reductase inhibitor.

  International journal of clinical practice 20010101

• M-100907 (Aventis).

  Current opinion in investigational drugs (London, England : 2000) 20010101

• 19F NMR study on the biological Baeyer-Villiger oxidation of acetophenones.

  Journal of industrial microbiology & biotechnology 20010101

• Stacking and stability of RNA duplexes containing fluorobenzene and fluorobenzimidazole nucleosides.

  Nucleosides, nucleotides & nucleic acids 20010101

• A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.

  Journal of neural transmission (Vienna, Austria : 1996) 20010101

• Rosuvastatin--'the super statin'.

  Journal of Ayub Medical College, Abbottabad : JAMC 20010101

• Use of S-Mosher acid as a chiral solvating agent for enantiomeric analysis of some trans-4-(4-fluorophenyl)-3-substituted-1-methylpiperidines by means of NMR spectroscopy.

  Chirality 20010101

• Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.

  Synapse (New York, N.Y.) 20001215

• 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.

  Pharmacology, biochemistry, and behavior 19990601

• Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.

  British journal of pharmacology 19990201

• Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine.

  Life sciences 19970101

• Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis.

  Anesthesia and analgesia 19961101

• Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.

  The Journal of pharmacology and experimental therapeutics 19951101

• Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist.

  Journal of clinical pharmacology 19870101

• Antiarrhythmic activity of flestolol, a novel ultra-short-acting beta-adrenoceptor antagonist, in the dog.

  European journal of pharmacology 19861112

• Tolerance and beta-adrenergic blocking activity of flestolol, a short-acting beta blocker.

  Clinical pharmacology and therapeutics 19860501

• Flestolol: an ultra-short-acting beta-adrenergic blocking agent.

  Journal of clinical pharmacology 19860301